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Oncogenic transformation, the gradual change of a normal cell into a cancerous cell, 
requires sequential alterations in several cellular processes and involves both activation 
of oncogenic pathways and inhibition of tumor suppressor pathways (reviewed by 
Hanahan and Weinberg, 2000). The retinoblastoma (pRB) pathway is a well known tumor 
suppressor pathway that is deregulated in the majority of (human) cancers (reviewed 
by Burkhart and Sage, 2008; Sherr, 1996). pRB and its two close homologs, p107 and 
p130, comprise the family of so-called pocket proteins and are essential for regulation 
of the cell cycle, differentiation and apoptosis. This thesis focuses on the role of the 
retinoblastoma proteins in tumor suppression: we have identified events that  collaborate 
with pocket protein ablation during in vitro transformation and we have studied the role 
of the interaction between pRB and proteins containing an LxCxE motif during cell cycle 
arrest and tumor suppression.
The mammalian cell cycle and regulation by cyclin-cdk complexes
The mammalian cell cycle generates two virtually identical daughter cells and can be 
divided into four sequential phases: G1, S, G2 and M phase. DNA duplication occurs in the 
Synthesis or S phase, whereas chromosome segregation and cell division occur in Mitosis 
or M phase. G1 and G2 comprise gap phases, during which both stimulatory and inhibitory 
signals of proliferation are integrated into the cell cycle machinery, resulting in cell cycle 
progression or arrest in G1 or G2 phase. Cells that are withdrawn from the cell cycle, for 
example during serum starvation or differentiation, are defined to be in G0. 
Progression through the cell cycle is driven by different cyclin-cdk complexes 
(Fig. 1). Full activation of cyclin dependent kinases, cdks, requires both binding to a 
cyclin protein and phosphorylation by a cyclin activating kinase, CAK. The expression 
and nuclear localization of cyclins fluctuates during the cell cycle, resulting in the 
timed activation of different cyclin-cdk complexes. During early G1, Cyclin D-CDK4/6 
complexes are activated, followed by Cyclin E-CDK2 complexes at the G1/S transition 
and Cyclin A-CDK1/2 complexes during S phase. Cyclin B1-CDK1 complexes enter the 
nucleus at the G2/M transition, and are, together with Cyclin A-CDK1 complexes, required 
for G2/M transition. Cyclin B1-CDK1 is subsequently required for M phase progression 
(Katsuno et al., 2009; Ciemerych and Sicinski, 2005; Sherr and Roberts, 2004; Pines 
and Hunter, 1992). The activity of cyclin-cdks is inhibited by the family of inhibitors of 
cdk4 (INK4) proteins, which inhibit Cyclin D-CDK4/6 kinase activity, and by the family 
of cdk-interacting protein/ kinase-inhibitory protein (CIP/KIP) proteins, which inhibit 
CDK1- and CDK2-associated kinase activities. Notably, the CIP/KIP proteins play a 
stimulatory role in the activation of Cyclin D-CDK4/6 complexes (reviewed by Berthet 
and Kaldis, 2007; Ciemerych and Sicinski, 2005; Sherr and Roberts, 1999). 
The pocket proteins play a key role in cell cycle regulation by maintaining the 
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Interaction of E2Fs and pocket proteins in the cell cycle 
An important function of the pocket proteins in G1 consists of binding and inhibiting 
the family of E2F transcription factors, which are essential for S phase entry. The E2F 
transcription factor family consists of at least 11 members and is classically divided into 
activator E2Fs (E2F1, E2F2 and E2F3a) and repressor E2Fs (E2F3b, E2F4, E2F5, E2F6a, 
E2F6b, E2F7a, E2F7b and E2F8). E2F1-6 require the interaction with a DP protein for 
proper binding to the DNA (reviewed by DeGregori and Johnson, 2006). The division 
between ‘activator’ and ‘repressor’ E2Fs is not black and white. The E2F3b, E2F4 and 
E2F5 ‘repressors’ contain a transcriptional activation domain (reviewed by Dimova and 
Dyson, 2005), and both E2F3b and E2F4 have been shown to function as transcriptional 
activators (Chong et al., 2009a; Tsai et al., 2008; Kinross et al., 2006; Wu et al., 2001; 
Muller et al., 1997). Additionally, the ‘activator’ E2Fs were recently shown to perform a 
‘repressor’ function as well (Sahin and Sladek, 2010; Chong et al., 2009b).
G0/G1 state in the absence of proliferative stimuli. Under growth stimulating conditions, 
Cyclin D-CDK4/6 and Cyclin E-CDK2 complexes phosphorylate the pocket proteins in 
G1, which causes pocket protein inactivation and subsequent S phase entry (reviewed by 
Cobrinik, 2005).
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Figure 1: Schematic representation of the mammalian cell cycle. Progression through the cycle is driven 
by the activity of Cyclin-CDK complexes. The pocket proteins, pRB, p107 and p130, play an inhibitory role 
during G1, which can be reverted by the activity of CyclinD-CDK4/6 and CyclinE/A-CDK2 complexes.
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The importance of E2Fs in S phase induction was first of all demonstrated by 
the presence of E2F-binding sites in various genes encoding proteins involved in DNA 
replication and cell cycle progression, such as PCNA, DNA polymerase α, Cyclin E and 
Cyclin A (reviewed by Lavia and Jansen-Durr, 1999). In line with this, ectopic expression 
of E2F1, -2, or -3 drove quiescent cells into S phase (DeGregori et al., 1997; Lukas et 
al., 1996; Johnson et al., 1993). Conversely, fibroblasts deficient for E2F1, -2 and -3 were 
unable to proliferate in culture and displayed impaired induction of several, but not all, 
E2F target genes (Wu et al., 2001). E2Fs have also been suggested to function beyond 
S phase, as they bind and regulate promoters of genes involved in DNA repair, DNA 
damage checkpoints, chromatin assembly and condensation, chromosome segregation, 
the mitotic spindle checkpoint, differentiation, development and apoptosis (Ren et al., 
2002; Muller et al., 2001).
 The different members of the pocket protein family interact with the different 
E2Fs with varying affinities: pRB interacts with E2F1-4 (Moberg et al., 1996; Lees et 
al., 1993), whereas p130 and p107 interact with E2F4 and E2F5. E2F6 and E2F7 do 
not interact with the pocket proteins, as they lack the pocket protein binding domain 
(reviewed by Dimova and Dyson, 2005; Frolov and Dyson, 2004). It should be noted that 
the identity of the pocket protein-E2F complexes can shift upon ablation of components, 
as combined depletion of pRB and E2F4 promoted binding of p130 and p107 to E2F1 and 
E2F3 (Lee et al., 2002). 
Both the presence and promoter binding of the different pocket protein-E2F 
complexes fluctuates during the cell cycle. During G0/G1, E2F4 was found to primarily 
complex with p130 and to a lower extent with pRB and p107. At this stage E2F4, p130 
and p107 were detected at the promoter regions of repressed E2F target genes. At the 
G1/S transition, E2F4-p130 complexes were replaced by E2F4-p107 and E2F4-pRB 
complexes. Simultaneously, free E2Fs, not in complex with pocket proteins, became 
visible. Moreover, E2F1-3 were detected at the promoter regions of E2F target genes, 
which correlates with the induction of transcription (Macaluso et al., 2006; Balciunaite et 
al., 2005; Rayman et al., 2002; Takahashi et al., 2000; Hurford, Jr. et al., 1997; Moberg et 
al., 1996; Cobrinik et al., 1993).
Transcriptional repression and silencing via the pRB-LxCxE interaction
Pocket proteins can inhibit E2F-mediated transcription in several ways (Fig. 2). First, 
pocket protein binding masks the E2F transactivation domain, abrogating its activity. 
Second, pocket proteins can simultaneously bind to both E2Fs and chromatin remodeling 
proteins, resulting in the recruitment of these remodeling proteins to E2F-regulated 
promoters (reviewed by Dick, 2007). Thus, the transactivation function of the activators 
E2Fs 1, 2 and 3a can be inhibited by pRB binding, whereas pocket protein-E2F-chromatin 
Chapter 1
12
remodeling complexes, which promote a chromatin state incompatible with transcription, 
can be formed by pRB-E2F3b, pRB-E2F4, p130/p107-E2F4 and p130/p107-E2F5. 
Various chromatin remodeling proteins that have been associated with 
transcriptional repression, contain an ‘LxCxE like’ motif through which they can bind 
to pRB and to the other pocket proteins. Among LxCxE-containing proteins are Class 
I histone deacetylases (HDACs), heterochromatin protein 1 (HP1), brahma (BRM) and 
brahma-related gene 1 (BRG1) ATPases of the mating-type switch (SWI)/sucrose non-
fermenting (SNF) nucleosome remodeling complex, the C-terminal binding protein 
(CtBP)/CtBP-interacting protein (CtIP) co-repressor, the retinoblastoma binding proteins 
RBP1 and RBP2, and possibly others (reviewed by Dick, 2007).
The interaction between pocket proteins  and HDACs in transcriptional repression
The three pocket proteins interact with Class I HDACs, which include HDAC1, 2 and 
3. Since de-acetylated chromatin is more condensed and therefore less accessible to 
transcription factors than acetylated chromatin, the recruitment of HDACs to the promoter 
region is considered to actively repress transcription. HDAC1 and HDAC2 both contain 
an LxCxE-like motif, which is required for formation of pRB-HDAC1/2 and p107-
HDAC1 complexes: mutating the LxCxE-like sequence in HDAC1 abrogated binding to 
pRB/p107 and additionally, mutating the LxCxE binding site in pRB abrogated binding 
to HDAC1/2 (Chen and Wang, 2000; Dahiya et al., 2000; Ferreira et al., 1998; Magnaghi-
Jaulin et al., 1998). Although these observations are suggestive for direct binding between 
Figure 2: Model showing the role of E2Fs and pocket proteins in transcriptional regulation of E2F-
target genes. Binding of  ‘activator’ E2Fs (E2F1-3a) to an E2F element in the promoter region induces 
transcriptional activation (upper picture, visualized by the bold arrow). E2F-mediated transactivation 
can be inhibited via binding of pocket proteins to the transactivation domain of E2Fs (lower left). Active 
repression of E2F-target genes is achieved via the recruitment of complexes containing ‘repressor’ E2Fs 
(E2F3b-5), pocket proteins and chromatin remodeling proteins (lower right). Note that E2F4 and E2F3b, 
which are generally viewed as ´repressor´ E2Fs, can also function in transactivation and that complexes 
between pRB and the E2F1-3a ‘activators’ can also repress transcription of E2F target genes.
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pRB/p107 and HDACs, experiments performed by Lai and co-workers indicated that 
this interaction requires bridging by the LxCxE-containing protein RBP1. In a similar 
way, RBP1 could possibly enable binding of pocket proteins to HDAC3, which lacks an 
LxCxE-like motif (Lai et al., 2001; Lai et al., 1999). Importantly, pRB-, p107- or p130-
mediated repression of E2F-inducible reporter constructs could (partially) be relieved 
by the HDAC inhibitor Trichostatin A (TSA). Additionally, pRB-mediated repression of 
several endogeneous E2F target genes was sensitive to TSA treatment, indicating that 
pocket protein-mediated repression indeed involves HDACs (Siddiqui et al., 2003; Chen 
and Wang, 2000; Dahiya et al., 2000; Brehm et al., 1998; Ferreira et al., 1998; Luo et al., 
1998; Magnaghi-Jaulin et al., 1998). 
Furthermore, various groups have demonstrated binding of pocket proteins, 
HDACs and/or E2Fs to repressed promoters in vitro: pRB and HDAC1 were recruited 
to the repressed Cyclin E promoter in serum-starved fibroblasts (Morrison et al., 2002), 
pRB, p130 and HDAC1 were recruited to the Cyclin E promoter in p16INK4A-arrested 
U2OS cells (Dahiya et al., 2001) and p107, p130, E2F4, HDAC1 and mSin3B were 
recruited to several E2F-regulated promoters in mouse embryonic fibroblasts arrested in 
G0 (Rayman et al., 2002). Notably, TSA treatment relieved repression of Cyclin E under 
serum starved conditions (Morrison et al., 2002). Furthermore, Rayman and colleagues 
(2002) demonstrated that combined ablation of p107 and p130 caused de-repression and 
loss of recruitment of E2F4, HDAC1 and mSin3B to the E2F-regulated B-Myb promoter. 
However, for most E2F promoters tested, p107 and p130 ablation caused de-repression 
and loss of recruitment of E2F4 and HDAC1, but not mSin3B. This implicates that p107/
p130-E2F4-HDAC and p107/p130-E2F4-mSin3B-HDAC1 complexes are involved in 
repression of different E2F-target genes. In conclusion, a great body of evidence points to 
the involvement of complexes containing pocket proteins and HDACs in transcriptional 
repression. 
 
The interaction between pocket proteins and Histone Methyl Transferases (HMTases) in 
transcriptional repression and silencing
The site in pRB that binds to the LxCxE motif has also been suggested to mediate binding 
to the Suv39h1 HMTase and to HP1. Suv39h1 specifically methylates Lysine 9 of Histone 
3, H3K9 (Rea et al., 2000), which creates a binding site for the heterochromatin protein 
HP1 (Lachner et al., 2001). Both H3K9 tri-Methylation (H3K9-triM) and the presence 
of HP1 are characteristics of transcriptionally inactive heterochromatin, suggesting a role 
for pRB in gene silencing via recruitment of these proteins. 
All three pocket proteins can bind Suv39h1 and contain HMTase activity 
when immunoprecipitated from nuclear extracts. In reporter assays, Suv39h1 enhanced 
repression by pRB, p107 or p130, indicating that recruitment of Suv39h1 can be involved 
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in pocket protein-mediated repression (Nicolas et al., 2003; Nielsen et al., 2001; Vandel 
et al., 2001). Interestingly, in MEFs, pRB was required for the recruitment of HP1 and 
methylated H3K9 to the Cyclin E promoter, indicating the involvement of both HP1 and 
Suv39h1 in pRB-mediated transcriptional repression of Cyclin E (Nielsen et al., 2001). 
In overexpression studies, the pRB-Suv39h1 and p107-Suv39h1 interaction could be 
inhibited by an LxCxE-containing peptide, indicating the involvement of the LxCxE 
binding site of pocket proteins in contacting Suv39h1 (Nicolas et al., 2003; Vandel et 
al., 2001). Additionally, HMTase activity of pulled down GST-pRB could be inhibited 
by an LxCxE-containing competitor peptide during precipitation (Nielsen et al., 2001). 
However, no LxCxE-like sequence has been detected in Suv39h1 (Vandel et al., 2001), 
suggesting that the interaction is indirect, and might for example involve the LxCxE-
containing protein HP1. Indeed, pRB, Suv39H1 and HP1 bound simultaneously to a 
peptide mimicking methylated H3K9 (Nielsen et al., 2001). Additionally, pRB, HP1 and 
methylated H3K9 were detected at the Cyclin A and PCNA  promoters in RASV12-induced 
senescent cells (Narita et al., 2003). It should be noted that p107, immuno-precipitated 
from Suv39h1-/-Suv39h2-/- double knockout MEFs still contained HMTase activity, 
pointing to the involvement of an HMTase other than Suv39h1/h2. Indeed, ectopically 
expressed p107 could interact with the EMT1 HMTase, that is also known to specifically 
methylate H3K9 (Nicolas et al., 2003). To further complicate matters, Suv39h1 can 
interact with HDAC1, 2 and 3. Moreover, Suv39h1-mediated repression involved HDAC 
activity and Suv39h1 could only methylate H3K9 when this residue was not acetylated 
(Vaute et al., 2002; Rea et al., 2000), suggesting a cooperation between pRB, Suv39h1, 
HDACs and HP1 in silencing.
 In line with the involvement of pocket proteins in recruiting HMTases to the 
chromatin, Gonzalo and co-workers (2005) showed that pocket protein-deficient MEFs 
displayed reduced H4K20-triM in both centromeric and telomeric heterochromatin. No 
defects in H3K9-triM could be detected in this study, although a recent study reported a 
mild reduction in total H3K9-triM upon acute pRB loss (Siddiqui et al., 2007). H4K20-
triM is performed by the Suv4-20h1 and -h2 HMTases (Schotta et al., 2004), which can 
bind pRB, p107 and p130 (Isaac et al., 2006; Gonzalo et al., 2005). Strikingly, disruption 
of E2F-pocket protein complexes in wild-type MEFs did not abrogate H4K20-triM 
(Gonzalo et al., 2005), suggesting that H4K20-triM is dependent on pocket proteins, but 
independent of E2Fs. 
Similar to pocket protein-deficient MEFs, MEFs expressing a pRB mutant 
deficient in binding LxCxE-containing proteins also displayed aberrant patterns of 
H4K20-triM in the heterochromatin. Surprisingly, the mutant pRB protein, defective in 
binding LxCxE-containing proteins, could still interact with Suv4-20h1/h2 HMTases 
(Isaac et al., 2006). Additionally, ectopically expressed Suv4-20h1/h2 was correctly 
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targeted to the chromatin in pocket protein-deficient MEFs and was able to rescue 
H4K20-triM (Gonzalo et al., 2005). The latter results argue against a role for the pocket 
proteins in recruiting Suv4-20h1/h2 to the chromatin. However, ablation of the LxCxE-
binding site in pRB did cause aberrant patterns of H4K20-triM (Isaac et al., 2006). This 
could imply that an LxCxE-containing protein is recruited to the chromatin by pRB and is 
required for stabilization of Suv4-20h1/h2 and subsequent induction of HMTase activity. 
Upon overexpression of Suv4-20h1/h2, this stabilization would not be required to obtain 
sufficient levels of HMTase activity. Alternatively, one can envision that, in addition to 
Suv4-20h1/h2, a yet unidentified LxCxE-containing HMTase is responsible for the pRB-
dependent methylation of H4K20. 
In conclusion, whereas the pocket protein-LxCxE interaction has been implicated 
in silencing via the establishment of heterochromatic marks, the exact mechanism remains 
obscure and might involve yet unspecified proteins.
The interaction of pocket proteins with the CtIP/CtBP and SWI-SNF complexes in 
transcriptional repression
The pocket proteins also interact with the CtBP/CtIP repressor complex. CtBP functions 
as a transcriptional repressor via binding and inhibiting several transcriptional factors, 
whereas CtIP interacts with CtBP and probably enhances repression (reviewed by Wu 
and Lee, 2006). Both pRB and p130 were reported to bind CtIP, and additionally, pRB 
was reported to bind CtBP (Dahiya et al., 2001; Meloni et al., 1999). CtBP/CtIP have 
been suggested to repress transcription in both an HDAC-dependent and -independent 
manner. HDAC independently, CtBP/CtIP is possibly involved in pocket protein-
mediated repression of Cyclin A and Cdk1 via recruitment of polycomb group proteins 
(Chinnadurai, 2002; Dahiya et al., 2001). CtIP contains an LxCxE sequence and deletion 
of the LxCxE and neighbouring sequence disrupted CtIP-p130 binding (Meloni et al., 
1999). Additionally, a pRB protein deficient in binding LxCxE-containing proteins, could 
no longer interact with CtBP1, indicating the involvement of the LxCxE binding site in 
contacting the CtBP/CtIP co-repressor (Isaac et al., 2006).
In addition, pRB interacts with the BRG1 and BRM ATPases of the SWI-SNF 
nucleosome remodeling complex (Dahiya et al., 2001; Strober et al., 1996; Singh et al., 
1995). The SWI-SNF complex is thought to function in both transcriptional activation and 
repression. Also, complex formation between p107 and BRG1, p107 and BRM and, to a 
lower extent, p130 and BRG1 was demonstrated in a yeast two-hybrid system (Strober et 
al., 1996). Both BRG1 and BRM1 contain an LxCxE sequence and deletion of the LxCxE 
plus the neighbouring sequence in BRG or BRM1 ablated formation of pRB-BRG1, 
pRB-BRM, p107-BRG1 and p107-BRM complexes (Strober et al., 1996; Singh et al., 
1995; Dunaief et al., 1994). LxCxE-mediated binding was, however, strongly questioned 
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by the observation that a pRB protein with a mutated LxCxE binding site was still able to 
bind BRG1, although unable to bind HDAC1 or HDAC2 (Dahiya et al., 2000; Zhang et 
al., 2000). An indication for the involvement of BRG1 in pRB-mediated repression was 
provided by the observation that dominant-negative BRG1 counteracted pRB-mediated 
repression of the E2F-target gene Cyclin A (Siddiqui et al., 2003). Additionally, repression 
of the polo-like kinase 1 gene by pRB depended on SWI/SNF activity, and could be 
reversed by TSA (Gunawardena et al., 2004). Since a tri-molecular complex containing 
BRG1, pRB and HDAC1 could be formed upon ectopic expression of these proteins 
(Zhang et al., 2000), this again points to an interplay of various chromatin remodeling 
activities during pRB-mediated transcriptional repression.
 
Extra-cellular signaling to the cell cycle machinery extends beyond G1/S
As described above, pocket proteins function in inhibiting E2F target gene expression, 
which involves the recruitment of LxCxE-containing proteins. The pocket proteins are 
active during G1, where they function as effectors of various extra-cellular stimuli to 
induce cell cycle progression under growth stimulating conditions, and conversely, 
to inhibit cell cycle progression under growth restricting conditions. Well-known 
examples of extra-cellular stimuli are signaling from the extra-cellular matrix (ECM) 
to the cell via integrin receptors, growth factor stimulation via Receptor Tyrosine 
Kinases (RTKs), or cell-cell signaling, which induces contact inhibition. Classically, 
extra-cellular signaling was suggested to convey the decision between proliferation or 
arrest during the G1 phase, specifically, before the Restriction point in mid G1 (Pardee, 
1974). However, our recent results have indicated that external stimuli can also interfere 
with cell cycle progression beyond S phase, i.e., independently of pocket proteins. 
Requirements for anchorage-induced signaling during G1/S progression  
Untransformed cells require combined signaling via anchorage and growth factors 
to stimulate cell cycle progression. Signaling via anchorage is mediated by integrin 
receptors, whereas growth factor signaling is mediated by RTKs.
Integrins are transmembrane glycoproteins that are composed of an α and β 
subunit and mediate binding between the ECM and the cell. Contact with the ECM induces 
integrin clustering at defined places (focal contacts or focal adhesions) and induces a 
signaling cascade in the cell that promotes proliferation. In addition, the cytoplasmic part 
of the integrin receptor binds to the actin cytoskeleton, which influences cell shape and 
migration (reviewed by Hood and Cheresh, 2002).
Integrins and RTKs cooperate to stimulate cell cycle progression by simultaneously 
inducing the RAS/RAF/MEK/ERK pathway. Integrin stimulation probably converges 
at different points in this pathway, as both RAS-dependent and RAS-independent 
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stimulation of ERK was reported upon adhesion-induced stimulation. Upstream in the 
pathway, integrins have been suggested to enhance activation of the RAS/RAF/MEK/
ERK pathway by inducing RTK-mediated signaling. This occurs via both association 
of integrins with RTKs and via inducing the presence of certain RTKs. Downstream, 
integrins were reported to stimulate transport of activated ERK into the nucleus (Aplin et 
al., 2002; Aplin et al., 2001; Schwartz and Assoian, 2001). 
Adhesion and growth factors are simultaneously required for the induction of 
Cyclin D1 protein and of Cyclin D1-associated kinase activity via the RAS/RAF/MEK/
ERK pathway. Although the RAS pathway could be stimulated by the individual actions 
of either integrins or RTKs, combined stimulation was required to induce sufficiently high 
levels of activated ERK to induce Cyclin D1 (Roovers and Assoian, 2000; Roovers et al., 
1999). In addition to inducing Cyclin D1-associated kinase activity, integrin signaling 
promoted the proteosomal degradation of the cdk-inhibitors p21CIP1 and p27KIP1 (Bao et 
al., 2002), which led to a rise in Cyclin E/A-CDK2 kinase activity. Together, the induced 
Cyclin D-CDK4/6 and Cyclin E/A-CDK2 kinase activities promote phosphorylation of 
the pocket proteins and entry into S phase.
Conversely, detachment from the ECM caused downregulation of Cyclin D1, 
via both inhibition of Cyclin D1 transcription and inhibition of protein translation (Zhu et 
al., 1996). Additionally, the cdk inhibitors p21CIP1 and p27KIP1 were induced upon loss of 
anchorage. Since integrin signaling promoted proteosomal degradation of these inhibitors 
(Bao et al., 2002), the absence of integrin signaling likely stabilizes p21CIP1 and p27KIP1 
via inhibition of proteosomal degradation. Additionally, loss of anchorage induced p21CIP 
at the transcriptional level, possibly via activation of p53 (Wu and Schonthal, 1997). 
Importantly, cells cultured in the absence of anchorage displayed increased association 
of p21CIP1 and p27KIP1 with Cyclin E/A-CDK2 complexes, which correlated with 
downregulation of CDK2 kinase activity. As a result, cells cultured without anchorage 
contain active, hypo-phoshorylated pRB and arrest in the G1 phase of the cell cycle (Wu 
and Schonthal, 1997; Fang et al., 1996; Zhu et al., 1996; Guadagno et al., 1993).
Anchorage signaling beyond S phase; requirements for transformation of pocket protein 
deficient MEFs
Consistent with a role for pocket proteins in G1 arrest upon loss of anchorage, ablation of 
pocket proteins in MEFs bypassed G1 arrest under non-adherent conditions. Additionally, 
pocket protein-deficient MEFs bypassed G1 arrest induced by prolonged culturing, 
expression of RASV12, cell-cell contact, growth factor depletion and DNA damage (Foijer 
et al., 2005; Dannenberg et al., 2004; Peeper et al., 2001; Dannenberg et al., 2000; Sage 
et al., 2000). Specifically, MEFs deficient for pRB and p107, pRB and p130 (double 
knockout, DKO MEFs) or all three pocket proteins (triple knockout, TKO MEFs) were 
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refractory to both replicative senescence and senescence induced by constitutively active 
RAS, RASV12, demonstrating the crucial role of pocket proteins in G1 control (Dannenberg 
et al., 2004; Peeper et al., 2001; Dannenberg et al., 2000; Sage et al., 2000). 
In line with the integrin-dependent induction of the RAS pathway, we have 
found that expression of RASV12 was required for anchorage-independent growth of 
DKO or TKO MEFs (Vormer et al., 2008, Chapter 2). Interestingly, RASV12 expression 
was not sufficient to induce anchorage-independent growth of these MEFs, but required 
additional events. Chapters 2 and 3 of this thesis focus on the additional requirements 
for anchorage-independent growth of pocket protein-deficient MEFs. In Chapter 2, we 
show that dependent on the level of pocket proteins, loss of adhesion induced both G1 and 
G2 arrest, demonstrating that anchorage signaling is required for cell cycle progression 
beyond S phase. Similarly, we have previously shown that serum stimulation was required 
beyond S phase (Foijer et al., 2005). Our present results show that a combination of pocket 
protein loss and either TBX2 overexpression or p53 downregulation induces G1 and G2-
associated kinase activities under non-adherent conditions, resulting in the induction of 
anchorage-independent growth and transformation. 
Moreover, the results described in Chapter 3 point to an involvement of the p38/
Mapkapk3 pathway in inhibiting anchorage-independent growth. The p38 MAPK, which 
induces several cell cycle inhibitors, is known to be activated upon stress signaling, but 
has also been placed downstream of the RAS/RAF/MEK/ERK pathway. Furthermore, 
the p38 pathway is suggested to activate the p53 tumor suppressor pathway. Mapkapk3 
functions downstream of p38, but also of MEK/ERK (Han and Sun, 2007; Zakowski et 
al., 2004; Ludwig et al., 1996). We show that downregulation of p38 or of Mapkapk3 
induced anchorage-independent growth in RASV12/pocket protein-deficient MEFs. It is 
likely that upon loss of anchorage, the p38 pathway plays an important role in tumor 
suppression via activation of p53.
In vitro transformation requirements for human and mouse fibroblasts
As mentioned above, we have found that transformation of MEFs requires expression of 
RASV12 plus downregulation of both the pocket protein and the p53 pathways. In contrast 
to our findings, others have claimed previously that RASV12-induced transformation of 
murine fibroblasts could be accomplished by ablation of either the pocket protein or 
the p53 pathway (Rangarajan et al., 2004; Sage et al., 2000). Since RASV12-induced 
transformation of human fibroblasts has been reported to require ablation of both 
pathways (Rangarajan et al., 2004; Voorhoeve and Agami, 2003), a widely held view 
has emerged that RASV12-induced transformation of human and murine fibroblasts meets 
different requirements.
 Although oncogenic, expression of constitutively active RAS, RASV12, induces 
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G1 arrest in wild-type fibroblasts, a phenomenon known as oncogene-induced senescence 
(Serrano et al., 1997). In murine fibroblasts, ablation of either the pocket protein or the p53 
pathway was sufficient to bypass RASV12-induced senescence (Dannenberg et al., 2004; 
Rangarajan et al., 2004; Peeper et al., 2001; Sage et al., 2000; Kamijo et al., 1997; Serrano 
et al., 1997). Concerning human fibroblasts, several studies implied that downregulation 
of both the pocket protein and p53 pathways was required to bypass RASV12-induced 
senescence (Wei et al., 2003; Hahn et al., 2002; Serrano et al., 1997). In contrast, others 
claimed that downregulation of either p53 or pocket proteins suffices to bypass RASV12-
induced senescence in human fibroblasts (Rangarajan et al., 2004; Voorhoeve and Agami, 
2003), implying that bypass of RASV12-induced senescence actually meets similar 
requirements in human and mouse fibroblasts.
RASV12-induced transformation clearly meets different requirements in human 
and mouse fibroblasts: expression of hTERT and SV40 small t antigen (st) are required 
for transformation of human fibroblasts (Voorhoeve and Agami, 2003; Hahn et al., 2002; 
Hahn et al., 1999), whereas they are dispensable for transformation of murine fibroblasts 
(Vormer et al., 2008; Rangarajan et al., 2004). Murine fibroblasts contain long telomeres 
(Prowse and Greider, 1995; Kipling and Cooke, 1990) and consequently do not require 
expression of hTERT. The requirement for st in transformation has been linked to the 
inactivation of PP2A (Hahn et al., 2002), which possibly causes downregulation of PTEN 
(Boehm et al., 2005) and stabilization of c-Myc (Yeh et al., 2004). Why st is dispensable for 
transformation of murine fibroblasts remains currently unknown. As already mentioned, 
a view has emerged that RASV12-induced transformation of human fibroblasts requires 
ablation of both the pocket protein and p53 pathways, whereas transformation of murine 
fibroblasts requires ablation of only one of the two pathways (Rangarajan et al., 2004; 
Voorhoeve and Agami, 2003; Sage et al., 2000). This contrasts sharply with our findings 
in murine fibroblasts, showing that ablation of the pocket protein and the p53 pathway 
synergistically supports RASV12-induced transformation. These results, described in 
Chapter 2, imply that transformation requirements for murine and human fibroblasts are 
not as different as previously claimed.
The role of the pocket proteins in development and tumorigenesis
In line with their key role in cell cycle control, differentiation and apoptosis, pocket 
proteins are essential for both tumor suppression and embryonic development. Rb-/- 
mouse embryos died between embryonic day 13.5 and 15.5 with defects in the nervous 
system, lens, placenta, liver and erythroid lineage. Elevated levels of both proliferation 
and apoptosis were detected in the lens and in both the central and peripheral nervous 
system. The presence of a wild-type placenta suppressed apoptosis in the central nervous 
system and rescued survival of Rb-/- embryos to term. However, the increased levels of 
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proliferation in the central nervous system and of both proliferation and apoptosis in 
the lens were maintained, demonstrating that these abnormalities were not caused by 
placental malfunctioning. Rescued Rb-/- animals died shortly after birth with a collapsed 
alveolar space and severe defects in the skeletal muscle (de Bruin et al., 2003; Wu et 
al., 2003; Tsai et al., 1998; Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992). 
p130-/- and p107-/- animals displayed normal survival, however, the combined loss of p130 
and p107 resulted in early neonatal death, probably caused by increased proliferation of 
chondrocytes, resulting in aberrant bone development (Cobrinik et al., 1996).
Loss of pocket proteins strongly predisposes to tumorigenesis. In human cancer, 
mutations in the Rb gene were first identified in the early childhood tumor retinoblastoma, 
and were subsequently found in various tumor types, including osteocarcoma,  small 
cell lung cancer as well as breast- and bladder carcinomas (reviewed by Burkhart and 
Sage, 2008; Sherr and McCormick, 2002; Nevins, 2001; Sherr, 1996; Weinberg, 1995). 
In addition, p130 was found mutated in a variety of tumor types including retinoblastoma 
and Burkitt’s lymphoma (De Falco G. et al., 2007; Tosi et al., 2005; Cinti et al., 2000), 
whereas an intragenic deletion in p107 was detected in a B-cell lymphoma cell line 
(Ichimura et al., 2000). Importantly, components of the pocket protein pathway were 
frequently found mutated in human cancer: loss of p16INK4A or overexpression of Cyclin 
D1 or CDK4, which all promote inactivation of the complete pocket protein family, were 
detected in melanoma, non-small cell lung cancer, mantle cell lymphoma, sarcomas, 
pancreatic- and breast cancers, and others. In conclusion, the pocket protein pathway has 
been suggested to be deregulated in the majority of human tumors (reviewed by Sherr and 
McCormick, 2002; Nevins, 2001; Sherr, 1996; Weinberg, 1995). 
In mice,  Rb loss clearly predisposes to tumorigenesis: Rb+/- germline and 
Rb-/- chimeric mice died of pituitary tumors at early age and additionally developed 
hyperplasia in the thyroid and pre-neoplastic lesions in the adrenals (Harrison et al., 
1995; Maandag et al., 1994; Williams et al., 1994). The wild-type Rb allele was lost in 
pituitary tumors recovered from Rb+/- germline mice, further emphasizing the role of Rb 
in counteracting tumorigenesis (Maandag et al., 1994). The tumor spectrum, induced by 
Rb loss, was extended by the additional loss of either p130 or p107, which drove the 
formation of various tumors, including retinoblastoma, osteocarcoma, lymphosarcoma, 
pheochromocytoma and adenocarcinoma in the coecum (Dannenberg et al., 2004; 
Robanus-Maandag et al., 1998). 
Implications for the role of pocket protein-chromatin remodeling complexes in 
tumorigenesis
Whereas the importance of loss of pocket proteins in tumor development has been clearly 
established, the contribution of pocket protein-E2F-chromatin remodeling complexes in 
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this process remains elusive. A view has emerged that mainly loss of control of ‘activator’ 
E2Fs is involved in tumorigenesis. Specifically, tumorigenesis in Rb+/- mice could be 
counteracted by the additional loss of the activator E2F1 or by loss of E2F4; the latter 
caused a redistribution of pocket protein-E2F complexes resulting in complex formation 
between p107/p130 and E2F1/E2F3, presumably inhibiting these activator E2Fs (Lee 
et al., 2002; Yamasaki et al., 1998). However, the interpretation of these experiments is 
hampered by the fact that the division between ‘activator’ and ‘repressor’ E2Fs is far from 
absolute. Recent studies have suggested that the ‘activator’ E2Fs also contain a repressor 
function (Sahin and Sladek, 2010; Chong et al., 2009b). Moreover, the ‘repressor’ 
E2Fs have been implicated in transcriptional activation. Both E2F3b and E2F4 could 
transactivate an E2F-luciferase-reporter in vitro (Chong et al., 2009a; Chapter 4 of this 
thesis) and overexpression of E2F4 in the nucleus could induce E2F target gene expression 
and cell cycle progression (Muller et al., 1997). Furthermore, free, unbound E2F4 was 
strongly implicated in the induction of E2F target genes and S phase progression in fetal 
erythrocytes (Kinross et al., 2006). Similarly, E2F3b was suggested to function as an 
activator in MEFs, as it could induce proliferation of the otherwise proliferation deficient 
E2f1-/-E2f2-/-E2f3-/- MEFs (Tsai et al., 2008; Wu et al., 2001). Finally, E2F3b was also 
implicated to function as an activator in the lens and possibly also in the central nervous 
system (Chong et al., 2009a).
 Importantly, a great body of evidence points to an involvement of pocket protein-
chromatin remodeling complexes in processes critical for tumor suppression, such as 
(irreversible) cell cycle arrest and senescence. This is described in detail in Chapter 5 of 
this thesis. p130, p107 and the ‘repressor’ E2F4 were recruited to repressed promoters in 
G0-arrested mouse fibroblasts (Rayman et al., 2002) and in G0/G1-arrested human T98G 
cells (Takahashi et al., 2000). Additionally, E2F-repressor complexes were shown to be 
involved in contact inhibition, replicative senescence and RASV12-induced senescence 
(Rowland et al., 2002; Zhang et al., 1999). Consistent with a role for LxCxE-containing 
proteins in executing pRB-mediated silencing, active repression of E2F target genes 
involving pRB and LxCxE-containing proteins was detected under various growth 
inhibitory conditions, such as serum starvation (Isaac et al., 2006; Morrison et al., 2002), 
RASV12-induced senescence (Narita et al., 2003) and cell cycle arrest induced by p16INK4A 
(Dahiya et al., 2001). Additionally, pRB-mediated silencing and cell cycle arrest occurred 
during differentiation of various cell types (Guo et al., 2009; Blais et al., 2007;  Khidr 
and Chen, 2006; Novitch et al., 1996; Gu et al., 1993). During muscle differentiation, the 
LxCxE-containing Suv39H1 was involved in establishing terminal silencing (Ait-Si-Ali 
et al., 2004) and moreover, pRB-mediated silencing of cell cycle genes correlated with the 
presence of repressive chromatin marks (Blais et al., 2007). Together, these studies imply 
an involvement for the recruitment of LxCxE-containing proteins by pocket proteins in 
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cell cycle arrest and tumor suppression.
To determine the role of the interaction between pocket proteins and LxCxE-
containing proteins in tumorigenesis, we have generated mice and MEFs expressing a 
mutant pRB protein, pRBN750F, from the endogenous locus. This protein was unable to 
interact with LxCxE-containing proteins and was thus impaired in recruiting chromatin-
remodeling proteins via the LxCxE binding site. Given the compensatory role of p130 and 
p107 in binding LxCxE-containing proteins, we combined this mutation with loss of p130 
or p107 and studied both cell cycle arrest in vitro and tumor predisposition in vivo. The 
results of these experiments are described in Chapter 4 and 5 of this thesis. Interestingly, 
we found that the pRB-LxCxE interaction contributed to cell cycle arrest in response 
to γ-irradiation or expression of RASV12. Surprisingly, mice homozygously expressing 
the pRBN750F protein were not tumor prone under the conditions tested. By combining 
the pRBN750F mutation with loss of p130 or p107, we show that reducing pocket protein-
E2F chromatin remodeling complexes to a level that is compatible with embryonic 
development, did not ablate the tumor suppressor function of the pocket proteins. As 
discussed in Chapter 4, we hypothesize that the pRB-LxCxE interaction might play a role 
during transcriptional silencing and tumor suppression in vivo, however, the presence 
of the remaining pocket proteins and/or of chromatin-remodeling proteins interacting 
independently of the LxCxE binding site, prevents a full relieve of transcriptional 
silencing in vivo and subsequently inhibits tumor formation.
Outline thesis
This thesis focuses on the role of the pocket proteins during in vitro transformation and in 
vivo tumorigenesis. The first part of this thesis describes the transformation requirements 
for pocket protein-deficient MEFs. In Chapter 2, we show that a combination of pocket 
protein loss and either TBX2 overexpression or p53 downregulation is required for the 
induction of G1- and G2-associated kinase activities under non-adherent conditions, 
resulting in the induction of anchorage-independent growth and transformation. In Chapter 
3, we describe the involvement of the p38 pathway and one of its downstream effectors, 
Mapkapk3, in counteracting transformation of pocket protein-deficient MEFs. The 
second part of this thesis focuses on the interaction between pRB and proteins containing 
an LxCxE motif during cell cycle arrest in vitro and tumorigenesis in vivo. In Chapter 
4, we show that the pRB-LxCxE interaction contributes to cell cycle arrest in response 
to γ-irradiation or overexpression of RASV12, whereas the interaction is dispensable for 
arrest in response to serum deprivation or cell-cell contact. Chapter 5 describes the effect 
of ablating the pRB-LxCxE interaction in mice. Surprisingly, we found that ablation 
of this interaction did not predispose mice to tumor formation, implying that the pRB-
LxCxE interaction does not comprise a major tumor suppressor role of pRB. 
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Abstract
Mouse embryonic fibroblasts (MEFs) deficient for pocket proteins (i.e., pRB/p107-, pRB/
p130-, or pRB/p107/p130-deficient MEFs) have lost proper G1 control and are refractory 
to RASV12-induced senescence. However, pocket protein-deficient MEFs expressing 
RASV12 were unable to exhibit anchorage-independent growth or to form tumors in nude 
mice. We show that depending on the level of pocket proteins, loss of adhesion induces G1 
and G2 arrest, which could be alleviated by overexpression of the TBX2 oncogene. TBX2-
induced transformation occurred only in the absence of pocket proteins and could be 
attributed to downregulation of the p53/p21CIP1 pathway. Our results show that a balance 
between the pocket protein and p53 pathways determines the level of transformation of 
MEFs by regulating cyclin-dependent kinase activities. Since transformation of human 
fibroblasts also requires ablation of both pathways, our results imply that the mechanisms 
underlying transformation of human and mouse cells are not as different as previously 
claimed. 
Introduction
Deregulation of the pRB tumor suppressor pathway is a frequent event in the development 
of cancer (reviewed by Nevins, 2001; Hanahan and Weinberg, 2000). pRB and its close 
homologs p107 and p130 comprise the family of so-called pocket proteins and are widely 
known for their role in cell cycle regulation, especially during G1 phase. In their active, 
hypophosphorylated form, pocket proteins restrict cell cycle progression by binding to 
E2F transcription factors. E2F-pocket protein complex formation inhibits the expression 
of E2F target genes both by blocking E2F’s ability to induce transcription and by active 
repression. As a result, initiation of S phase is inhibited. Upon cell cycle stimulation, 
Cyclin D-CDK4/6 (Cyclin-dependent kinase 4 or 6) and Cyclin E-CDK2 complexes 
are activated and hyperphosphorylate the pocket proteins, resulting in liberation and 
activation of E2F transcription factors and initiation of S phase. Further cell cycle 
progression requires Cyclin A-CDK1/2 activity in S phase and Cyclin A-CDK1/2 and 
Cyclin B1-CDK1 activities in G2/M phase. The activity of cyclin-cdk complexes can 
be inhibited by the INK4a (inhibitor of cyclin-dependent kinase 4a) and the CIP/KIP 
families of cdk inhibitors (reviewed by Berthet and Kaldis, 2007).
Consistent with a role for pocket proteins in G1 control, we and others have 
shown that complete ablation of pocket proteins in mouse embryonic fibroblasts (MEFs) 
abrogated G1 arrest in response to growth-inhibitory signals, such as cell-cell contact, 
growth factor depletion and DNA damage. Additionally, upon prolonged culturing or 
expression of constitutively active RAS (RASV12), wild-type MEFs arrested in G1 and 
displayed hallmarks of senescence, while MEFs deficient for both pRB and p107 or 
both pRB and p130 (double-knockout, DKO MEFs) or all three pocket proteins (triple-
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knockout, TKO MEFs) were refractory to replicative and RASV12-induced senescence 
(Dannenberg et al., 2004; Peeper et al., 2001; Dannenberg et al., 2000; Sage et al., 2000). 
Similar to ablation of pocket proteins, ablation of the tumor suppressor p53 or its upstream 
regulator p19ARF also bypassed replicative and RASV12-induced senescence in MEFs 
(Kamijo et al., 1997). However, while p53- or p19ARF-deficient MEFs could easily be 
transformed by RASV12, pocket protein-deficient MEFs expressing RASV12 were unable 
to exhibit anchorage-independent growth and did not form tumors in nude mice (Peeper 
et al., 2001; this communication). This demonstrates that the loss of pocket proteins in 
primary MEFs is not sufficient for RASV12-induced transformation. 
 In the present study, we performed a cDNA screen aimed at identifying 
oncogenes that collaborate with the loss of pocket proteins and RASV12 in transformation 
of MEFs. We identified the oncogene TBX2 as a cooperating factor in transformation of 
pocket protein-deficient MEFs. TBX2 downregulates the p53/p21CIP1 pathway both in 
wild-type and pocket protein-deficient MEFs, and indeed, downregulating the p53/p21CIP1 
pathway by RNA interference transformed pocket protein-deficient MEFs. In contrast to 
previous reports, our results demonstrate that RASV12-induced transformation of murine 
fibroblasts requires downregulation of both the pocket protein and p53 pathways. Since 
downregulation of both pathways is also required for transformation of human fibroblasts 
(Boehm et al., 2005; Rangarajan et al., 2004; Voorhoeve and Agami, 2003), our results 
indicate that the mechanisms underlying RASV12-induced transformation of human and 
mouse fibroblasts are not fundamentally different. Furthermore, we show that anchorage-
independent growth not only requires bypass of G1 control but also requires bypass of G2 
control. 
Results
Gain-of-function screen for anchorage-independent growth of RASV12-expressing 
pocket protein-deficient MEFs
We have previously shown that ablation of pRB and p107 rendered MEFs insensitive to 
replicative and RASV12-induced senescence but was not sufficient for RASV12-induced 
transformation: RASV12-expressing DKO MEFs were unable to exhibit anchorage-
independent growth in culture and did not form tumors in nude mice (Peeper et al., 2001; 
Dannenberg et al., 2000). To identify events enabling RASV12-induced transformation of 
pocket protein-deficient MEFs, we performed a gain-of-function screen using Rb-/-p130-/- 
(DKO) MEFs expressing RASV12. In short, DKO MEFs were retrovirally transduced 
with pBABE-RASV12 and subsequently with the pEYK-MCF7 cDNA library or with 
pEYK-GFP. Transduced cells were then seeded in soft agar. Although some colonies 
appeared in the control vector-infected cells, infection with the pEYK-MCF7 library 
increased the number of colonies three times. Colonies were picked, and the presence 
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Figure 1: TBX2 specifically transforms RASV12/pocket protein-deficient MEFs. (A) Primary MEFs of the 
indicated genotypes were first transduced with pEYK-TBX2 and subsequently with pBABE-RASV12 (TBX2 
+ RASV12) and plated in soft agar. The left bottom dish shows Rb-/-p107-/-p130-/- MEFs infected with pEYK-
GFP and pBABE-RASV12 (GFP + RASV12). Pictures of soft agar plates were taken using a non-phase-contrast 
lens (×2.5 magnification). (B) Detailed pictures of Rb-/-p107-/-p130-/- (TKO) MEFs transduced with either 
pEYK-TBX2 or pEYK-GFP and subsequently with pBABE-RASV12. Pictures show the same cells as in panel A, 
taken using a phase-contrast lens (×5 magnification). (C) RASV12 and TBX2 protein levels in the cell lines 
depicted in panels A and B. (Left) MEFs infected with pEYK-TBX2 and pBABE-RASV12. (Right) MEFs infected 
with pEYK-GFP and pBABE-RASV12.
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of a pEYK-cDNA integration was determined by both PCR analysis and by a shuttling 
method that enabled excision of the integrated pEYK-cDNA from the genomic DNA 
and its propagation as a plasmid in Escherichia coli (Koh et al., 2002). Sequencing of 
recovered pEYK vectors revealed many fragmented cDNA sequences in the sense or 
antisense orientation. Three independent colonies contained a full cDNA encoding the 
TBX2 oncogene. Only reintroduction of the TBX2-expressing vector into pocket protein-
deficient MEFs expressing RASV12 caused robust colony formation in soft agar (Fig. 1A, 
compare left top and left bottom dishes).
TBX2 transforms pocket protein-deficient MEFs expressing RASV12 
To determine whether transformation by TBX2 required the loss of specific pocket 
proteins, we retrovirally transduced MEFs deficient for all different combinations of 
pocket proteins with either pEYK-TBX2 or pEYK-GFP, followed by pBABE-RASV12, 
and tested their ability to form colonies in soft agar. In all the cell lines tested, expression 
of RASV12 alone hardly induced anchorage-independent growth (see Fig. 1A and B for 
TKO MEFs; also data not shown). Concomitant expression of TBX2 induced colony 
formation in TKO, DKO, and Rb-/- MEFs (Fig. 1A and B). The strongest colony formation 
was observed with TKO MEFs, followed by Rb-/-p107-/- MEFs and then by Rb-/-p130-/-, 
p107-/-p130-/-, and Rb-/- MEFs. In contrast, expression of TBX2 and RASV12 did not 
support anchorage-independent growth of p107-/-, p130-/-, and wild-type MEFs, the latter 
being consistent with previous results (Jacobs et al., 2000). Note that RASV12 and TBX2 
were expressed to comparable levels in all cell lines (Fig. 1C). Expression of TBX2 alone 
in pocket protein-deficient MEFs did not induce colony formation (data not shown). 
Together, these results indicate that the combination of pocket protein ablation, RASV12 
expression, and TBX2 expression is required for transformation of primary MEFs.
Transformation of TBX2/RASV12-expressing MEFs requires ablation of pocket proteins
To provide independent proof for collaboration between TBX2 and the loss of pocket 
proteins, we made use of RbF/Fp130-/- MEFs. In these cells, exon 19 of both Rb alleles 
is flanked by LoxP sites and can therefore be deleted by Cre-mediated recombination, 
which inactivates the gene. RbF/Fp130-/- MEFs were transduced with retroviral vectors 
expressing TBX2 and RASV12 and subsequently with either pMSCV-Cre-ERT2 or 
empty pMSCV. Even without the addition of tamoxifen, transduction of Cre-ERT2 in 
RbF/Fp130-/- MEFs already resulted in nuclear Cre activity, yielding a mixed population 
of cells containing active (RbF) and/or inactive (RbΔ19) Rb alleles (Fig. 2A). Expression of 
Cre-ERT2 in TBX2/RASV12/RbF/Fp130-/- MEFs increased colony formation in soft agar, 
indicating that inactivation of the Rb allele promoted anchorage-independent growth (Fig. 
2B). Conversely, expression of TBX2, RASV12, and Cre-ERT2 in Rb+/+p130-/- MEFs did 
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not enhance colony formation (data not shown). Note that some colonies appeared in the 
control vector-infected cells (Fig. 2B, right part), which was probably due to the prolonged 
culturing required for transduction with three retroviral vectors, creating a window for 
the selection for additional growth-stimulating mutations. Soft agar colonies derived 
from RbF/Fp130-/- MEFs transduced with TBX2, RASV12, and Cre-ERT2 were picked and 
analyzed for Rb status by PCR. Strikingly, while the starting population of cells consisted 
Figure 2: Transformation by TBX2 and RASV12 requires ablation of pocket proteins. (A) Expression of 
Cre-ERT2 yields a mixed population of cells containing active (RbF) and/or inactive (RbΔ19) Rb alleles. 
RbF/Fp130-/- MEFs were transduced with TBX2, RASV12, and pMSCV-Cre-ERT2 viruses. Genomic DNA (gDNA) 
was isolated and analyzed for the presence of active and inactive Rb by PCR. Lane 1, 100 ng of input 
gDNA; lanes 2 to 10, genomic DNA diluted 2-, 4-, 8-, 16-, 32-, 64-, 128-, 256-, and 512-fold, respectively, 
showing that both alleles could be detected at a low input concentration of gDNA; lane 11, 1-kilobase 
ladder. (B) Expression of Cre-ERT2 enhances colony formation in RbF/Fp130-/- MEFs. RbF/Fp130-/- MEFs 
infected with TBX2 and RASV12 and either pMSCV-Cre-ERT2 (left) or pMSCV-empty (right) viruses were 
plated in soft agar. Pictures were taken using a non-phase-contrast lens (×2.5 magnification). (C) 
Nineteen soft agar colonies derived from RbF/Fp130-/- MEFs expressing TBX2, RASV12, and Cre-ERT2 were 
picked and immediately analyzed for the presence of active and inactive Rb by PCR. Each lane represents 
one soft agar colony; the leftmost lane contains a 1-kilobase ladder. Five colonies (-) failed to produce 
PCR fragments. The positions of active and inactive Rb alleles are indicated by RbF and RbΔ19.
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of a mixed population carrying active and inactive Rb alleles (Fig. 2A), all 14 soft agar 
colonies exclusively carried inactive Rb alleles (Fig. 2C; note that 5 colonies failed to 
produce PCR fragments, probably due to the loss of cells during picking). Together with 
the results presented in  Fig. 1, these experimental results show that transformation of 
MEFs by RASV12 requires both ablation of pocket proteins and expression of TBX2.
Figure 3: Expression of TBX2 promotes tumor formation of pocket protein-deficient MEFs expressing 
RASV12. Immunocompromised mice (nude mice) were injected with MEFs of the indicated genotypes, 
which had been transduced with either pBABE-RASV12 and pEYK-GFP (RASV12 + GFP) (injected into the left 
flanks) or pBABE-RASV12 and pEYK-TBX2 (RASV12 + TBX2) (injected into the right flanks). Unless indicated, 
106 MEFs were injected per flank. Three mice were injected per cell line; two additional mice were injected 
with 105 Rb-/-p107-/-p130-/- (TKO) MEFs. (A) Graphical representation of tumor mass. Error bars denote 
standard deviations. (B) Pictures of immunocompromised mice injected with MEFs of the indicated 
genotypes. MEFS were transduced with either pEYK-TBX2 (+TBX2) or with pEYK-GFP (-TBX2).
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Requirements for growth of MEFs in nude mice 
To study transformation in an in vivo system, Rb-/-p107-/-, Rb-/-p130-/-, and Rb-/-p107-/-
p130-/- MEFs were retrovirally transduced with either RASV12 and TBX2 or RASV12 and 
green fluorescent protein (GFP) and injected into immunocompromised mice (nude mice) 
(Fig. 3). TBX2 and RASV12 expression levels were comparable in the different cell lines 
(data not shown). Rb-/-p107-/-p130-/- MEFs expressing RASV12 and TBX2 formed tumors 
within a shorter time window than Rb-/-p107-/- or Rb-/-p130-/- MEFs expressing RASV12 and 
TBX2; mice injected with TKO MEFs had to be sacrificed between 16 and 21 days, while 
mice injected with DKO MEFs were sacrificed after 26 days. This suggests, consistent 
with the soft agar experiments (Fig. 1), that MEFs deficient for all three pocket proteins 
were more easily transformed than MEFs partially deficient for pocket proteins. DKO 
and TKO MEFs expressing RASV12 and TBX2 formed robust tumors, weighing between 
0.1 and 0.7 g upon dissection. In contrast, MEFs expressing RASV12 and GFP formed 
very small clumps of cells, in 9 out of 11 cases weighing less than 0.01 g. In the other 
two cases, small tumors were formed; these tumors were 10 and 4 times smaller than the 
corresponding tumors expressing RASV12/TBX2. These results demonstrate that also in 
vivo, expression of TBX2 strongly supports transformation of RASV12-expressing DKO 
and TKO MEFs.
Downregulating the p53 pathway transforms pocket protein-deficient MEFs
Overexpression of TBX2 induces bypass of both replicative and RASV12-induced 
senescence. This has been attributed to downregulation of p19ARF, and as a consequence, 
to downregulation of p53 (Dobrzycka et al., 2006; Jacobs et al., 2000). Furthermore, 
TBX2 has been reported to directly repress the promoter of the p53 target gene p21CIP1 
(Vance et al., 2005; Prince et al., 2004). Given the importance of p53 in transformation, we 
investigated whether TBX2-induced transformation could be attributed to downregulation 
of the p53/p21CIP1 pathway. To this aim, we expressed a pBABE-p21CIP1 vector in TKO 
MEFs expressing TBX2 and RASV12. Ectopic expression of p21CIP1 dramatically reduced 
the number of soft agar colonies induced by TBX2 (Fig. S1), indicating that TBX2-
induced transformation involves downregulation of p21CIP1.
To further address the involvement of downregulating the p53/p21CIP1 pathway 
in transformation, we used pRetroSuper (pRS) vectors to suppress expression of p53 
or p21CIP1 in DKO MEFs by RNA interference. Similar to overexpression of TBX2, 
downregulation of either p53 or p21CIP1 supported anchorage-independent growth of 
RASV12-expressing Rb-/-p107-/- MEFs (Fig. 4A). Knockdown of p53 was more potent 
in inducing anchorage-independent growth than knockdown of p21CIP1 was. Residual 
levels of p21CIP1 were comparable or even somewhat higher in p53 knockdown cells 
(see Fig. 6D), suggesting that p53 protects against anchorage-independent growth only 
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Figure 4: Similar to TBX2 overexpression, downregulation of either p21CIP1 or p53 specifically transforms 
pocket protein-deficient MEFs. (A) Rb-/-p107-/- MEFs were transduced with the indicated constructs and 
plated in soft agar. Pictures were taken using a non-phase-contrast lens (×2.5 magnification). (B) Wild-
type MEFs were transduced with the indicated constructs and plated in soft agar. Pictures were taken 
using a non-phase-contrast lens (×2.5 magnification). (C) Detailed pictures of the indicated cell lines, 
plated in soft agar. Pictures show the same cells as in panels A and B, taken using a phase-contrast lens 
(×5 magnification).
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Figure 5: A balance between the activities of the pocket protein and p21CIP1 pathways determines the 
level of transformation of MEFs. (A) Downregulation of p21CIP1 using various constructs. Rb-/-p107-/- MEFs 
were infected with the indicated constructs and plated in suspension culture 6 days postinfection. After 
24 h, cells were harvested, lysed, and immunoblotted for the indicated proteins. (B) Rb-/- MEFs were first 
infected with pEYK-GFP or pEYK-TBX2, next with pRS-GFP or a pRS-p21 vector, and last with pBABE-
RASV12. Forty-eight hours postinfection, cells were plated in soft agar. Pictures were taken using a non-
phase-contrast lens (×2.5 magnification). + and - symbols refer to the quantification of colony formation 
as depicted in Table 1.
partially via p21CIP1. As observed for transformation by TBX2, transformation by p21CIP1 
knockdown required pocket protein loss; p21CIP1 downregulation and RASV12 expression 
in wild-type MEFs did not induce colony formation in soft agar (Fig. 4B). Although p53 
downregulation and RASV12 expression in wild-type MEFs induced a small number of 
colonies (Fig. 4B), this sharply contrasted to the robust colony formation observed for 
RASV12/Rb-/-p107-/- MEFs (Fig. 4C). These results show that in a RASV12 transformation 
assay, downregulation of the p53 pathway mimics overexpression of TBX2. Similar as 
observed for TBX2, transformation by downregulation of the p53 pathway requires the 
loss of pocket proteins.
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A balance between the p53 pathway and the pocket protein pathway determines the 
level of transformation of MEFs
Since colony formation in TBX2/RASV12-expressing MEFs was more robust upon the 
loss of two or three pocket proteins compared to the loss of pRB alone (Fig. 1) and 
transformation by TBX2 could be attributed to downregulation of the p53/p21CIP1 
pathway (Fig. 4), we hypothesized that a balance between the activities of the pocket 
protein and the p53/p21CIP1 pathways determines the rate of transformation of MEFs. 
We therefore used pRS vectors downregulating p21CIP1 to different levels, referred to as 
pRS-p21weak and pRS-p21strong. Figure 5A shows that infection with pRS-p21weak 
in Rb-/-p107-/- MEFs caused a mild decrease of p21CIP1 levels compared to infection 
with control vectors (pRS or pRS-GFP), while infection with pRS-p21strong caused a 
strong decrease. We downregulated p21CIP1 to different degrees by combined expression 
of the pRS-p21 vectors and the pEYK-TBX2 expression vector in MEFs deficient 
for different combinations of pocket proteins. Briefly, TKO MEFs, Rb-/-p107-/- MEFs, 
Rb-/- MEFs, and wild-type MEFs were first infected with pEYK-GFP or pEYK-TBX2, 
subsequently with pRS-GFP or a pRS-p21 vector, and finally with pBABE-RASV12. The 
colony-forming capacity in soft agar was monitored, and the results are summarized in 
Table 1. Expression of RASV12 and TBX2, without additional p21CIP1 downregulation, 
induced colony formation most robustly in TKO MEFs, followed by Rb-/-p107-/- and 
Rb-/- MEFs, but expression of RASV12 and TBX2 did not induce colony formation in wild-
type MEFs (Table 1 and Fig. 1). Strikingly, in Rb-/- MEFs, coexpression of the pRS-p21 
growtha  in soft agar of cell line infected with the following construct:
Rb-/-
wild-type
TKO
Rb-/-p107-/-
Control vector pEYK-TBX2 + 
pRS-21strong
pRS-p21weak pEYK-TBX2 pEYK-TBX2 + 
pRS-p21weak
genotype of cell line
-  
-  
-  
-  
-  
-  
-  -  
+/- +/- 
+  ++  
+/- 
+++
++++   ++++   ++++   
+++++ +++++ +++++
Summary of growth of the cell lines in soft agar
Table 1: Summary of growth of the cell lines in soft agar. A balance between the activities of the pocket 
protein and p21CIP1 pathways determines the level of transformation of MEFs. Cells were infected as 
described in the legend to Fig. 5, plated in soft agar, and monitored for anchorage-independent growth. 
aSymbols: −, no growth; +/−, less than 20 colonies; +, ++, +++, ++++, and +++++, indicate the relative 
capacity for growth in soft agar, where each additional + indicates an approximately twofold increase. 
+, ++, and +++ correspond to the levels of soft agar growth shown in Fig. 5B.
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vectors enhanced TBX2-induced colony formation (Fig. 5B). These results show that 
relatively mild p21CIP1 downregulation was sufficient to induce transformation of MEFs 
with complete pocket protein loss (pEYK-TBX2 expression in RASV12/TKO MEFs), 
while strong p21CIP1 downregulation was required to induce transformation of MEFs 
partially deficient for pocket proteins (pEYK-TBX2 plus pRS-p21strong in RASV12/Rb-/- 
MEFs). Thus, a balance between pocket protein and p21CIP1 levels determines the rate of 
transformation of RASV12-expressing MEFs.
RASV12-induced transformation of pocket protein-deficient MEFs requires rescue of G2 
arrest
Whereas under adherent conditions, the loss of pocket proteins turned RASV12 expression 
from a growth-inhibiting signal to a growth-promoting signal, RASV12/TKO MEFs were 
largely unable to form colonies in soft agar. To determine why proliferation ceased upon 
removal of anchorage, we analyzed the cell cycle profile of anchorage-deprived DKO 
and TKO MEFs by FACS. For this experiment, we cultured cells in methylcellulose, 
which like soft agar, prohibits attachment but enables easy recovery of nonproliferating 
cells. Upon removal of anchorage, wild-type fibroblasts arrest in G1 (Fang et al., 1996; 
Guadagno et al., 1993; Guadagno and Assoian, 1991). Here, we show that the majority 
of RASV12/Rb-/-p107-/- MEFs arrested in both G1 and G2 upon removal of anchorage (Fig. 
6A). Knockdown of p21CIP1 reduced the fraction of G2 cells (Fig. 6A). As the number of 
S-phase cells remained low, this indicates that a large fraction of the cells had arrested 
in G1. In contrast, knockdown of p53 increased the number of S-phase cells, indicating 
rescue of both G1 and G2 arrest in non-adherent cells (Fig. 6A). RASV12/TKO MEFs 
predominantly arrested in G2 upon removal of anchorage, which could be alleviated by 
knockdown of p21CIP1 or p53 (Fig. 6B) or by overexpression of TBX2 (Fig. 6C). Note 
that G2 arrest under non-adherent conditions in RASV12/TKO MEFs was not induced by 
expression of RASV12, as TKO MEFs also arrested in G2 upon removal of anchorage 
(Fig. S2). Similar to knockdown of p53 or p21CIP1, knockdown of p19ARF also rescued G2 
arrest in non-adherent RASV12/TKO MEFs (Fig.7C; note that while the vector used targets 
the INK4A/ARF locus, the effect was due to knockdown of p19ARF, as downregulation 
of p16INK4A alone did not rescue G2 arrest of RASV12/TKO MEFs). As TBX2 expression 
downregulated p19ARF (Fig. 7A), these results suggest that transformation by TBX2 
involved downregulation of p19ARF, and subsequently p53 and p21CIP1. In conclusion, our 
results demonstrate that the loss of anchorage induces checkpoint activation in G1 and 
G2, the latter becoming more prominent upon the loss of pocket proteins. Transformation 
requires rescue of cell cycle arrest, which can be achieved by expression of TBX2 or 
downregulation of the p19ARF/p53/p21CIP1 pathway.
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Figure 6: Anchorage-independent growth of RASV12/pocket protein-deficient MEFs requires rescue of G2 
arrest. Rb-/-p107-/- MEFs (A) or Rb-/-p107-/-p130-/- (TKO) MEFs (B and C) were infected with the indicated 
constructs and cultured either under adherent conditions or for 6 days in methylcellulose. Cells were 
harvested, stained with propidium iodide, and analyzed by FACS. The percentages of cells in G1 and G2 are 
shown in the top right corners of graphs. (D) Downregulation of p21CIP1 and p53 in RASV12/Rb-/-p107-/- and 
RASV12/TKO MEFs upon infection with the indicated constructs. Cells were plated in suspension culture for 
24 h, lysed, and immunoblotted for the indicated proteins.
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Downregulating the p53/p21CIP1 pathway by TBX2 expression or RNA interference 
rescues cyclin-dependent kinase activities under non-adherent conditions 
As the G1/S and G2/M transitions require Cyclin E-CDK2 and Cyclin B1-CDK1, 
respectively, we analyzed the activity of these complexes under non-adherent conditions. 
Figure 8A shows that expression of TBX2 induced Cyclin B1- and CDK2-associated 
kinase activities in RASV12-expressing TKO cells under non-adherent conditions  (Fig. 
8A, panels 1 and 2). Increased kinase activity in TBX2-expressing cells was related to 
reduced association of p21CIP1 with Cyclin B1 and CDK2 (Fig. 8A, panels 3 and 4). This 
is most likely due to reduction of p53 levels by TBX2 (Fig. 8A, panels 5, 6, and 7). These 
results indicate that expression of TBX2 relieves inhibition of cyclin-dependent kinase 
activity by p21CIP1, leading to rescue of cell cycle arrest and anchorage-independent 
growth. 
Downregulating the p53/p21CIP1 pathway transformed DKO and TKO MEFs more 
effectively than Rb-/- MEFs (Fig. 1 and Table 1). We therefore compared the regulation of 
cyclin-dependent kinase activities in Rb-/- and Rb-/-p107-/- MEFs under both adherent and 
non-adherent conditions. Both cell lines were infected with either pRS-p21 or pRS-GFP 
and then with pBABE-RASV12 and plated either in methylcellulose or under adherent 
conditions. Cyclin B1- and CDK2-associated kinase activities in Rb-/-p107-/- MEFs were 
higher than in Rb-/- MEFs, which was particularly visible under adherent conditions  (Fig. 
8B, compare lanes 1 and 3 and lanes 5 and 7). The loss of anchorage caused inhibition 
of kinase activities in Rb-/- and Rb-/-p107-/- MEFs (Fig. 8B, compare lanes 1 and 5 and 
lanes 3 and 7). Knockdown of p21CIP1 induced kinase activities under both adherent 
and non-adherent conditions, and as expected, no association of p21CIP1 with CDK2 
could be detected (Fig. 8B, lanes 2, 4, 6, and 8). However, in non-adherent RASV12/Rb-/- 
MEFs (Fig. 8B, lane 6), the increase in CDK2 and Cyclin B1-associated kinase activity 
was minor and apparently not sufficient to support anchorage-independent growth. In 
contrast, knockdown of p21CIP1 in RASV12/Rb-/-p107-/- MEFs (Fig. 8B, lane 8) raised kinase 
activities to much higher levels than observed in RASV12/Rb-/- MEFs (lane 6). Note that 
knockdown of p21CIP1 induced Cyclin B1-associated kinase activity more robustly than 
CDK2-associated kinase activity. This fits with the observation that knockdown of p21CIP1 
was more potent in rescuing G2 arrest than in rescuing G1 arrest (Fig. 6). We conclude that 
downregulation of p21CIP1 sufficiently rescued the decrease in kinase activities induced by 
the loss of adhesion only in RASV12/Rb-/-p107-/- MEFs. This allowed bypass of G2 arrest 
and, to a lower extent, G1 arrest, enabling anchorage-independent growth.
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> Figure 8: A combination of pocket protein loss and downregulation of the p53/p21CIP1 pathway rescues 
cyclin-dependent kinase activities under non-adherent conditions. (A) Rb-/-p107-/-p130-/- (TKO) MEFs 
infected with pBABE-RASV12 (RASV12) and either pEYK-TBX2 or pEYK-GFP were cultured in methylcellulose 
for 6 days. (Panels 1 and 2) Cyclin B1- and CDK2-associated kinase activities as determined by in vitro 
phosphorylation of histone H1. IP, immunoprecipitate; P-Histone H1, phosphorylated histone H1. (Panels 
3 and 4) Cyclin B1 and CDK2 immunoprecipitates were immunoblotted for p21CIP1. (Panels 5, 6, and 7) 
Total protein levels of TBX2, p53, and CDK4 as loading control. (B) Rb-/- and Rb-/-p107-/- MEFs infected with 
either pRS-p21 or pRS-GFP and subsequently with pBABE-RASV12 were cultured under adherent conditions 
or in methylcellulose for 5 days. Cyclin B1- and CDK2-associated kinase activities as well as association of 
p21CIP1 with CDK2 are shown in the top, middle, and bottom panels, respectively.
Discussion
Pocket protein depletion is not sufficient for RASV12-induced transformation of MEFs
Functional inactivation of the pocket protein and p53 tumor suppressor pathways is one of 
the most frequent events in the development of cancer. Consistent with their importance 
in G1 control, the loss of either p53 or pocket proteins bypasses replicative senescence 
in primary murine embryonic fibroblasts (Dirac and Bernards, 2003; Dannenberg et 
al., 2000; Sage et al., 2000; Harvey et al., 1993). Furthermore, inactivation of the p53 
pathway or the loss of pRB and at least one other pocket protein reversed the growth-
inhibitory effect of RASV12 into a proliferative stimulus (Peeper et al., 2001; Serrano 
et al., 1997). However, unlike abrogation of p53, the loss of pocket proteins was not 
sufficient to support oncogenic transformation by RASV12 (Peeper et al., 2001). This 
observation contradicts a report by others (Sage et al., 2000) but is strongly confirmed 
in the present study; RASV12-expressing MEFs deficient for both pRB and p130, both 
pRB and p107, or all three pocket proteins were largely unable to exhibit anchorage-
independent growth or to form tumors in nude mice. By screening a cDNA library, we 
have identified a missing link: overexpression of the TBX2 oncogene strongly induced 
transformation of pocket protein-deficient MEFs by RASV12, as evidenced by anchorage-
independent growth in vitro and in vivo (Fig. 1 and 3). Consistently, we have shown that 
transformation of MEFs overexpressing TBX2 and RASV12 required the loss of pocket 
proteins (Fig. 2). These results show that the loss of pocket proteins and overexpression 
of TBX2 strongly act synergistically in RASV12-induced transformation of primary murine 
embryonic fibroblasts.
The pRB and p53 pathways cooperate in suppression of transformation
TBX2 overexpression is known to attenuate the p53/p21CIP1 tumor suppressor pathway 
by downregulating transcription of the Mdm2 inhibitor p19ARF. Consistently, we show 
that partial RNA interference-mediated knockdown of p19ARF, p53, or p21CIP1 strongly 
supported RASV12-induced transformation of pocket protein-deficient MEFs  (Fig. 4A, 
6, and 7). Moreover, expression of p21CIP1 inhibited TBX2-induced transformation (Fig. 
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S1). The complete loss of p53 was sufficient for RASV12-induced transformation of wild-
type MEFs (Peeper et al., 2001). Here we show that partial knockdown of p53 induced 
anchorage-independent growth only to a very limited degree in wild-type MEFs but was 
very effective in pocket protein-deficient MEFs (Fig. 4B and C). Furthermore, we found 
that anchorage-independent growth upon RASV12 expression could be achieved by either a 
combination of moderate p21CIP1 downregulation and severe pocket protein loss or strong 
p21CIP1 downregulation and mild pocket protein loss (Fig. 5 and Table 1). Apparently, the 
p53 and pRB pathways act synergistically in preventing anchorage-independent growth.
The complete loss of pocket proteins did not support anchorage-independent 
growth upon expression of RASV12, although it should be noted that a small number of 
colonies appeared in the soft agar culture. This may be explained by downregulation 
of the p53/p21CIP1 pathway in a subset of the cells. Indeed, Sage and coworkers (2000) 
reported that two out of five TKO MEF cultures displayed downregulation of p53 and 
p21CIP1 during culturing under adherent conditions.
Regulation of cell cycle arrest and cyclin-dependent kinase activity by pRB, TBX2, and 
p53
Anchorage-independent growth is a hallmark of transformed cells. Untransformed cells 
are dependent on anchorage via integrin signaling. Upon attachment to the extracellular 
matrix, integrin signaling induces Cyclin D1 and inhibits p21CIP1 and p27KIP1 expression, 
thereby authorizing cell cycle progression (Walker et al., 2005; Bao et al., 2002; Roovers 
and Assoian, 2000). Conversely, detachment from the extracellular matrix is associated 
with downregulation of Cyclin D1, induction of p21CIP1 and p27KIP1, and increased 
association of p21CIP1 and p27KIP1 with Cyclin-CDK complexes (Wu and Schonthal, 1997; 
Fang et al., 1996; Zhu et al., 1996). As a result, cells deprived of attachment downregulate 
CDK2 activity and arrest in G1 (Fang et al., 1996; Guadagno et al., 1993). We show 
here that in anchorage-deprived RASV12/DKO MEFs, there was only partial G1 arrest, 
as a substantial fraction of cells arrested in G2 (Fig. 6A). In RASV12/TKO MEFs, which 
have completely lost the G1 restriction point, G2 arrest predominated (Fig. 6B). Thus, 
anchorage dependence is regulated via both G1 and G2 checkpoints. Our results therefore 
indicate that the transforming activity of TBX2 not only relies on override of the G1 
checkpoint but also on override of the G2 checkpoint and involves downregulation of the 
p53 pathway (Fig. 6).
Are G2-arrested cells senescent? We were unable to perform a senescence-
associated β-galactosidase staining on arrested cells, as both DKO and TKO MEFs were 
targeted with a lacZ reporter gene. However, we have strong indications that the arrest is 
reversible, which according to the current definition excludes senescence. To address this 
issue, we centrifuged RASV12/TKO MEFs harvested from methylcellulose at low speed to 
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separate the low number of growing colonies from G2-arrested cells. By FACS, we found 
that the population of cells in the supernatant was enriched for G2-phase cells. These cells 
entered the cell cycle upon reattachment, as observed by growth of the cells and by FACS 
profiles (data not shown).
The level of p21CIP1 knockdown required to induce transformation was dependent 
on the extent of pocket protein ablation: relatively moderate p21CIP1 knockdown was 
sufficient to induce anchorage-independent growth in TKO MEFs, whereas strong p21CIP1 
knockdown was required to transform Rb-deficient MEFs. Our results indicate that these 
different requirements for anchorage-independent growth are due to different levels of 
kinase activities in pocket protein-ablated cells. Despite high levels of cyclins A, E, and 
B1 in Rb-/- MEFs (Dannenberg et al., 2004; Gad et al., 2004; Lukas et al., 1999; Hurford, 
Jr. et al., 1997), their associated kinase activities were lower than in Rb-/-p107-/- MEFs 
(Fig. 8), and this may be caused by E2F-dependent induction of p107 (Williams et al., 
2006). As Rodier and coworkers (2005) suggested that overexpression of p107 reduces 
the half-life of Skp2 protein, this could lead to downregulation of Skp2 in Rb-/- MEFs and 
subsequently, inhibition of p27KIP1 degradation. However, we did not observe different 
p27KIP1 levels in Rb-/- and Rb-/-p107-/- MEFs (data not shown). An alternative may be that 
high p107 levels in Rb-/- cells, together with p130, inhibit kinase activities in Rb-/- MEFs 
via direct binding to Cyclin E-A/CDK2 (Coats et al., 1999; Grana et al., 1998). This 
mechanism may explain why the extent of p21CIP1 knockdown needed to achieve sufficient 
cyclin-dependent kinase activity to support anchorage-independent growth was lower in 
DKO and TKO MEFs than in Rb-/- cells. In conclusion, we propose that the pocket protein 
and p53 pathways synergistically protect against anchorage-independent growth by their 
shared ability to regulate cyclin-dependent kinase activities.
Roles of pRB, TBX2, and p53 in tumorigenesis 
We identified TBX2 as a transforming oncogene in pocket protein-deficient cells. Several 
lines of evidence point to a role for TBX2 during in vivo tumorigenesis. TBX2 was 
found amplified in a range of human tumor samples and cancer cell lines of different 
developmental origin, such as melanoma cell lines (Vance et al., 2005), a subset of human 
breast tumors (Sinclair et al., 2002; Jacobs et al., 2000), and pancreatic cancer cell lines 
(Mahlamaki et al., 2002). The combined loss of components of the pRB and p53 pathways 
cooperates in tumorigenesis in vivo. The loss of p16INK4A accelerated tumorigenesis in 
p53-/- mice (Sharpless et al., 2002), and similarly, INK4A/ARF knockout mice developed 
tumors with a shorter latency than p16INK4A-/- or p19ARF-/- mice (Sharpless et al., 2004). In 
a p16INK4A null background, the loss of one p19ARF allele accelerated tumorigenesis, while 
strikingly, the wild-type allele was retained in a subset of the tumors (Krimpenfort et 
al., 2001). This indicates that also in vivo, tumor development by abrogation of the pRB 
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pathway can be accelerated by partial ablation of the p53 pathway. Moreover, various 
mouse tumor models have been generated by combined deletion of p53 and Rb, including 
tumors of the lung (Meuwissen et al., 2003), central nervous system (Marino et al., 
2000), breast (Simin et al., 2004), and pineal and pituitary glands (Vooijs et al., 2002). 
Finally, simultaneous mutations in both pathways have been found in a variety of mouse 
and human tumor samples (Miwa et al., 2006; Burke et al., 2005). Thus, the synergism 
between the loss of the pocket protein and p53 pathways, as observed in this study during 
transformation of MEFs, also applies to tumorigenesis in both mice and humans. While 
this synergism has been explained by alleviation of apoptosis by p53, our previous (Foijer 
et al., 2005) and present findings indicate that the loss of p53 may also be required for 
alleviation of cell cycle arrest of cells with abrogated pocket protein function.
Comparison of the requirements for transformation of human and murine fibroblasts 
By using variants of simian virus 40 large T antigen (LT) that specifically target p53 or 
the pRB family, Rangarajan and co-workers (2004) suggested that in both human and 
mouse cells, the loss of p53 or the loss of pocket proteins is sufficient for bypassing 
RASV12-induced senescence. However, RASV12-induced transformation met different 
requirements in human and murine fibroblasts. First, transformation of human fibroblasts 
required expression of hTERT and simian virus 40 small t antigen (ST) (Hahn et al., 
1999), which was dispensable for transformation of murine fibroblasts. Since murine cells 
contain long telomeres due to active telomerase (Prowse and Greider, 1995; Kipling and 
Cooke, 1990), mTERT overexpression is not required for transformation. The requirement 
for ST in transformation of human fibroblasts is caused by its interaction with protein 
phosphatase 2A (Hahn et al., 2002), which possibly downregulates PTEN (phosphatase 
and tensin homolog) (Boehm et al., 2005). Why ST expression is not required for murine 
transformation is currently unknown. Second, LT-mediated ablation of either the pRB 
or the p53 pathway appeared sufficient for RASV12-induced transformation of mouse 
embryonic fibroblasts, while ablation of both pathways was required for transformation 
of human fibroblasts (Rangarajan et al., 2004). Similarly, Boehm et al. (2005) claimed 
that expression of a dominant-negative version of p53, c-Myc, and RASV12 was sufficient 
for transformation of MEFs, whereas human fibroblasts needed expression of ST and 
suppression of pRB. Also, RASV12- and hTERT-expressing BJ primary human fibroblasts 
could exhibit anchorage-independent growth only upon concomitant knockdown of p53 
and pRB (Voorhoeve and Agami, 2003). Taken together, a widely held view has emerged 
that suppression of both the p53 and pRB pathways is mandatory to transformation of 
human cells while either one of these events is sufficient for transformation of murine 
cells. This view was supported by Sage et al. (2000), who reported anchorage-independent 
growth of TKO MEFs upon expression of RASV12. However, our previous (Peeper et al., 
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2001; Dannenberg et al., 2000) and present results sharply contrast with this view: partial 
or complete pocket protein-deficient MEFs were largely unable to exhibit anchorage-
independent growth upon RASV12 expression. Furthermore, we found that partial ablation 
of the p53 pathway strongly stimulated anchorage-independent growth of pocket protein-
deficient MEFs. We therefore conclude that in murine cells, ablation of the p53 and pRB 
pathways synergistically supports oncogenic transformation and that in this respect, 
mouse fibroblasts are not fundamentally different from human fibroblasts.
Materials and Methods
MEF isolation, cell culture, and retroviral infections 
Rb-/-, p107-/-p130-/-, Rb-/-p107-/-, Rb-/-p130-/-, and Rb-/-p107-/-p130-/- MEFs were isolated from chimeric 
embryos, which were generated by injection of mutant embryonic stem cells into blastocysts as 
previously described (Dannenberg et al., 2000). p107-/- and p130-/- MEFs were isolated from embryos 
which were generated by intercrossing p107+/- and p130+/- mice, respectively. MEFs were cultured in 
Glasgow minimal essential medium (GMEM) (Invitrogen/Gibco) containing 10% fetal calf serum, 
1 mM nonessential amino acids (Invitrogen/Gibco), 1 mM sodium pyruvate (Invitrogen/Gibco), 100 
units of penicillin/ml (Invitrogen/Gibco), 100 μg streptomycin/ml (Invitrogen/Gibco), and 0.1 mM 
β-mercaptoethanol and incubated at 37°C in the presence of 5% CO2. Retroviral supernatants were 
produced by calcium phosphate transfection (Invitrogen) of phoenix cells with 16 μg of the desired 
construct and 4 μg pCL-eco. Forty-eight hours posttransfection, retroviral supernatant was filtered 
using 0.45-μm filters (mixed cellulose ester membrane; Millipore) and immediately frozen using a 
dry ice-ethanol bath and stored at −80°C. After viral supernatant was harvested, phoenix cells were 
supplemented with GMEM containing medium supplements as described above, and supernatant was 
again harvested using the same procedure, with an interval of at least 7 h. MEFs were twice infected 
with viral supernatant, supplemented with Polybrene to a concentration of 4 μg/ml, during a time 
span of at least 7 h per infection. For serial infections, MEFs were cultured in non-virus-containing 
medium for 48 h between infections and reseeded before infection to obtain optimal cell density. 
After the last infection, MEFs were cultured in non-virus-containing medium for at least 48 h.
Constructs 
The pEYK-MCF7 library and pEYK-GFP were a gift of G. Q. Daley. pCl-Eco was kindly provided 
by D. Peeper. pBABE-RASV12 was kindly provided by T. Brummelkamp, pRetroSuper-p53 and 
pRetroSuper-p16INK4A by A. Dirac, and pBABE- p21CIP1 by J. Dannenberg. The pRetroSuper-
p21strong vector was previously generated and contains the following 19-mer p21CIP1 targeting 
sequence: GCCCTCACTCTGTGTGTCT (Foijer et al., 2005). The 19-mer p21CIP1 targeting 
sequence in pRetroSuper-p21weak is ACAGGAGCAAAGTGTGCCG. The pRISC-p16INK4A/p19ARF 
vector was a gift of S. Huang; this vector is a variant of pRetroSuper (pRS) containing an additional 
chloramphenicol resistance marker under the control of a TET promoter and contains the following 
targeting sequence: ATCAAGACATCGTGCGATA.
Soft agar and methylcellulose assays 
For soft agar assays, 6 × 104 MEFs were suspended in 2 ml of a 37°C, 0.35% soft agar solution (low 
gelling agarose type VII from Sigma) in GMEM containing 10% fetal calf serum, the same medium 
supplements as mentioned above plus gentamicin to a concentration of 0.02 mg/ml (Invitrogen/
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Gibco) and plated in one well of a six-well plate. To prevent cells from attaching to the bottom of 
the well, the 0.35% soft agar solution was poured into an ultra-low-attachment surface plate (catalog 
no. 3471; Corning Incorporated) coated with a 1% soft agar layer. To allow solidification of the agar, 
plates were incubated at 4°C for 30 min. Subsequently, cells were incubated at 37°C in the presence 
of 5% CO2 for 2 to 4 weeks. A few drops of fresh medium were added twice a week. Pictures 
were taken using a non-phase-contrast lens (×2.5 magnification) and assembled using Axiovision 
4.5. Detail images were taken using a phase-contrast lens (×5 magnification). For methylcellulose 
assays, 3 × 105 MEFs were suspended in 4 ml of a 37°C, 1.3% methylcellulose solution in GMEM 
supplemented with fetal calf serum to a concentration of 5%, penicillin to a concentration of 100 
units/ml (Invitrogen/Gibco), streptomycin to a concentration of 100 μg/ml (Invitrogen/Gibco), and 
gentamicin to a concentration of 0.02 mg/ml (Invitrogen/Gibco) and plated in one well of a six-well 
ultra-low-attachment surface plate (catalog no. 3471; Corning Incorporated). A 2.6% methylcellulose 
stock solution was obtained from Stem Cell Technologies (catalog no. H4100). Cells were harvested 
by suspending 4 ml of methylcellulose culture with 40 ml ice-cold phosphate-buffered saline (PBS) 
(Invitrogen/Gibco), followed by centrifugation and aspiration of methylcellulose-PBS.
Recovery of retroviral integrations from soft agar colonies 
Soft agar colonies were isolated using sterilized glass pipettes and propagated under attached 
conditions. Cells were lysed overnight (O/N) at 55°C in lysis mix containing 0.1 M Tris HCl (pH 
8.5), 5 mM EDTA, 0.2 M NaCl, 0.2% sodium dodecyl sulfate (SDS), and 100 μg/ml proteinase K. 
Genomic DNA was isolated by phenol-chloroform-isoamyl alcohol extraction, precipitated using 
isopropanol, and dissolved O/N at 37°C in 10 mM Tris HCl (pH 8.0)-0.1 mM EDTA. Recovery 
of retroviral inserts was performed using a shuttle strategy modified from the method of Koh et al. 
(2002). Five micrograms of genomic DNA was digested using 50 units of either NotI (Roche) or AscI 
(New England Biolabs) O/N in 100 μl, followed by an additional 3 h digestion upon the addition 
of 25 units. For each analyzed colony, both digestions were performed. Subsequently, fragments 
were purified using phenol-chloroform-isoamyl alcohol extraction and ethanol precipitated in the 
presence of 200 μg of type VII mussel glycogen (catalog no. G1508; Sigma) at -80°C. Ligation was 
performed O/N at 16°C in a total volume of 200 μl using 2 units of T4 DNA ligase (Roche) and in 
the presence of extra ATP to a concentration of 0.05 mM. An extra 3 h ligation was performed the 
next day upon the addition of 2 units of T4 DNA ligase. Ligated plasmids were purified as described 
above, electroporated in 5 μl of DH10B electromax competent cells per reaction (Invitrogen/Life 
Technologies), and plated on LB plates containing 5 μg of NaCl/liter and 100 μg of zeocin/ml 
(Invitrogen/Life Technologies). Colonies were propagated, and plasmids were isolated according to 
standard protocols. Sequencing was performed using the following primers: FW (5′ CAC CCC CAC 
CGC CCT CAA AGT AG 3′) and RV (5′ GGA ACG GCA CTG GTC AAC TTG G 3′).
MEF injections in immunocompromised mice 
A total of 1 × 106 MEFs were suspended in 200 μl PBS and injected into immunocompromised 
BALB/c nude mice. Mice were inspected twice a week.
Protein isolation, immunoblot, immunoprecipitation, and in vitro kinase assays 
For protein isolations, cells were lysed for 30 min on ice in lysis buffer containing 150 mM NaCl, 
50 mM HEPES (pH 7.5), 5 mM EDTA, 0.1% NP-40, 5 mM NaF, 0.5 mM vanadate, 20 mM 
β-glycerolphosphate, and 1 tablet complete protease inhibitor cocktail (Roche) per 50 ml. After 
centrifugation, protein concentration was determined using Bio-Rad protein assay. For immunoblot 
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analysis, 20 to 30 μg protein was separated on 12% SDS-polyacrylamide gels. Blotting was 
performed by using standard protocols. For immunoprecipitation reactions, lysates were incubated 
with antibody and 50% beads in lysis buffer (either protein A [Pharmacia] or protein A/G [Santa 
Cruz Biotechnology], depending on the antibody used) and incubated O/N at 4°C while rotating. 
Prior to immunoblot analysis, lysates were washed five times in lysis buffer and loaded on 12% SDS-
polyacrylamide gels. Prior to kinase assays, lysates were washed three times in lysis buffer and then 
washed two times in kinase buffer containing 50 mM HEPES (pH 7.5), 5 mM MgCl2, 2.5 mM MnCl2, 
and 1 mM dithiothreitol. Kinase assays were performed by incubating 50 μg protein (CDK2 assay) or 
20 μg protein (Cyclin B1 kinase assay) with 5 μg histone H1 (Roche) and 2.5 μCi [γ-32P]ATP in kinase 
buffer for 30 min at 37°C while shaking. After the reaction was stopped by adding protein loading 
buffer, one-third of this mixture was separated on 10% SDS-polyacrylamide gels, blotted by using 
standard protocols, and exposed to Kodak BioMax XAR films. The antibodies used for immunoblot 
analysis were mouse monoclonal anti- p21CIP1 (F-5, SC-6246; Santa Cruz), mouse monoclonal anti-
RAS (catalog no. 610002; BD Transduction Laboratories), sheep polyclonal anti-p53 (Ab-7, PC35; 
Calbiochem), rabbit anti-TBX2 (kindly provided by M. van Lohuizen), rabbit polyclonal anti-p19ARF 
(ab80; Abcam), and goat polyclonal anti-CDK4 (C-22, SC-260-G; Santa Cruz Biotechnology). 
Secondary antibodies were horseradish peroxidase-conjugated goat anti-mouse, goat anti-rabbit, 
and rabbit anti-goat antibodies (DakoCytomation). The antibodies used for immunoprecipitation 
reactions were rabbit anti-CDK2 (M2; Santa Cruz), mouse anti-Cyclin B1 (GNS1; Santa Cruz) for 
kinase assays, and rabbit anti-Cyclin B1 (H433; Santa Cruz) for immunoblots. Immunoprecipitation 
reactions for Cyclin B1 kinase assay were performed using protein A/G beads (Santa Cruz). All other 
immunoprecipitation reactions were performed using protein A beads (Pharmacia).
FACS analysis
For fluorescence-activated cell sorting (FACS) analysis, cells were trypsinized and fixed in 70% 
ethanol in PBS at 4°C. Subsequently, cells were washed in PBS, suspended in PBS containing 200 
μg/ml RNase A and 20 μg/ml propidium iodide, incubated at 37°C for 15 min, and analyzed using 
Cell Quest and Summit software.
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Supplemental figures
Figure S1: Ectopic expression of p21CIP1 inhibits TBX2-induced transformation of RASV12/ Rb-/-p107-/-p130-/- 
(TKO) MEFs. Cells were transduced with pBABE-RASV12, pEYK-TBX2 and either a pBABE control vector or 
pBABE-p21CIP1. Infected cells were plated in soft agar and pictures were taken after 11 days using a non-
phase contrast lens (2.5x magnification) (A) or a phase contrast lens (5x magnification) (B).
Figure S2: Both TKO and RASV12/TKO MEFs arrest in G2 upon loss of adhesion. Cells were infected with the 
indicated constructs and cultured under adherent conditions or in methylcellulose for 6 days, stained 
with propidium iodide and analyzed by FACS.
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Abstract
Ablation of the pocket proteins pRB, p107 and p130 in mouse embryonic fibroblasts 
(MEFs) abrogated RASV12-induced senescence, but was not sufficient to support RASV12-
induced transformation. To identify events that support transformation, we performed an 
insertional mutagenesis screen in RASV12/Rb-/-p130-/-p107-/- MEFs. As insertional mutagen 
we used the ERM vector, which was specifically designed to enhance gene function, 
and scored for colony formation in soft agar. In one of the colonies, we identified an 
ERM integration in Mapkapk3, however, this integration appeared to abrogate rather than 
to enhance Mapkapk3 expression. Consistently, we found that shRNA-mediated down 
regulation of Mapkapk3 or chemical inhibition of the upstream Map kinase p38 promoted 
anchorage-independent growth.
Introduction
The pocket proteins pRB, p107 and p130 play a key role during cell cycle regulation by 
promoting the G0/G1 state. Consistently, our previous experiments in mouse embryonic 
fibroblasts (MEFs) showed that G1 arrest in response to various growth inhibitory signals 
was abrogated by loss of either pRB and p130, pRB and p107 or all three pocket proteins 
simultaneously. E.g., whereas wild-type MEFs entered premature senescence upon 
expression of RASV12, Rb-/-p130-/- (DKO), Rb-/-p107-/- (DKO) and Rb-/-p130-/-p107-/- (TKO) 
MEFs continued to proliferate. Strikingly though, these pocket-protein deficient MEFs 
could not grow anchorage independently upon expression of RASV12, demonstrating that 
transformation requires additional events (Vormer et al., 2008; Dannenberg et al., 2004; 
Peeper et al., 2001; Dannenberg et al., 2000). 
In Chapter 2, we showed that transformation of RASV12-expressing DKO or TKO 
MEFs could be achieved by expression of TBX2. The TBX2 transcription factor, which 
can both activate and repress transcription of a variety of target genes (Paxton et al., 2002; 
Chen et al., 2001), can downregulate well-known cell cycle inhibitors such as p19ARF 
and, to a lower extent, p16INK4A (Lingbeek et al., 2002; Jacobs et al., 2000). As p16INK4A 
functions upstream of the pocket proteins, TBX2-mediated downregulation of p16INK4A is 
unlikely to contribute to the transformation of pocket protein-deficient MEFs. In line with 
this, we found that downregulation of p19ARF, p53 or p21CIP1 contributed to anchorage-
independent growth of RASV12/TKO MEFs, whereas downregulation of p16INK4A did not 
(Vormer et al., 2008). Interestingly, downregulation of p53 more robustly induced soft agar 
colony formation than downregulation of p21CIP, indicating that additional p53 effectors 
contributed to the induction of transformation. Similarly, one may envision that targets 
of TBX2 functioning in distinct tumor suppressor pathways could contribute to TBX2-
induced transformation of pocket protein-deficient MEFs. We therefore aimed to identify 
additional inducers of anchorage-independent growth. For this purpose, we performed 
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an insertional mutagenesis screen in RASV12/TKO MEFs and found that an inactivating 
proviral insertion in the Mapkapk3 (mitogen-activated-protein-kinase-activated protein-
kinase 3) gene promoted anchorage-independent growth. Consistently, shRNA-mediated 
down-regulation of Mapkapk3 induced anchorage-independent growth of RASV12/pocket 
protein-deficient MEFs.
Results
A retroviral insertional mutagenesis screen to identify mediators of anchorage-
independent growth 
To identify promoters or inhibitors of anchorage-independent growth, we performed 
a retroviral insertional mutagenesis screen in RASV12/TKO MEFs using the Enhanced 
Retroviral Mutagen (ERM) vector (Liu et al., 2000). This retroviral vector is a derivative 
of pBABE and was designed to enhance gene transcription upon integration into the 
genomic DNA. When the ERM virus integrates upstream of an endogenous promoter, 
transcription can be increased via enhancer elements present in ERM. Additionally, a 
splice donor site at the 3’ end of ERM enables splicing towards a splice acceptor site of an 
endogenous exon, resulting in a fusion transcript under the control of the ERM-promoter. 
The latter can occur when integration occurs either upstream or within a genetic locus. 
RASV12/TKO MEFs were infected with ERM, plated under non-adherent conditions (soft 
agar) and monitored for colony formation. Infection with ERM caused a four-fold increase 
in the number of soft agar colonies compared to non-infected RASV12/TKO MEFs. Soft 
agar colonies produced by ERM/RASV12/TKO MEFs were isolated and the position of 
the ERM integration in the genomic DNA was determined using splinkerette PCR. This 
analysis identified an ERM-integration in intron 2 of Mapkapk3 in one of the colonies 
(Fig. 1A). The position of the ERM-integration into Mapkapk3 was confirmed by PCR 
analysis using genomic DNA (Fig. 1B) and by RT-PCR analysis. Sequencing of the RT-
PCR product revealed that the ERM vector had spliced to exon 3 of Mapkapk3 but that the 
ERM-Mapkapk3 fusion was out of frame (Fig. 1C). This suggested that transformation 
was not due to increased expression of Mapkapk3. To study the effect of this integration, 
we generated cDNA from the ERM-Mapkapk3 out-of-frame fusion and inserted this into 
pBABE. Additionally, full-length wild-type Mapkapk3 cDNA was inserted into pBABE. 
Infection of RASV12/TKO MEFs with these vectors and subsequent soft agar plating 
showed that pBABE-Mapkapk3 inhibited the number of background colonies produced 
by RASV12/TKO MEFs, whereas pBABE-ERM-Mapkapk3 had no effect (data not 
shown). These results suggest that overexpression of Mapkapk3 suppressed anchorage-
independent growth and furthermore, that inactivation of one allele of Mapkapk3 by 
ERM insertion had induced transformation.
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RNAi-mediated downregulation of Mapkapk3 promotes anchorage-independent 
growth
To verify that downregulation of Mapkapk3 promotes anchorage-independent growth, we 
generated five different pRetroSuper (pRS) vectors targeting Mapkapk3. Upon infection 
of RASV12/Rb-/-p107-/- MEFs, 2 out of 5 pRS-Mapkapk3 vectors induced colony formation 
in methylcellulose (Fig. 2A). Additionally, we investigated whether downregulation of 
the p38 MAPK pathway, which is an upstream regulator of Mapkapk3, could support 
anchorage-independent growth. Indeed, treatment with the p38 inhibitor SB203580 
induced colony formation in RASV12/Rb-/-p107-/- MEFs, cultured in methylcellulose (Fig. 
2B). In conclusion, downregulation of p38/Mapkapk3 induced anchorage-independent 
growth in RASV12/pocket protein-deficient MEFs.
Figure 1: An insertional mutagenesis screen for anchorage-independent growth of RASV12/TKO MEFs 
reveals integration of ERM into Mapkapk3. (A) Genomic organization of the Mapkapk3 locus in a RASV12/
TKO soft agar colony (number 3.17). ERM is integrated into intron 2 of Mapkapk3. (B) PCR analysis of 3 
different soft agar colonies, demonstrating the presence of the ERM-Mapkapk3 fusion in colony 3.17. The 
positions of the used primers are depicted in (A). (C) Sequence of the ERM-Mapkapk3 RT-PCR product that 
was derived from colony 3.17. Reverse transcription and amplification of ERM-Mapkapk3 was performed 
as described in the Materials and Methods section. Red bases represent the last part of the ERM sequence, 
blue bases represent the out-of-frame Mapkapk3 sequence, which is the resultant of splicing of ERM 
towards exon 3 of Mapkapk3. After reaching a stop codon, the sequence is shown in black.
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Figure 2: Downregulation of Mapkapk3 or p38 MAPK promotes anchorage-independent growth. 
(A) Rb-/-p107-/- MEFs were infected with pBABE-RASV12 plus pRS-Mapkapk3 or empty pRS and cultured 
in methylcellulose for 3 weeks. (B) Rb-/-p107-/- MEFs were infected with pBABE-RASV12, treated with the 
indicated concentrations of the p38 inhibitor SB203580 and subsequently cultured in methylcellulose for 
3 weeks. Pictures were taken using a non-phase-contrast lens (2.5x magnification).
Mapkapk3 regulation by TBX2 and anchorage
Since TBX2 over-expression induced anchorage-independent growth, we performed 
micro-array analyses of RASV12/Rb-/-p107-/- MEFs to identify mRNAs that were regulated 
by loss of anchorage or the presence of TBX2. Strikingly, Mapkapk3 appeared to be one of 
the regulated genes. Fig. 3A shows that non-adherent RASV12/Rb-/-p107-/- MEFs displayed 
a two-fold increase in Mapkapk3 mRNA level compared to their adherent counterparts. 
Expression of TBX2 in non-adherent RASV12/Rb-/-p107-/- MEFs reverted Mapkapk3 
expression to the level observed in adherent RASV12/Rb-/-p107-/- MEFs (Fig. 3A). These 
results suggest that the induction of Mapkapk3 upon loss of anchorage functions as a 
growth suppressor mechanism that can be abrogated by expression of TBX2. Of note, 
the related Mapkapk2, which was previously identified as a downregulated TBX2-target 
(Chen et al., 2001), was not transcriptionally induced upon loss of anchorage, and was 
only slightly inhibited by TBX2. For comparison, loss of anchorage also caused a two- 
to three-fold increase in p21CIP1 and p27KIP1 mRNA levels, which could be inhibited by 
expression of TBX2 (Fig. 3B). This is in line with our previous studies showing that 
downregulation of p21CIP1 could promote anchorage-independent growth of RASV12/
pocket protein-deficient MEFs (Vormer et al., 2008). Taken together, our results identify 
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B
pRS pRS-Mapkapk3-1 pRS-Mapkapk3-2
0 µM 20 µM 40 µM SB203580
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Mapkapk3 as a haploinsufficient suppressor of anchorage-independent growth and 
suggest that the transforming activity of TBX2 is at least partially mediated by down 
regulation of Mapkapk3.
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Figure 3: Regulation of Mapkapk3, p21CIP1 and p27KIP1 by TBX2 and anchorage. (A, B) RASV12/Rb-/-p107-/- 
MEFs were cultured in the presence of TBX2 (cells were infected with pEYK-TBX2) or in the absence of 
TBX2 (cells were infected with pEYK-GFP), under adherent conditions (+ anchorage) or in methylcellulose 
(- anchorage). cDNA was generated from these cells and analyzed on micro-array. The relative expression 
was calculated by dividing the signal produced by the gene of interest by the signal produced by Gapdh.
Discussion
In this study, we have identified Mapkapk3 as a suppressor of anchorage-independent 
proliferation of pocket protein-defective cells. Mapkapk3 was found to be transcriptionally 
induced upon anchorage deprivation and downregulation of Mapkapk3 enabled anchorage-
independent growth: inactivation of one allele of Mapkapk3 by retroviral insertion or 
shRNA-mediated downregulation of Mapkapk3 promoted proliferation under non-
adherent conditions of RASV12/TKO and RASV12/DKO MEFs. Furthermore, we found that 
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the oncogene TBX2 can downregulate Mapkapk3. Thus, downregulation of Mapkapk3 is 
likely to be one of the mechanisms through which TBX2 exerts its transforming activity.
Mapkapk3 can be activated by three different mitogen-activated-protein-kinases 
(MAPK): p38, extracellular-signal-regulated kinase (ERK) and Jun-N-terminal kinase 
(JNK) (Ludwig et al., 1996; Zakowski et al., 2004). These three MAPK pathways can 
all become activated by oncogenic RAS, although ERK and JNK are generally more 
strongly activated than p38 (Chen et al., 2000). The ERK pathway is well known for its 
stimulatory effect on cell cycle progression, however, high levels of activated ERK can 
induce cell cycle arrest. This controversy is illustrated by ERK’s ability to induce both 
Cyclin D1 and p21CIP1 (Sebolt-Leopold and Herrera, 2004; Roovers and Assoian, 2000) 
The stress-activated p38 pathway functions in inhibiting proliferation and counteracting 
transformation (Loesch and Chen, 2008; Han and Sun, 2007). Of relevance, various ways 
of cross talk have been reported between the different MAPK pathways. Particularly, 
active MEK could induce p38 and additionally, activation of p38 by oncogenic RAS 
required the RAF/MEK/ERK pathway (Han and Sun, 2007; Wang et al., 2002; Chen et 
al., 2000). On the other hand, activated p38 could inhibit MEK/ERK (Aguirre-Ghiso et 
al., 2003; Li et al., 2003) and has also been reported to inhibit the proliferation-stimulating 
JNK pathway (Loesch and Chen, 2008; Chen et al., 2000).
 Given the reported growth inhibitory effect of the p38 pathway, we wondered 
whether down-regulation of p38 could promote transformation of RASV12/Rb-/-p107-/- 
MEFs. Indeed, treatment with the p38 inhibitor SB203580 supported anchorage-
independent growth of these cells (Fig. 2B). A tumor suppressor role for p38 could 
simply be explained by the aforementioned inhibition of the proliferation- and survival-
stimulating ERK pathway (Sebolt-Leopold and Herrera, 2004; Li et al., 2003). Along 
these lines, Aguirre-Ghiso and co-workers (2003) suggested that a high p38/ERK ratio 
correlated with cell cycle arrest in cancer cell lines. Additionally, experiments performed 
by Wang and colleagues (2002) pointed to a role for p38 in cell cycle arrest: chemical 
inhibition of p38 or chemical inhibition of MEK, which in turn inhibited p38, counteracted 
RASV12-induced senescence. Thus, their results suggest that RASV12-induced senescence 
is mediated via MEK/p38. 
In addition to inhibiting MEK/ERK, p38 can induce several cell cycle inhibitors 
and tumor suppressors, including p19ARF, p53, p21CIP1, p27KIP1 and p16INK4A (Han and Sun, 
2007), which can all contribute to growth inhibition. In line with this, Bulavin and co-
workers (2004) showed that ablation of the WIP1 phosphatase in MEFs raised the level 
of activated p38, which correlated with inhibition of tumor formation in nude mice via the 
p16INK4A/p19ARF pathways, however, this effect was independent of p53. In contrast, Dolado 
and co-workers (2007) suggested that p38 could inhibit RASV12-induced transformation 
independently of p16INK4A/p19ARF and also independently of affecting ERK. In fact, they 
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correlated p38 with the induction of apoptosis in response to reactive oxygen species 
(ROS), which were produced in response to RASV12 signaling. Similarly, Nicke and co-
workers (2005) suggested that ROS, induced by RASV12, caused activation of p38. In 
conclusion, several different mechanisms could contribute to the tumor suppressor role 
of p38 in our system. 
We consider it likely that p38 suppresses transformation via the induction of cell 
cycle inhibitors, since (1) our previous studies clearly demonstrated that downregulation 
of the p19ARF/p53/p21CIP1 pathway induced transformation of RASV12/pocket protein-
deficient MEFs and (2) Mapkapk3 is possibly involved in regulation of p19ARF. 
Experiments by Voncken et al. (2005) showed that Mapkapk3 can phosphorylate the 
Polycomb group protein BMI1, resulting in its release from the chromatin. BMI1 is part 
of the Polycomb-Repressive Complex which represses the INK4A/ARF locus (Bracken 
et al., 2007; Jacobs et al., 1999). Together, this suggests that Mapakpk3 might inhibit 
transformation via phosphorylation and displacement of BMI1 upon loss of anchorage, 
resulting in the induction of p19ARF. Future studies are required to address this possibility.
 Whereas Mapkapk3 is relatively uncharacterized, Mapkapk2 is a well 
established target of the p38 pathway. A growth suppressive role for p38/Mapkapk2 was 
demonstrated by the observation that expression of p38 or of Mapkapk2 inhibited RASV12-
induced S-phase entry in serum-deprived NIH3T3 cells. Strikingly, both Mapkapk2 
and p38 could inhibit RAS-induced transcription in in vitro reporter assays (Chen et 
al., 2000). Additionally p38/Mapkapk2 was implicated in DNA-damage-induced cell 
cycle arrest in the absence of p53 (Reinhardt et al., 2007; Manke et al., 2005). We did 
not detect transcriptional induction of Mapkapk2 upon loss of anchorage, in contrast to 
Mapkapk3, which was clearly induced. However, since Mapkapk proteins are activated 
by phosphorylation, the possibility remains that Mapkapk2 is activated upon loss of 
anchorage and performs a similar role as Mapkapk3.
 In conclusion, we identified downregulation of Mapkapk3 or p38 as an additional 
event that could promote anchorage-independent growth of RASV12-expressing, pocket-
protein-deficient MEFs. These results point to a tumor suppressor role for Mapkapk3 
signaling upon loss of anchorage. Future experiments are required to determine the 
upstream and downstream mechanisms that mediate this growth-inhibitory role, and 
whether a similar role can be performed by the related Mapkapk2.
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Materials and Methods
Cell culture
MEFs were cultured in GMEM (Invitrogen/Gibco), containing 10% fetal calf serum, 1 mM 
nonessential amino acids (Invitrogen/Gibco), 1 mM sodium pyruvate (Invitrogen/Gibco), 100 
units/ml penicillin (Invitrogen/Gibco), 100 μg/ml streptomycin (Invitrogen/Gibco) and 0.1 mM 
β-mercaptoethanol and incubated at 37 °C in the presence of 5% CO2. 
Retroviral supernatants were produced by calcium phosphate transfection (Invitrogen) of 
phoenix cells with 16 μg of the desired construct and 4 μg pCL-Eco. Forty-eight h post transfection, 
retroviral supernatant was filtered using 0.45 μm filters (MCE membrane, Millipore) and either used 
directly or immediately frozen using a dry-ice ethanol bath and stored at -80 °C. After harvesting 
viral supernatant, phoenix cells were supplemented with GMEM containing media supplements as 
described above, and supernatant was again harvested using the same procedure, with an interval of 
at least 6 h. Subconfluent cell cultures were infected twice with retroviral supernatants, supplemented 
with polybrene to a concentration of 4 μg/ml during a time-span of at least 6 h per infection. For serial 
infections, MEFs were cultured in non-virus containing media for at least 36 h between infections 
and reseeded before infection to obtain optimal cell density. 
 Culturing without anchorage was performed in either soft agar or in methylcellulose-
containing medium, as described in Vormer et al. (2008). In short, MEFs were suspended in a 37 
°C, 0.35% soft agar solution (low gelling agarose type VII from Sigma) in GMEM containing 
10% fetal calf serum, the same medium supplements as mentioned above plus gentamicin to 
a concentration of 0.02 mg/ml (Invitrogen/Gibco) and plated on top of a pre-casted 1% soft agar 
layer. For methylcellulose assays, MEFs were suspended in a 37 °C, 1.3% methylcellulose solution 
(diluted from 2.6% methylcellulose medium, Stem Cell Technologies, catalog no. H4100) in GMEM 
supplemented with fetal calf serum to a concentration of 10%, penicillin to a concentration of 100 
units/ml (Invitrogen/Gibco), streptomycin to a concentration of 100 μg/ml (Invitrogen/Gibco) and 
gentamicin to a concentration of 0.02 mg/ml (Invitrogen/Gibco) and plated in ultra-low-attachment 
surface plates (catalog no. 3471; Corning incorporated). Pictures were taken using a non-phase-
contrast lens (2.5x magnification) and assembled using ‘Axiovision 4.5’. Cells were harvested by 
suspending 4 ml of methylcellulose culture with 40 ml ice-cold phosphate-buffered saline (PBS) 
(Invitrogen/Gibco), followed by centrifugation and aspiration of methylcellulose-PBS.
Constructs and PCR analysis
The ERM vector was kindly provided by Dr. Z. Songyang, pBABE-RASV12 by Dr. T Brummelkamp 
and pCL-Eco by Dr. D. Peeper. The pEYK-TBX2 vector was previously isolated from MEFs infected 
with the pEYK-MCF7 library (Vormer et al., 2008), which was a gift of Dr. G.Q. Daley. 
PCR analysis (Fig. 1B) which demonstrated the ERM-Mapkapk3 fusion in a soft agar 
colony isolated from the insertional mutagenesis screen was performed with the following primers: 
ERM forward (fv): 5’ GGC CAT GGA CAC CTA CCG CTA CAT CG 3’; Intron 2 fv: 5’ CTC ATA 
AGC TGA CCC ACC CT 3’; Intron 2 reverse (rv): 5’ CCT TGA CTC ACC TTC ATG ATC C 3’. 
For analysis of the ERM-Mapkapk3 fusion at the mRNA level (Fig. 1C), reverse transcription 
was performed using a primer annealing to the 3’ end of Mapkapk3, downstream of the stopcodon 
(5’ CCC CAA GTT CAA TGT GAC AC 3’). The RT fragment was subsequently amplified using the 
same primer and a primer annealing to the myristylation signal of ERM (5’ ACC ATG GGG AGC 
AGC AAG AGC AAA CCA AAA GAC CCC AGC CAA CGC 3’ (Liu et al., 2000)). The resulting 
RT-PCR product was cloned into pGEM-Teasy and sequenced using primers annealing to the T7 or 
Sp6 sequence present in pGEM-Teasy. Next, the ERM-Mapkapk3 RT-PCR product was cloned from 
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pGEM-Teasy into pBABE-bleomycin using the EcoRI site, generating pBABE-ERM-Mapkapk3. 
Full-length, wild-type Mapkapk3 was reverse transcribed using the primer annealing to 
the 3’ end of Mapkapk3 (see above), amplified using this primer and a primer located upstream of 
the Mapkapk3 start codon (5’ GCT GTA CGT GCC TCT GGA C 3’), cloned into pGEM-Teasy and 
sunsequently into pBABE-bleomycin using the EcoRI site, generating pBABE-Mapkapk3.
Targeting sequences in pRetroSuper-Mapkapk3 vectors are: GCT CCT CAG CCT CAC 
AAG G (pRS-Mapkapk3-1) or GGA AAA AGC AGG CAG GCA GC (pRS-Mapkapk3-2).  
Insertional mutagenesis screen
Rb-/-p107-/-p130-/- MEFs were retrovirally infected with pBABE-RASV12 and ERM and subsequently 
cultured in 0.35% soft agar. Soft agar colonies were isolated using sterilized glass pipettes and 
propagated under adherent conditions, after which genomic DNA (gDNA) was isolated by lysis in 
0.1 M TrisHCl pH 8.5, 5 mM EDTA, 0.2 M NaCl, 0.2 % SDS and 100 µg/ml Proteinase K (O/N 
at 55 ºC) and subsequent ethanol precipitation. gDNA was dissolved in Milli-Q water and purified 
using phenol/chloroform extraction. The position of the ERM integrations in the genomic DNA was 
determined using splinkerette PCR conform Mikkers et al. (2002), followed by sequencing. 
Micro-array analysis
RNA was isolated using the RNeasy mini kit (Qiagen, catalog nr 74106). mRNA amplification 
using the Superscript RNA Amplification System (Invitrogen, catalog no. L1016-01), labeling and 
hybridization to MouseWG-6 v2.0 Expression BeadChip (Illumina) was performed as described on:
http://microarray.nki.nl/download/protocols.html.
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Abstract
Members of the pocket protein family (pRB, p130 and p107) play a key role in G1 by 
binding and inhibiting the activity of E2F transcription factors via blockage of E2F’s 
transactivation domain and via the recruitment of chromatin remodeling proteins. The 
latter occurs via binding of the pocket region to an LxCxE motif in the target protein. 
In this study, we generated mouse embryonic fibroblasts (MEFs) carrying a mutation 
in pRB, pRBN750F, which abrogated binding of pRB to LxCxE-containing proteins, 
while maintaining the ability to inhibit E2F-mediated transactivation. We show that 
RbN750F/N750F and RbN750F/N750Fp130-/- MEFs arrested efficiently in G1 in response to growth 
factor deprivation or cell-cell contact. Strikingly, RbN750F/N750F MEFs were impaired 
in arresting in response to γ-irradiation. Additionally, RbN750F/N750Fp130-/- MEFs, but 
not p130-/- MEFs, were impaired in arresting in response to expression of RASV12. In 
conclusion, our results show that the pRB-LxCxE interaction is critical for G1 arrest in 
response γ-irradiation or expression of RASV12, thereby possibly contributing to the tumor 
suppressor activity of pRB.
Introduction
A frequent event towards the development of cancer is loss of the retinoblastoma tumor 
suppressor gene, RB1, or one of its upstream regulators. pRB and its close homologs 
p130 and p107 form the family of pocket proteins and play a key role during cell cycle 
regulation. They collectively regulate the family of E2F transcription factors, whose 
activity is essential for progression of the cell cycle from G1 into S phase. To date, eleven 
E2F transcription factors have been identified, which are generally classified as activator 
E2Fs (E2F1, E2F2 and E2F3a) and repressor E2Fs (E2F3b, E2F4, E2F5, E2F6a, E2F6b, 
E2F7a, E2F7b and E2F8). Whereas pRB can interact with E2F1-4 (Moberg et al., 1996), 
p130 and p107 interact with E2F4 and E2F5. E2F6-8 do not bind pocket proteins and thus 
function independently (reviewed by DeGregori and Johnson, 2006; Dimova and Dyson, 
2005; Frolov and Dyson, 2004).
Pocket protein-E2F complexes fluctuate during the cell cycle. E2F4 is present at 
all cell cycle stages, though binding to promoters mainly occurs in G0 and early G1, and is 
correlated with repression of E2F target genes. At this stage, E2F4 primarily complexes 
with p130 and to a lower extent with pRB and p107. At the G1/S transition, E2F4-p130 
complexes are replaced by E2F4-p107 and E2F4-pRB complexes. Simultaneously, free, 
unbound E2Fs become visible at the G1/S transition, coinciding with transcription of E2F 
target genes (Balciunaite et al., 2005; Rayman et al., 2002; Takahashi et al., 2000; Moberg 
et al., 1996; Cobrinik et al., 1993). The balance between pocket protein-bound and free 
E2Fs is regulated by the Cyclin-dependent kinases, which phosphorylate the pocket 
proteins, causing disruption of pocket protein-E2F binding. This enables activating E2Fs 
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to induce transcription and to drive cell cycle progression (reviewed by Macaluso et al., 
2006; Frolov and Dyson, 2004).
Expression of E2F target genes, which is required for cell cycle progression, 
is inhibited by the formation of pocket protein-E2F complexes. Pocket protein-binding 
blocks E2F’s transactivation domain, resulting in direct inhibition of E2F-mediated 
transcription. Additionally, pocket proteins can recruit chromatin-remodeling complexes 
to promoters of E2F target genes by their capacity to simultaneously bind to E2Fs and 
to proteins containing an LxCxE-like motif (x encoding any amino acid) (reviewed by 
Dick, 2007). 
The LxCxE motif was originally identified as the motif present in viral 
oncoproteins that is used to bind and inactivate pRB. The LxCxE-binding site in pRB 
is highly conserved and a variety of proteins use an LxCxE motif to interact with pRB 
and the other pocket proteins (reviewed by Dick, 2007). Many LxCxE-containing 
proteins have been implicated in chromatin remodeling and transcriptional repression, 
indicating that pocket protein-E2F complexes can favor a chromatin state incompatible 
with transcription. Examples of chromatin remodeling proteins containing an LxCxE-
like sequence are histone deacetylase 1 (HDAC1), HDAC2, heterochromatin protein 1 
(HP1) and the CtBP-interacting protein (CtIP) (reviewed by Dick, 2007). HDAC1/2-
pocket protein binding was shown to involve the LxCxE binding site (Chen and Wang, 
2000; Dahiya et al., 2000; Ferreira et al., 1998; Magnaghi-Jaulin et al., 1998) and pocket 
protein-mediated repression of E2F-reporter constructs involved HDAC activity (Brehm 
et al., 1998; Ferreira et al., 1998; Magnaghi-Jaulin et al., 1998). Moreover, pocket 
proteins and HDACs could be detected at the promoter regions of E2F-regulated genes 
during cell cycle arrest (Morrison et al., 2002; Rayman et al., 2002; Dahiya et al., 2001), 
pointing to the involvement of the pocket protein-LxCxE interaction in HDAC-mediated 
transcriptional repression. In addition to HDACs, the Suv39h1 histone methyltransferase 
enhanced pocket protein-mediated repression of reporter constructs in vitro, however, no 
LxCxE-like sequence was detected in Suv39h1. Strikingly, pRB/p107-Suv39h1 complex 
formation and histone methyl transferase activity of pulled down GST-pRB could be 
inhibited by an LxCxE-containing competitor peptide (Nicolas et al., 2003; Nielsen et 
al., 2001; Vandel et al., 2001). Since a pRB-Suv39h1-HP1 complex could be formed in 
vitro (Nielsen et al., 2001), this suggests that pocket protein-Suv39h1 binding possibly 
involves the LxCxE-containing protein HP1. In conclusion, the pocket protein-LxCxE 
interaction has been implicated in both HDAC- and Suv39h1-mediated transcriptional 
repression.
 Given the involvement of LxCxE-mediated interactions between pocket proteins 
and chromatin remodeling proteins in transcriptional repression, we wondered whether 
these interactions are crucial for pRB’s tumor suppressor function. To this aim, we 
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generated MEFs carrying a mutation in the LxCxE binding site of pRB (RbN750F/N750F 
MEFs). As the induction of G1 arrest upon growth inhibitory signals is an important 
aspect of pRB’s tumor suppressor function, we analyzed the response of RbN750F/N750F 
MEFs to various growth inhibitory signals in tissue culture. Importantly, loss of pRB can 
be compensated for by expression of p130: while ablation of pRB had no or a minor effect 
on G1 arrest induced by serum deprivation, prolonged culturing or RASV12 expression, 
the additional loss of p130 bypassed cell cycle arrest and stimulated proliferation 
(Dannenberg et al., 2004; this communication). Therefore, we generated MEFs mutant 
for pRB and deficient for p130 (RbN750F/N750Fp130-/- MEFs) and analyzed the response of 
these MEFs to various growth inhibitory signals in tissue culture. Our results show that 
the pRB-LxCxE interaction contributes to cell cycle arrest in response to expression of 
RASV12 or γ-irradiation.
Results
Mutating the LxCxE binding site of pRB impairs transcriptional repression
The crystal structure of human pRB bound to a human papillomavirus-16 E7 LxCxE 
peptide revealed that LxCxE-mediated binding occurs via a hydrophobic groove in the 
B domain of the pRB pocket. Whereas the A domain is required for stable folding of 
the B domain, binding to the LxCxE peptide involves four conserved residues in the 
B domain: Asn 757, Tyr 756, Lys 713 and Tyr 709 (Lee et al., 1998). Mutating Asn 
757 to phenylalanine in human pRB is predicted to cause steric hindrance and to disrupt 
hydrogen bonding with the LxCxE motif. Indeed, this mutation disrupted binding to 
LxCxE-containing proteins. Importantly, binding to E2F1, which does not contain an 
LxCxE sequence, remained intact (Chen and Wang, 2000; Dahiya et al., 2000). To 
investigate whether binding of LxCxE containing proteins to pRB is crucial for pRB’s 
role in cell cycle regulation, we mutated Asn 750 in murine pRB, which corresponds to 
Asn 757 in human pRB, to phenylalanine. Co-immunoprecipitation experiments showed 
that the N750F substitution abrogated the interaction of pRB with the LxCxE containing 
protein SV40 large T antigen (TAg) (Fig. 1A). This confirms disruption of the LxCxE 
binding site in murine pRBN750F, as was described for human pRBN757F (Chen and Wang, 
2000; Dahiya et al., 2000).
To test the ability of pRBN750F to repress transcription, we introduced a reporter 
construct containing 6 E2F binding sites upstream of the luciferase gene into mouse 
Rb-/- 3T9 cells. Luciferase activity was induced by ectopic expression of E2F1 (Fig. 1B, 
lanes 1 and 2) and could be efficiently reversed by co-expression of either wild-type 
pRB or pRBN750F (Fig. 1B, compare lanes 3 to 5 with lane 6 to 8). As a control, we used 
pRBC699F, the murine variant of human pRBC706F, which is considered a null mutant: the 
C706F mutation disrupted binding to E2Fs (Otterson et al., 1997) and LxCxE-containing 
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Figure 1: Characterization of pRBN750F. (A) pRBN750F does not interact with SV40 TAg. Rb-/- C33A cells were 
transfected with pSG5-TAg plus empty pcDNA3.1(-) (vector) or pcDNA3.1(-) encoding HA-tagged wild-
type or mutant versions of murine pRB. Upper panel: protein extracts were immunoprecipitated using 
anti-HA antibody and immunoblotted using anti-TAg and anti-HA, the latter visualizing HA-pRB. Lower 
panel: total protein extracts (input) were immunoblotted for TAg and HA. (B-E) Transcriptional repression 
by wild-type and mutant pRB in various luciferase reporter assays. Rb-/- 3T9 cells were transfected with 
the indicated constructs, using the following amounts of plasmid per well of a 12-wells plate: 6xE2F-
luciferase reporter or GAL4-TK-luciferase reporter: 200 ng; CMV-HA-E2F1: 0.8 ng; CMV-HA-E2F4: 20 ng; 
pcDNA3.1(-)-mRb wild-type or pcDNA3.1(-)-mRb mutant: 3.2, 8 and 20 ng in (B), 3.2 ng in (C) and 140 
ng in (D); pM encoding GAL4-pRB wild-type or GAL4-pRB mutant: 20 ng; CMV-Renilla: 4 ng. Luciferase/
Renilla luminescence is plotted in B-D and set to 100% in lane 2 (B and D) or lane 1 (C). Fold repression, 
defined as (Luciferase/Renilla luminescence)GAL4-pRB wildtype or  mutant / (Luciferase/Renilla luminescence)GAL4 
is plotted in E. 
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proteins (Kratzke et al., 1992; Bignon et al., 1990; Kaye et al., 1990), caused impaired 
transcriptional repression in reporter assays (Sellers et al., 1995) and was unable to 
inhibit proliferation of SAOS2 cells (Otterson et al., 1997). Indeed, pRBC699F was severely 
impaired in repressing E2F1-induced transcription (Fig. 1B, lanes 9 to 11). In the absence 
of ectopically-expressed E2F1, pRBN750F repressed the luciferase reporter with similar 
efficiency as wild-type pRB, whereas pRBC699F did not repress the reporter at all (Fig. 
1C). These experiments demonstrate the ability of pRBN750F to bind and inhibit E2F 
transcription factors, probably by masking E2F’s transactivation domain.
In contrast to the results obtained with E2F1, pRBN750F could only partly repress 
the E2F-luciferase reporter upon expression of E2F4 (Fig. 1D, compare lanes 2, 3 and 
4). Recruitment of E2F4 to promoters generally correlates with transcriptional repression 
(Rayman et al., 2002; Takahashi et al., 2000), most likely via the formation of E2F4-
pocket protein-chromatin remodeling complexes. Alternatively, E2F4 can also function 
as a transcriptional activator (Kinross et al., 2006; Muller et al., 1997) and indeed, we 
observed E2F4-mediated induction of the E2F-luciferase reporter (Fig. 1D, compare 
lanes 1 and 2). We propose that pRBN750F can inhibit E2F4-mediated transactivation, but 
is impaired in the formation of E2F4-pRB-chromatin remodeling complexes, resulting in 
the observed partial inhibition of E2F4-mediated transcription. 
To specifically analyze repressor activity of pRB, we fused pRBwt, pRBN750F 
and pRBC699F to a GAL4-DNA binding motif, targeting pRB to a co-transfected GAL4-
TK-luciferase reporter construct. Compared to pRBwt, both pRBN750F and pRBC699F were 
severely impaired in repressing transcription of this reporter (Fig. 1E). All together, 
we conclude that pRBN750F is able to interact with E2F transcription factors, as it can 
efficiently inhibit E2F1-induced transcription of the E2F-luciferase reporter. However, 
pRBN750F is unable to establish complete transcriptional repression, as it is impaired in (1) 
repressing E2F4-induced transcription of the E2F-luciferase reporter and (2) repressing 
transcription when targeted to the GAL4-TK-luciferase reporter. 
Generation of RbN750F/N750F and RbN750F/N750Fp130-/- MEFs
To test the impact of mutating the LxCxE binding site in pRB on cell cycle control, we 
generated MEFs homozygous for the RbN750F mutation. As the tumor suppressor function 
of pRB is believed to rely on establishing cell cycle arrest under growth inhibitory 
conditions, the generated MEFs were tested for their ability to arrest in response to various 
inhibitory signals in culture (see below). We and others have previously shown that loss 
of pRB alone did not bypass cell cycle arrest in MEFs, due to compensation by p130 and 
p107. Importantly, while ablation of pRB had no or a minor effect on G1 arrest in response 
to various inhibitory signals, the additional loss of either p130 or p107 bypassed cell cycle 
arrest and stimulated proliferation (Dannenberg et al., 2004; Dannenberg et al., 2000). As 
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p130 is the main pocket protein recruited to repressed promoters during G0 and G1, we 
additionally generated the RbN750F mutation in a p130 null background. 
To generate MEFs containing the RbN750F mutation, we made use of RbN750F/wt mice 
that were generated by Aarts et al. (2006) using oligonucleotide-directed modification 
of the endogenous Rb gene in murine embryonic stem cells (Fig. S1A). These mice 
were crossed with p130wt/- mice and subsequent intercrossings enabled the isolation of 
RbN750F/N750Fp130-/- and RbN750F/N750Fp130wt/wt MEFs. Additionally, Rb-/-p130-/-, Rb-/-p130wt/wt, 
Rbwt/wtp130-/- and Rbwt/wtp130wt/wt MEFs were isolated from inter- and intra-crosses of 
Rbwt/-p130wt/wt and Rbwt/wtp130wt/- mice. 
When compared to Rbwt/wtp130-/- MEFs, RbN750F/N750Fp130-/- MEFs expressed 
similar levels of pRB (Fig. S1B, compare lanes 1 and 3, 4 and 6, and 7 and 8). Strikingly, 
RbN750F/N750Fp130-/- MEFs displayed elevated expression of Cyclin E and p107 during 
asynchronous proliferation (Fig. S1B, lanes 1 and 3), upon expression of RASV12 (Fig. 
S1B , lanes 4 and 6) and after serum starvation (Fig. S1B , lanes 7 and 8). Additionally, 
increased expression of Cyclin A was observed in RbN750F/N750Fp130-/- MEFs upon expression 
of RASV12 (Fig. S1B, lanes 4 and 6). These observations demonstrate the involvement 
of the pRB-LxCxE interaction in repression of E2F target genes. In Rb-/-p130-/- MEFs 
the levels of Cyclin E, Cyclin A and p107 were higher than in RbN750F/N750Fp130-/- MEFs 
(Fig. S1B, compare lanes 2 and 3, 5 and 6). These results are consistent with the relieve 
of pRB-mediated repression of E2F-target genes in RbN750F/N750Fp130-/- MEFs, while the 
regulation of E2F transactivation activity was still intact.
Response of RbN750F/N750F and RbN750F/N750Fp130-/- MEFs to growth inhibitory signals in 
tissue culture
We tested the ability of RbN750F/N750F and RbN750F/N750Fp130-/- MEFs to arrest in response 
to the following growth inhibitory signals: growth factor deprivation, cell-cell contact, 
expression of constitutively active RAS (RASV12), γ-irradiation, and anchorage deprivation. 
We have previously found that (partial) override of cell cycle arrest in response to serum 
deprivation, cell-cell contact or expression of RASV12 could be achieved by loss of both 
pRB and p130, whereas loss of pRB only had a very minor effect (Foijer et al., 2005; 
Dannenberg et al., 2004; Dannenberg, unpublished). In contrast, G1 arrest in response 
to γ-irradiation was predominantly dependent on functional pRB (Brugarolas et al., 
1999; Dannenberg, unpublished). Concerning anchorage deprivation, we have found that 
Rb-/-p130-/- MEFs arrested efficiently in the absence of anchorage, but this could be 
overcome by the combined expression of RASV12 and TBX2 (Vormer et al., 2008).
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Growth factor deprivation
Serum deprivation of wild-type MEFs causes an arrest in both the G1 and G2 phases 
of the cell cycle. Consistent with their role during G1, loss of all three pocket proteins 
bypassed G1 arrest and shifted the arrest towards G2 (Foijer et al., 2005).  Table 1 shows 
the response of RbN750F/N750F, RbN750F/N750Fp130-/- and wild-type MEFs to serum deprivation. 
The strength of the arrest is depicted by the (G1+G2)/S ratios in serum starved versus 
serum stimulated cells. Consistent with previous results (Foijer et al., 2005; Dannenberg, 
unpublished), the single loss of either pRB or p130 did not affect cell cycle arrest upon 
serum deprivation, whereas the combined loss of pRB and p130 resulted in an impaired 
arrest (compare ratios of wild-type, Rb-/-, p130-/- and Rb-/-p130-/- MEFs). In contrast to 
Rb-/-p130-/- MEFs, RbN750F/N750Fp130-/- MEFs arrested as efficiently as wild-type and 
p130-/- MEFs. Additionally, RbN750F/N750Fp130-/- MEFs arrested efficiently in G1, whereas 
arrest in Rb-/-p130-/- MEFs had shifted slightly towards G2 (Fig. S2). These results 
confirm that bypass of G1 arrest upon serum deprivation requires loss of at least two 
pocket proteins, and furthermore, demonstrate that the interaction of pRB with LxCxE-
containing proteins is not required for G1 arrest upon serum deprivation.
Table 1: RbN750F/N750Fp130-/- MEFs arrest efficiently in response to growth factor deprivation, which is in 
contrast to Rb-/-p130-/- MEFs and demonstrates that the pRB-LxCxE interaction is not required for G1 arrest 
under these conditions. MEFs were cultured in the presence or absence of serum, stained for BrdU and 
propidium iodide incorporation and analyzed by FACS. G1- and G2-phase populations were defined as 
the populations of cells with a 2N or 4N DNA content as apparent in the propidium iodide profile. The 
S-phase population was defined as the BrdU-positive population of cells with a DNA content ranging 
from 2N to 4N.
Rb-/-
wild-type
Rb-/-p130-/-
Cell line Condition (G1 + G2)/S
Fold increase in (G1+G2)/S 
upon serum starvation
p130-/-
RbN750F/N750F
RbN750F/N750Fp130-/-
+ serum
7 days serum starved
 2,4
27,6
+ serum
7 days serum starved
+ serum
7 days serum starved
+ serum
7 days serum starved
+ serum
7 days serum starved
+ serum
7 days serum starved
 1,6
15,5
 1,8
18,2
 1,6
10,2
 1,7
20,0
 1,7
18,7
11,6
9,6
10,0
6,3
11,8
10,9
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It still remained possible that, in response to serum deprivation, pRBN750F induced 
a less stringent arrest than pRBwt. To test this possibility, we analyzed the rate of cell 
cycle re-entry of serum-starved RbN750F/N750Fp130-/- MEFs upon serum re-addition. As 
shown in Fig. 2, RbN750F/N750Fp130-/- MEFs re-entered the cell cycle with similar kinetics as 
p130-/- MEFs. In contrast, release from G1 arrest occurred slightly earlier in Rb-/-p130-/- 
MEFs compared to RbN750F/N750Fp130-/- or p130-/- MEFs (Fig. 2, compare lane 4 of the upper, 
middle and lower panels: a reduction in G1 phase and increase in S-phase is observed in 
Rb-/-p130-/-, but not in RbN750F/N750Fp130-/- or p130-/- MEFs). We conclude that ablation of 
the pRB-LxCxE interaction did not affect G1 arrest in response to serum deprivation.
Figure 2: Similar kinetics of cell cycle re-entry after growth factor deprivation for RbN750F/N750Fp130-/- and 
p130-/- MEFs. p130-/-, RbN750F/N750Fp130-/- and Rb-/-p130-/- MEFs were either cultured in 10% serum or in 0% 
serum for 7 days, after which they were provided with 10% serum for the indicated time points. BrdU was 
added 1 h before harvesting. Harvested cells were stained for BrdU and propidium iodide incorporation 
and analyzed by FACS. G1-, G2- and S-phase populations were defined conform the legend of Table 1.
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Cell-cell contact 
Similar to serum deprivation, cell-cell contact induced arrest of wild-type MEFs in both 
G1 and G2 phase. Ablation of all three pocket proteins resulted in complete override of 
cell cycle arrest (Table 2 and Dannenberg et al., 2000). Analyzing the (G1+G2)/S ratio 
in contact inhibited versus subconfluent cultures demonstrated a small but reproducible 
reduction of cell cycle arrest in Rb-/-p130-/-, but not in RbN750F/N750Fp130-/- MEFs (Table 2). 
This indicates that in a p130 null background, loss of pRB, but not abrogation of the pRB-
LxCxE interaction, partially bypassed cell cycle arrest (Table 2).
Table 2: RbN750F/N750Fp130-/- MEFs arrest efficiently in response to cell-cell contact, demonstrating that 
the pRB-LxCxE interaction is not required for G1 arrest under these conditions. Subconfluent or contact-
inhibited MEFs were stained with propidium iodide and analyzed by FACS to determine G1-, G2- and 
S-phase populations.
Rb-/-
wild-type
Rb-/-p130-/-
Cell line Condition (G1 + G2)/S
Fold increase in (G1+G2)/S 
upon contact inhibition
p130-/-
RbN750F/N750F
RbN750F/N750Fp130-/-
subconfluent
contact inhibited
 6,2
34,1
 6,8
27,0
 6,4
26,1
 8,2
23,1
 4,7
35,6
 5,3
33,0
5,5
4,0
4,1
2,8
7,6
6,3
Rb-/-p130-/-p107-/-
subconfluent
contact inhibited
subconfluent
contact inhibited
subconfluent
contact inhibited
subconfluent
contact inhibited
subconfluent
contact inhibited
subconfluent
contact inhibited
6,2
7,8
1,2
Ionizing radiation
Also γ-irradiation-induced cell cycle arrest occurs in G1 and G2. However, G1 arrest in 
response to γ-irradiation was primarily dependent on functional pRB (Brugarolas et 
al., 1999; Dannenberg, unpublished). Indeed, we found that Rb-/- MEFs were severely 
impaired in arresting the cell cycle in response to γ-irradiation: in response to irradiation 
with 5.5 Gy, wild-type and p130-/- MEFs displayed a 45-50% reduction in S phase cells, 
whereas Rb-/- MEFs displayed a reduction of only 25% (Fig. 3A, lanes 1-6). Similarly, the 
fold increase in (G1+G2)/S ratio of irradiated versus untreated cells revealed an impaired 
arrest in Rb-/- MEFs (Fig. 3B, compare fold increase of wild-type and Rb-/- MEFs, lanes 
1 and 2). 
In addition to Rb-/- MEFs, we found that also RbN750F/N750F MEFs were impaired in 
arresting in response to irradiation: RbN750F/N750F MEFs treated with 5.5 Gy of γ-irradiation 
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displayed a reduction in S phase cells of only 35% (Fig. 3A, lanes 9 and 10) and the fold 
increase in (G1+G2)/S ratio upon irradiation was very similar for RbN750F/N750F and Rb-/- 
MEFs (Fig. 3B, compare lanes 2 and 5). Thus, RbN750F/N750F MEFs were almost as impaired 
as Rb-/- MEFs in irradiation-induced cell cycle arrest. These results are consistent with 
recent findings of Talluri and co-workers (2010), who showed that MEFs with an impaired 
pRB-LxCxE interaction arrested less stringently in G1 upon γ-irradiation. Furthermore, 
we found that p130 did not affect the cellular response to irradiation, as RbN750F/N750Fp130-/- 
MEFs displayed a similar fold increase in (G1+G2)/S ratio as RbN750F/N750F MEFs upon 
irradiation (Fig. 3B, compare lanes 5 and 6). 
Treatment with higher doses of irradiation demonstrated that RbN750F/N750F MEFs 
displayed an intermediate phenotype: RbN750F/N750F MEFs arrested less efficiently than 
wild-type MEFs, but more efficiently than Rb-/- MEFs upon irradiation with 10 or 15 Gy 
(Fig. 3C, lanes 4 to 6 and 7 to 9). Interestingly, irradiation with 10 or 15 Gy induced a 
shift from G1 towards G2 arrest in both RbN750F/N750F MEFs and Rb-/- MEFs (Fig. S3). These 
results demonstrate that both RbN750F/N750F and Rb-/- MEFs were impaired in arresting in G1 
upon irradiation, resulting in an increase in G2 arrest. 
To study the stringency of the residual G1 arrest in RbN750F/N750F MEFs in response 
to γ-irradiation, we analyzed S phase entry of synchronized, γ-irradiated MEFs: serum 
starved RbN750F/N750F, Rb-/- and Rbwt/wt  MEFs were re-stimulated with serum and subsequently 
irradiated 7 h later. As shown in Fig. 3D, both RbN750F/N750F and Rb-/- MEFs entered S 
phase slightly earlier compared to Rbwt/wt MEFs, with Rb-/- MEFs again displaying a more 
severe phenotype than RbN750F/N750F MEFs. In conclusion, our results point to a small but 
reproducible involvement of the pRB-LxCxE interaction in inducing G1 arrest in response 
to γ-irradiation.
Expression of RASV12
We have previously shown that loss of pRB only was not sufficient for bypass of RASV12-
induced senescence in MEFs. However, senescence bypass could be accomplished by 
loss of pRB and p130, pRB and p107, or all three pocket proteins (Dannenberg et al., 
2004; Peeper et al., 2001). To test whether the pRB-LxCxE interaction is involved in 
G1 arrest in response to RASV12, we analyzed proliferation rates of RbN750F/N750Fp130-/-, 
Rb-/-p130-/- and p130-/- MEFs upon expression of RASV12 (Fig. 4). Strikingly, we found 
that similar to Rb-/-p130-/- MEFs, RbN750F/N750Fp130-/-  MEFs maintained a high proliferation 
rate in the presence of RASV12, whereas proliferation of p130-/- MEFs almost ceased. 
These results show that the pRB-LxCxE interaction is critical for the establishment of cell 
cycle arrest in response to RASV12.
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Figure 3: The pRB-LxCxE interaction is involved in cell cycle arrest after γ-irradiation. (A) MEFs of the 
indicated genotypes were either untreated or irradiated with 5.5 Gy and harvested 16 h post irradiation. 
BrdU was added 1 h before harvesting. Harvested cells were stained for BrdU and propidium iodide 
incorporation and analyzed by FACS. (B) Fold increase in (G1+G2)/S in 5.5 Gy-irradiated versus untreated 
MEFs. Depicted is the average fold increase, calculated from 2 independent experiments. One of 
these experiments is shown in (A). (C) Fold increase in (G1+G2)/S in response to the indicated doses of 
irradiation. (D) Cell cycle re-entry of synchronized, irradiated MEFs. Cells were serum-starved for 7 days 
and subsequently stimulated with 10% serum. Seven h after serum stimulation, cells were irradiated with 
15 Gy and fixed at the indicated time after irradiation. BrdU was again added 1 h before harvesting and 
cells were analyzed by FACS. G1-, G2- and S-phase populations were defined conform the legend of Table 
1.
0 %
20 %
10 %
A
70 %
60 %
50 %
40 %
80 %
90 %
100 %
30 %
C
5.5 Gy
10 Gy
15 Gy
+ + +
+ + +
+ + +
0.0Fo
ld
 in
cr
ea
se
 ( 
G
1+
G
2/
S)
 
1.5
1.0
0.5
2.0
2.5
3.0
3.5
B
D
ir
ra
d
ia
te
d
 v
er
su
s 
n
o
n
-t
re
at
ed
0.0
0.5
w
ild
-t
yp
e
Rb
-/
-
p1
30
-/
-
Rb
-/
- p
13
0-
/-
Rb
N
75
0F
/N
75
0F
Rb
N
75
0F
/N
75
0F
p1
30
-/
-
1.5
1.0
2.0
2.5
+ ++ + + +
Fo
ld
 in
cr
ea
se
 ( 
G
1+
G
2/
S)
 
ir
ra
d
ia
te
d
 v
er
su
s 
u
n
tr
ea
te
d
 1      2      3      4      5       6      7      8      9     10    11    12    1       2        3       4       5        6         
 1       2       3       4        5       6       7       8       9   0 2 4 6 8 10 12 14 16
0
5
10
15
20
25
30
35
Rb-/-
Rbwt/wt
RbN750F/N750F
Time after irradiation (h)
%
 B
rd
U
 p
o
si
ti
ve
 c
el
ls
irradiation 
(5.5 Gy )
+- +- +- +- +- +-
w
ild
-t
yp
e
Rb
-/
-
p1
30
-/
-
Rb
-/
- p
13
0-
/-
Rb
N
75
0F
/N
75
0F
Rb
N
75
0F
/N
75
0F
p1
30
-/
-
G1
8N
G2
S (BrdU+)
irradiation 
(5.5 Gy)
w
ild
-t
yp
e
Rb
N
75
0F
/N
75
0F
Rb
-/
-
w
ild
-t
yp
e
Rb
N
75
0F
/N
75
0F
Rb
-/
-
w
ild
-t
yp
e
Rb
N
75
0F
/N
75
0F
Rb
-/
-
irradiation:
Chapter 4
88
RASV12-induced transformation
Cell cycle arrest upon loss of anchorage is a characteristic of non-transformed cells. 
We have previously shown that Rb-/-p130-/- MEFs could be induced to proliferate under 
non-adherent conditions by expression of RASV12 and TBX2 and that this anchorage-
independent growth was strictly dependent on the absence of both pRB and p130 
(Vormer et al., 2008). We therefore tested whether also RbN750F/N750Fp130-/-  MEFs could 
proliferate under these conditions. Surprisingly, we found that in contrast to Rb-/-p130-/-, 
RbN750F/N750Fp130-/- MEFs could not grow anchorage-independently upon expression of 
RASV12 and TBX2 (Fig. 5). These results demonstrate that ablation of the pRB-LxCxE 
interaction did not render cells susceptible to transformation. Moreover, our results show 
that bypass of RASV12-induced senescence was not sufficient to support TBX2-induced 
transformation.
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Figure 4: The pRB-LxCxE interaction is involved in cell cycle arrest in response to expression of RASV12. 
p130-/-, RbN750F/N750Fp130-/- and Rb-/-p130-/- MEFs were infected with pBABE-RASV12-puro (+ RASV12) or pBABE-
puro (- RASV12) and plated for proliferation assays 4 days after infection. Cells were fixed and stained with 
crystal violet at the indicated time points, the relative cell number was determined by dividing OD590nm at 
time point x by OD590 at time point 0. Two independent experiments, performed in triplicate, are shown.
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Rb-/-p130-/- RbN750F/N750Fp130-/-
TBX2 + RASV12
A
B
Rb-/-p130-/- RbN750F/N750Fp130-/-
TBX2 + RASV12
Figure 5: Ablation of the pRB-LxCxE interaction in a p130 null background is not sufficient to induce 
anchorage-independent growth upon expression of TBX2 and RASV12. RbN750F/N750Fp130-/- and Rb-/-p130-/- 
MEFs were infected with pEYK-TBX2 and subsequently with pBABE-RASV12-puro and plated in soft agar. 
Pictures were taken after 2 weeks using a non-phase-contrast lens (x2.5 magnification) in (A) and a 
phase-contrast lens (x5 magnification) in (B). RASV12 and TBX2 were expressed to comparable levels in 
the 2 cell lines (not shown).
Discussion
The pRB tumor suppressor protein is primarily known for binding and inhibiting E2F 
transcription factors. Besides E2Fs, pRB can simultaneously interact with a wide variety 
of proteins via a site that recognizes an LxCxE motif in the target protein. Many of these 
interacting proteins are involved in chromatin remodeling and transcriptional repression 
(examples are HDAC1 and -2, Suv39h1 and HP1). Thus, tri-molecular complexes 
containing pocket proteins, E2Fs and LxCxE-containing proteins can promote a chromatin 
state incompatible with transcription, resulting in active repression of E2F target genes 
(reviewed by Dick, 2007). Whereas chromatin remodeling complexes containing p130 
and p107 are thought to function in G0/G1, pRB-containing chromatin remodeling 
complexes have been implicated in irreversible gene repression during terminal cell cycle 
exit (Balciunaite et al., 2005; Frolov and Dyson, 2004; Narita et al., 2003; Rayman et al., 
2002; Dahiya et al., 2001). E.g., association of pRB and HP1 with stably repressed E2F-
Chapter 4
90
regulated promoters could specifically be detected in RASV12-induced senescent cells, 
but not in reversibly arrested, quiescent cells (Narita et al., 2003). However, pRB and 
HDAC1 were recruited to the Cyclin E promotor in cells arrested by p16INK4A (Dahiya 
et al., 2001) and in G0 arrested MEFs (Morrison et al., 2002). Furthermore, the pRB-
LxCxE interaction was required for the establishment of irreversible cell cycle arrest 
during myogenic differentiation (Chen and Wang, 2000). These results led to the view 
that the interaction of pRB with chromatin remodeling proteins mainly plays a role during 
terminal cell cycle exit. 
Given the proposed role of the pRB-LxCxE interaction in gene repression and 
cell cycle exit, we asked whether this interaction is essential for pRB’s role in cell cycle 
arrest under growth inhibitory conditions. To this aim, we generated a mutation in the 
LxCxE binding site of murine pRB at position 750: pRBN750F. This mutant protein retained 
the ability to efficiently inhibit an E2F1-induced E2F-reporter, but was unable to bind 
the LxCxE-containing protein SV40 large T antigen. Moreover, pRBN750F was impaired 
in repressing an E2F4-induced E2F-reporter and in repressing a GAL4-TK-luciferase 
reporter when fused to the GAL4 DNA binding domain (Fig. 1). These results are 
consistent with the view that LxCxE-containing proteins are involved in pRB-dependent 
transcriptional repression. Concerning repression of E2F1-induced transcription and 
repression of a GAL4-reporter construct, results similar to ours were obtained with 
human pRB-LxCxE mutants: pRBN757F, the human equivalent of murine pRBN750F, and 
other LxCxE mutants could efficiently repress an E2F1-induced E2F-reporter, but were 
impaired in repressing a GAL4-reporter when targeted via fusion to the GAL4 DNA 
binding domain (Chan et al., 2001; Dahiya et al., 2000). In line with the involvement 
of the pRB-LxCxE interaction in gene repression and chromatin remodeling, Isaac et 
al. (2006) observed aberrant methylation patterns in the pericentric heterochromatin of 
MEFs expressing a pRB protein deficient in binding LxCxE-containing proteins. This 
further underlines the proposed role for the pRB-LxCxE interaction in permanent gene 
silencing.
To study the involvement of the pRB-LxCxE interaction in cell cycle arrest, we 
generated MEFs in which both Rb alleles encode the mutant pRBN750F protein (RbN750F/N750F 
MEFs) and analyzed the ability of these MEFs to bypass cell cycle arrest in response to 
growth inhibitory signals. We generated this mutation both in a wild-type and a p130-/- 
background, since bypass of G1 arrest in response to various inhibitory signals in culture 
required loss of pRB plus loss of either p130 or p107 (Dannenberg et al., 2004; this 
communication). We did not find a contribution of the pRB-LxCxE interaction in the 
induction of cell cycle arrest in response to serum deprivation, contact inhibition or loss 
of anchorage (Tables 1 and 2; Fig. 2 and 5). However, the pRB-LxCxE interaction was 
critical for G1 arrest in response to γ-irradiation and expression of RASV12 (Fig. 3 and 4).
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Growth factor deprivation
The normal cell cycle arrest of RbN750F/N750Fp130-/- MEFs that we observed upon growth 
factor deprivation was somewhat surprising, since active repression of E2F target genes 
was shown to occur during serum starvation (Isaac et al., 2006; Morrison et al., 2002). 
Morrison and co-workers (2002) detected recruitment of pRB and HDAC1 to the Cyclin 
E promoter upon serum starvation and showed that repression of the Cyclin E gene under 
these conditions depended on pRB, could be relieved by the HDAC inhibitor trichostatin 
A, and involved pRB dependent de-acetylation of a part of the Cyclin E promotor. 
Moreover, Isaac and co-workers (2006) detected increased expression of Cyclin E and 
other E2F regulated genes during serum starvation in MEFs carrying a mutation in the 
LxCxE binding site of pRB. This suggests that, during serum starvation, active repression 
of E2F target genes might contribute to cell cycle arrest. However, we found that 
RbN750F/N750Fp130-/- MEFs arrested normally in response to serum starvation, whereas 
Rb-/-p130-/- MEFs displayed an impaired arrest (Table 1). Note that both RbN750F/N750F 
and Rb-/- MEFs arrested efficiently in G1 upon serum deprivation, which is in line 
with our previous findings that pRB loss was not sufficient to bypass G1 arrest upon 
serum deprivation (Table 1, Figure S1, and Foijer et al., 2005). Furthermore, we found 
that serum-starved RbN750F/N750Fp130-/- MEFs re-entered the cell cycle upon serum re-
stimulation with similar kinetics as Rbwt/wtp130-/- MEFs (Fig. 2), demonstrating that cell 
cycle arrest induced by the pRBN750F protein, which is still able to inhibit E2F transcription 
factors, was as stable as arrest induced by pRBwt. Apparently, relieve of repression by 
mutation of the LxCxE binding site in pRB plus loss of p130 was not sufficient to bypass 
cell cycle arrest upon serum starvation. Therefore, although serum deprivation may 
induce pRB-dependent chromatin remodeling, our results imply that bypass of cell cycle 
arrest after serum withdrawal requires loss of pocket protein-mediated inhibition of the 
transactivation activity of E2Fs. 
Ionizing radiation
In response to γ-irradiation, cell cycle arrest enables repair of DNA damage, after which 
cell cycle progression can be resumed. Because of the transient nature of this arrest 
we intuitively expected pRB-chromatin remodeling complexes, and thus pRB-LxCxE 
interactions, not to play a major role. We found that cell cycle arrest after γ-irradiation 
critically depends on pRB and, strikingly, involved its interaction domain with LxCxE-
containing proteins. Thus, RbN750F/N750F MEFs were impaired in the establishment of cell 
cycle arrest after γ-irradiation (Fig. 3) and additionally, in response to higher doses of 
irradiation, residual cell cycle arrest in RbN750F/N750F MEFs had shifted to G2 (Fig. S3). 
These results clearly point to an involvement of pRB-LxCxE interactions in DNA-
damage-induced G1 arrest. In agreement with our data, Pennaneach and co-workers 
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(2001) reported that ectopically expressed human pRBN757F protein could not induce cell 
cycle arrest in UV-irradiated Rb-/- C33a cells. Moreover, Talluri et al. (2010) reported 
recently that MEFs expressing a pRB protein with a mutated LxCxE-binding site arrested 
less stringently in G1 in response to γ-irradiation.
Previous work has shown that cell cycle arrest upon γ-irradiation coincided with 
reduced CDK2 kinase activity (Brugarolas et al., 1999). This may point to pRB-HDAC-
mediated repression of the CDK2 regulator Cyclin E. Besides HDACs, several other 
LxCxE containing proteins are candidates for mediating pRB-induced cell cycle arrest 
after γ-irradiation. First, Pennaneach and co-workers (2001) reported that the LxCxE 
containing protein RF-Cp145 enhanced survival after DNA damage in the presence of 
pRB. RF-Cp145 is a component of the replication factor C (RF-C) complex that is involved 
in DNA replication. Strikingly, RF-C can also function in transcriptional repression: 
RF-C enhanced pRB-mediated repression of a p73-luciferase reporter (Pennaneach et al., 
2004). Therefore, a possible role for RF-Cp145 in inducing cell cycle arrest could involve 
direct inhibition of DNA replication and/or transcriptional repression. Second, members 
of the p200 family, which contain an LxCxE motive and bind to the pocket proteins, 
have been reported to inhibit S phase entry in a pRB proficient background (Hertel et 
al., 2000). As the p205 protein, a member of the p200 family, contains a putative ATM 
phosphorylation site (Dermott et al., 2004), it is possible that p200 proteins are activated 
by ATM/ATR signaling after DNA damage. These proteins can then interact with pRB via 
the LxCxE binding site and inhibit S phase entry, for example by stabilization of the hypo-
phosphorylated form of pRB. Of interest, a differential sensitivity to phosphorylation 
of wild-type and mutant pRB was found during muscle differentiation: whereas wild-
type pRB was stabilized in the hypo-phosphorylated form and could no longer be 
phosphorylated by serum stimulation, the pRBN757F protein remained sensitive to serum-
induced phosphorylation (Chen and Wang, 2000). Possibly, a similar mechanism occurs 
after irradiation, involving the stabilization of pRBwt in the active, hypo-phosphorylated 
state, while the pRBN750F protein is inactivated by Cdk-dependent phosphorylation, 
causing aberrant S phase entry. Finally, an interesting observation was made by Binne 
and colleagues (2007), who showed that pRB could bind to APC-cdh1 in an LxCxE-
dependent manner and suggested that the pRB-APC interaction in G1 downregulates Skp2 
and stabilizes p27KIP1. Thus, reduced p27KIP1 levels in RbN750F/N750F MEFs could contribute 
to bypass of G1 arrest in response to irradiation.
RASV12-induced senescence
Previously, we found that bypass of RASV12-induced senescence could be accomplished 
by combined ablation of pRB and p130 (Dannenberg et al., 2004). Strikingly, we have 
now found that not only Rb-/-p130-/-, but also RbN750F/N750Fp130-/- MEFs were refractory 
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to the growth inhibitory effect of RASV12 (Fig. 4). Thus, the interaction between pRB 
and LxCxE-containing proteins is critical for the establishment of cell cycle arrest in 
response to RASV12. This is in agreement with the view that cell cycle arrest induced 
by RASV12 is irreversible and involves transcriptional silencing via the recruitment of 
chromatin remodeling proteins. A role for E2F-repressor complexes during RASV12-
induced senescence was previously suggested by Rowland et al. (2002), who showed 
that expression of the DNA binding domain of E2F1 (E2F-DB) could bypass RASV12-
induced senescence. Since E2F-DB was unable to activate or repress transcription and 
could displace endogenous E2Fs from promoter regions, these results implied that relieve 
of E2F-mediated transcriptional repression can overcome RASV12-induced senescence. 
Additionally, Narita and colleagues (2003) detected recruitment of HP1γ and the presence 
of methylated H3K9 to promoter regions specifically in RASV12-induced senescent cells, 
and not in confluent quiescent cells, pointing to the involvement of chromatin remodeling 
proteins during RASV12-induced senescence. Our present results using RbN750F/N750Fp130-/- 
MEFs clearly point to an essential role for the pRB-LxCxE interaction during RASV12-
induced senescence and suggest that E2F-pRB-chromatin remodeling complexes are 
critical for the establishment of RASV12-induced cell cycle arrest.
RASV12-induced transformation
Loss of anchorage generally induces cell cycle arrest and bypass of this arrest is a 
hallmark of transformation. Our previous studies showed that expression of RASV12 and 
TBX2 bypassed cell cycle arrest in Rb-/-p130-/- MEFs under non-adherent conditions and 
induced tumor formation in nude mice (Vormer et al., 2008). We wondered whether 
RbN750F/N750Fp130-/- MEFs could also be induced to proliferate anchorage-independently 
by expression of RASV12 and TBX2. To our surprise, we found that, in contrast to 
Rb-/-p130-/- MEFs, RbN750F/N750Fp130-/- MEFs could not grow anchorage-independently upon 
expression of RASV12 and TBX2 (Fig. 5). Since RbN750F/N750Fp130-/- MEFs were refractory 
to RASV12-induced senescence, but were not transformed by RASV12 and TBX2, these 
results demonstrate that bypass of RASV12-induced senescence meets lower requirements 
than transformation induction by RASV12 and TBX2. Interestingly, we found that 
RbN750F/N750Fp130-/- MEFs displayed higher Cyclin E protein levels compared to p130-/- 
MEFs, but lower levels compared to Rb-/-p130-/- MEFs (Fig. S1). Thus, pocket protein-
mediated suppression of Cyclin E transcription in wild-type MEFs occurs via both 
recruitment of chromatin remodeling proteins, as was previously suggested (Morrison et 
al., 2002; Dahiya et al., 2001; Nielsen et al., 2001) and via inhibition of E2F-mediated 
transactivation. Elevated expression of Cyclin E is expected to induce Cyclin E-CDK2 
kinase activity. Possibly, derepression of Cyclin E in RbN750F/N750Fp130-/- MEFs induces 
Cyclin E-CDK2 kinase activity to a level sufficient to bypass RASV12-induced senescence, 
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but insufficient to counteract the dramatic drop in kinase activities, which occurs upon 
loss of anchorage (Vormer et al., 2008). 
In summary, we have shown that the pRB-LxCxE interaction is not involved 
in cell cycle arrest upon serum starvation or cell-cell contact, suggesting that blocking 
the transactivation function of E2F is the main mechanism by which pRB establishes 
cell cycle arrest under these conditions. The pRB-LxCxE interaction is critical for cell 
cycle arrest in response to γ-irradiation and expression of RASV12. However, ablation of 
the pRB-LxCxE interaction was not sufficient to induce anchorage-independent growth 
upon additional ablation of p130 plus expression of RASV12 and TBX2. We conclude 
that, whereas ablation of the pRB-LxCxE interaction in MEFs bypasses some barriers 
involved in counteracting transformation, it is not sufficient to bring cells beyond the 
verge of transformation. We are currently investigating whether the pRBN750F mutation in 
a p130 null background predisposes to tumorigenesis in vivo.
Materials and Methods
Constructs
The 6xE2F-luciferase reporter, CMV-HA-E2F1, CMV-HA-E2F4, CMV-Renilla and pJ3-mRb were 
kindly provided by Dr. R. Bernards, GAL4-TK-luciferase was obtained from Dr. R. Medema and 
pECE-pRbΔcdk-HA was from Dr. J. Lukas. An N-terminal HA-tag was added to pRB by replacing 
the EcoRI/ClaI fragment from pJ3-mRb with the EcoRI/ClaI fragment from pECE-pRbΔcdk-
HA, thereby creating pJ3-HA-mRb. Mutation of the Rb cDNA was done by subcloning the BglII 
fragment (~1 kb) from pJ3-Rb into the BglII site of LITMUS 28, followed by mutagenesis using 
the QuikChange Site-Directed Mutagenesis Kit (Stratagene 200518). Regeneration of full-length 
Rb in an expression vector was achieved by co-ligation of the EcoRI/BglII fragment from pJ3-HA-
mRb and the wild-type or mutated BglII fragment from LITMUS 28 into the EcoRI/BamHI site of 
pcDNA3.1(-), thereby creating pcDNA3.1(-)-HA-mRb, pcDNA3.1(-)-HA-mRb N750F, pcDNA3.1(-
)-HA-mRb C699F and pcDNA3.1(-)-HA-mRb R654W. Generation of vectors encoding GAL4-pRB 
fusion proteins was achieved by PCR cloning of an Rb fragment (encoding amino acid residues 372-
921) from the pcDNA3.1(-)-HA-mRb series using 5’ and 3’ primers encompassing EcoRI and XbaI 
sites, respectively. These EcoRI/XbaI fragments were inserted in-frame into the EcoRI/XbaI site of 
pM (Clontech). pSG5-Tag was kindly provided by Dr. J. A. DeCaprio, pBABE-RASV12-puro by Dr. 
T. Brummelkamp and pCL-Eco by Dr. D. Peeper. The pEYK-TBX2 vector was previously isolated 
from MEFs infected with the pEYK-MCF7 library (Vormer et al., 2008), which was a gift of Dr. G. 
Q. Daley.
Reporter assays
Subconfluent Rb -/- 3T9 cells were transfected one day after seeding using FuGENE6 Transfection 
Reagent (Roche) according to the manufacturer’s protocol. Transfections were performed using 0.4 
µg DNA per well of a 12-well plate, in a DNA-FuGENE ratio of 1 to 3 (µg and µl respectively). All 
transfections included a luciferase reporter plasmid (6xE2F-luciferase or GAL4-TK-luciferase) and a 
Renilla luciferase expression plasmid. Empty pcDNA3.1 or empty pM plasmids were added to each 
reaction to reach the total amount of 0.4 µg DNA/well. Twenty-four h post transfection, cells were 
washed in PBS and lysed in 100 µl lysis buffer (provided with the Dual-Luciferase Reporter Assay 
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System (Promega E1910). Lysates were measured for Luciferase and Renilla luminescence activity by 
using the Dual-Luciferase Reporter Assay System (Promega E1910) according to the manufacturer’s 
protocol. For each sample, luciferase luminescence was divided by Renilla luminescence. All 
transfection experiments were carried out at least in duplicate.
MEF isolation
We previously generated RbN750F/wt mice by injecting an RbN750F/wt embryonic stem cell clone into 
B6 blastocysts. The RbN750F/wt embryonic stem cell clone was generated by oligonucleotide-directed 
modification of the endogenous Rb gene in 129OLA embryonic stem cells (Aarts et al., 2006). The 
resulting RbN750F/wt chimeras were backcrossed to FVB. Subsequently, RbN750F/wt mice were crossed with 
previously generated p130wt/- FVB mice (Dannenberg et al., 2000), generating RbN750F/wtp130wt/- mice. 
These animals were intercrossed enabling the isolation of RbN750F/N750Fp130-/- and RbN750F/N750Fp130wt/wt 
MEFs at embryonic day 14.5 (day of vaginal plug was defined as day 0.5). Additionally, we generated 
Rbwt/-p130wt/- animals by crossing Rbwt/-  FVB animals (Dannenberg et al., 2000; te Riele et al., 1992) 
with Rbwt/wtp130wt/- mice, which had been derived from RbN750F/wtp130wt/- intercrossings. Subsequent 
intercrossings of Rbwt/-p130wt/- animals enabled isolation of Rb-/-p130-/- MEFs. Lastly, intercrossing 
Rbwt/-p130wt/wt  animals enabled isolation of Rb-/-p130wt/wt MEFs, whereas intercrossing Rbwt/wtp130wt/- 
animals was used to isolate Rbwt/wtp130-/- and Rbwt/wtp130wt/wt MEFs. Due to embryonic lethality, 
Rb-/-p130-/- MEFs were isolated at embryonic day 13.5, all other MEF isolations were performed at 
embryonic day 14.5. Rb-/-p130-/-p107-/- MEFs were previously generated by (Dannenberg et al., 2000).
Cell culture
MEFs were cultured in GMEM (Invitrogen/Gibco), containing 10% fetal calf serum, 1 mM 
nonessential amino acids (Invitrogen/Gibco), 1 mM sodium pyruvate (Invitrogen/Gibco), 100 
units/ml penicillin (Invitrogen/Gibco), 100 μg/ml streptomycin (Invitrogen/Gibco) and 0.1 mM 
β-mercaptoethanol and incubated at 37 °C in the presence of 5% CO2. 
For serum starvation experiments, cells were seeded at a density of 8 x 105 per 10- cm 
dish. Three h after plating, cells were washed in PBS and medium as described above was added, but 
containing 0% fetal calf serum. Cells were harvested for FACS at the indicated time points and BrdU 
was added to a concentration of 10 µΜ 1 h before harvesting.
For contact inhibition experiments, cells were plated at a density of 8 x 105 per 10-cm dish 
and analyzed 10 days after plating. Cells were given fresh medium every 2 or 3 days. 
For γ-irradiation experiments, cells were plated at a density of 5 x 105 per 10-cm dish, 
irradiated the next day with 5.5, 10 or 15 gray and analyzed 16 h after irradiation. One h before 
harvesting, BrdU was added to a concentration of 10 µΜ.
 For retroviral infections, cells were plated at a density of 8.5 x 105 per 10-cm dish and infected 
twice the next day with retroviral supernatants, supplemented with polybrene to a concentration of 
4 μg/ml during a time-span of at least 6 h per infection. For serial infections, MEFs were cultured 
in non-virus containing media for at least 36 h between infections and reseeded before infection to 
obtain optimal cell density. Retroviral supernatants were produced by calcium phosphate transfection 
(Invitrogen) of phoenix cells with 16 μg of the desired construct and 4 μg pCL-Eco. Forty-eight h post 
transfection, retroviral supernatant was filtered using 0.45 μm filters (MCE membrane, Millipore) 
and either used directly or immediately frozen using a dry-ice ethanol bath and stored at -80 °C. 
After harvesting viral supernatant, phoenix cells were supplemented with GMEM containing media 
supplements as described above, and supernatant was again harvested using the same procedure, with 
an interval of at least 6 h. 
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Soft agar plating was performed as previously described (Vormer et al., 2008): 6 x 104 
MEFs were suspended in 2 ml of a 37 °C, 0.35% soft agar solution (low gelling agarose type VII from 
Sigma) in GMEM containing 10% fetal calf serum, the same medium supplements as mentioned 
above plus gentamicin (Invitrogen/Gibco) to a concentration of 0.02 mg/ml and plated in one well of 
a six-well plate. To prevent cells from attaching to the bottom of the well, the 0.35% soft agar solution 
was poured into an ultra-low-attachment surface plate (catalog no. 3471; Corning Incorporated) 
coated with a 1% soft agar layer. To allow solidification of the agar, plates were incubated at 4°C 
for 30 minutes. Subsequently, cells were incubated at 37°C in the presence of 5% CO2 for 2 weeks. 
Pictures were taken using a non-phase-contrast lens (x2.5 magnification) and assembled using 
Axiovision 4.5. Detail images were taken using a phase-contrast lens (x5 magnification).
Proliferation curves: crystal violet assays
For proliferation curves, cells were seeded in triplicate at a density of 2.5 x 104 cells per well of a 
12-well plate (Corning Incorporated, 3512). At the indicated time points (time point 0 was defined 
as 3 h after seeding), cells were fixed for 5 minutes in 4% formaldehyde in PBS, which was freshly 
made from a 37% formaldehyde stock. Subsequently, cells were washed three times in demineralized 
water and stained with 0.1% crystal violet solution for 30 minutes. Again, cells were washed three 
times in demineralized water and allowed to dry in the dark. Dye was extracted by adding 1 ml 10% 
acetic acid per well. 100 µl of this solution was used to determine the optical density at 590 nm using 
a microplate reader (M200 Tecan).
BrdU staining and FACS
For BrdU labeling, BrdU was added to the culture medium 1 h before harvesting to a concentration 
of 10 µM. After this incubation, cells were trypsinized and fixed in 70% ethanol in PBS at 4 ºC. To 
detect incorporated BrdU, cells were first washed in cold PBS and then suspended in 5 M HCl/0.5% 
Triton and incubated at room temperature for 20 minutes. Next, cells were washed in 1 M TrisHCl pH 
7.5 and subsequently in PBS/0.5% Tween 20. Cells were thereafter incubated with mouse anti-BrdU 
Antibody (DAKO, clone BU20A M0744) in a concentration of 1:40 in PBS/0.5% Tween 20/1% 
BSA for 30 minutes at room temperature. Next, cells were washed twice in PBS/0.5% Tween 20 and 
incubated with goat anti-mouse immunoglobulins/FITC (DAKO F0479) in a concentration of 1:20 in 
PBS/0.5% Tween 20/1% BSA for 30 minutes at room temperature in the dark. After washing twice 
with PBS/0.5% Tween 20, cells were suspended in PBS containing 200 µg/ml RNase A and 20 µg/ml 
propidium iodide, incubated at 37 ºC for 15 min, measured in FL1 for FITC and FL3 for propidium 
iodide, and analyzed using ‘Cell Quest’ and ‘Summit’ software.
 Cells that were analyzed for propidium iodide only were fixed overnight in 70% ethanol in 
PBS at 4 ºC, washed in PBS and directly suspended in PBS containing 200 µg/ml RNase A and 20 
µg/ml propidium iodide, incubated at 37 ºC for 15 min and measured in FL3.
Protein isolation, immunoprecipitation and immunoblot
For protein isolations, cells were lysed for 30 minutes on ice in lysis buffer containing 150 mM NaCl, 
50 mM Hepes pH 7.5, 5 mM EDTA, 0.1% NP-40 and 1 tablet complete protease inhibitor cocktail 
(Roche) per 50 ml. After centrifugation, protein concentration was determined using Bio-Rad protein 
assay (Bio-Rad). For immunoblot analysis, protein was separated on 3-8% Tris-Acetate and 4-12% 
Bis-Tris NuPage gradient gels (Invitrogen). Blotting was performed using standard protocols. 
For immunoprecipitation experiments, Rb-/- C33A cells were co-transfected with pSG5-
TAg and pcDNA3.1(-)-HA-mRb (wild-type, N750F, R654W or C699F) or empty pcDNA3.1(-) 
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using calcium phosphate (Invitrogen). Protein was isolated using the lysis buffer described above 
plus 5 mM NaF, 0.5 mM vanadate, 20 mM β-glycerolphosphate and 1mM PMSF. Lysates were 
incubated O/N at 4 °C with anti-HA antibody and 50 % protein A/G beads (Santa Cruz) in lysis 
buffer while rotating. Subsequently, lysates were washed 5 times in lysis buffer, separated on a 12% 
polyacrylamide gel and immunoblotted. The membrane was probed with mouse anti-TAg and mouse 
anti-pRB and next with HRP-conjugated secondary antibody. 
Used primary antibodies were: mouse monoclonal anti pRB (554136, BD Biosciences 
Pharmingen), rabbit polyclonal anti-p107 (C18, SC-318, Santa Cruz), rabbit polyclonal anti-cyclin 
E (M20, SC-481, Santa Cruz), rabbit polyclonal anti-cyclin A (C19, SC-596, Santa Cruz) and goat 
polyclonal anti-cdk4 (C22-G, SC260-G, Santa Cruz). Secondary antibodies were: HRP conjugated 
goat anti mouse, goat anti rabbit and rabbit anti goat (DakoCytomation).
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Supplemental figures
Figure S1: RbN750F/N750Fp130-/- MEFs express wild-type levels of pRB, but increased levels of E2F-target genes. 
(A) Oligonucleotide-directed modification of exon 22 of Rb in murine ES cells resulted in the substitution 
of asparagine at position 750 with phenylalanine. The upper sequence shows a part of wild-type Rb 
encoding asparagine at position 750. The lower sequence depicts the oligonucleotide which was used 
for modification of the Rb locus, resulting in incorporation of phenylalanine at position 750. The part 
of the oligonucleotide that differs from the wild-type sequence is shown in red. A detailed description 
of the procedure can be found in (Aarts et al., 2006). (B) MEFs of the indicated genotypes were infected 
with pBABE-puro (lanes 1 to 3) or pBABE-RASV12 (lanes 3 to 6) and cultured in the presence of serum. 
Additionally, non-infected MEFs were cultured in the absence of serum (lanes 7 and 8). Protein extracts 
were immunoblotted using the depicted antibodies.
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>Figure S2: RbN750F/N750Fp130-/- MEFs arrest efficiently in G1 upon serum starvation. MEFs of the indicated 
genotypes were cultured in the presence or absence of serum, stained for BrdU and propidium iodide 
incorporation and analyzed by FACS. Shown are cell cycle profiles of the MEFs depicted in Table 1. The 
depicted numbers of G1- and G2–phase cells represent the percentages of cells with a 2N or 4N DNA 
content based on propidium iodide incorporation (FL3-A). The depicted number of S-phase cells represent 
the BrdU-positive population of cells with a DNA content ranging from 2N to 4N.
Figure S3: Cell cycle arrest in RbN750F/N750F and Rb-/- MEFs shifts towards G2 in response to high doses of 
γ-irradiation. MEFs of the indicated genotypes were treated with γ-irradiation, harvested after 16 h and 
stained for BrdU and propidium iodide incorporation. Shown are cell cycle profiles of the MEFs depicted 
in Fig. 3C. The depicted numbers of G1, G2 and S phase cells were determined as described in the legend 
of Fig. S2.
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Abstract
Loss of the retinoblastoma gene Rb can initiate tumorigenesis in both humans and mice. 
pRB and its two close homologs, p107 and p130, form the family of pocket proteins 
and collectively regulate the activity of E2F transcription factors during G1. pRB-E2F 
interaction blocks E2F’s transactivation domain but can also actively repress E2F target 
genes through the recruitment of proteins containing an LxCxE-motif. This motif is present 
in many proteins involved in chromatin remodeling and transcriptional repression. To 
investigate whether active repression is involved in pRB’s role in development and tumor 
suppression, we generated mice expressing a variant pRB protein in which the asparagine 
at position 750 was replaced for phenylalanine. pRBN750F is abrogated in binding LxCxE-
containing proteins while still able to inhibit E2F-induced transactivation. In sharp 
contrast to Rb+/- mice and Rb-/- chimeras, RbN750F/N750F mice had a normal life span and 
were not predisposed to tumorigenesis, demonstrating that ablation of the pRB-LxCxE 
interaction was not sufficient to induce tumor formation. Because of the compensatory 
role of other pocket proteins in binding LxCxE-containing proteins and in inhibiting E2F-
induced transcription, we combined the RbN750F mutation with loss of p130. Interestingly, 
the RbN750F/N750Fp130-/- genotype caused embryonic lethality, indicating a role for LxCxE-
containing proteins in embryonic development. Furthermore, RbN750F/N750Fp130+/- and 
RbN750F/wtp130-/- mice were viable but showed a reduced lifespan. However, these genotypes 
did not predispose to tumorigenesis, indicating that inhibiting the transactivation function 
of E2Fs is the dominant mechanism of tumor suppression by the pocket proteins.
Introduction
The retinoblastoma tumor suppressor pathway plays a major role in the inhibition of 
human and mouse tumorigenesis. The retinoblastoma protein, pRB, has two homologs, 
p130 and p107, which together form the family of pocket proteins. Pocket proteins are 
essential for regulation of the cell cycle, differentiation and apoptosis. 
Pocket proteins play a key role in the G1 phase of the cell cycle, where they 
inhibit the activity of E2F transcription factors. Binding to pocket proteins blocks E2F’s 
transactivation domain, resulting in inhibition of E2F-dependent transcription. In addition 
to binding E2Fs, pocket proteins can simultaneously bind to proteins containing an 
LxCxE motive (x encoding any amino acid). Since many LxCxE-containing proteins have 
been implicated in chromatin remodeling and transcriptional repression, the recruitment 
of complexes containing pocket proteins, E2Fs and LxCxE-containing proteins may 
result in active repression of E2F target genes. Examples of transcriptional repressors 
that interact with pRB via the LxCxE binding site are histone deacetylase 1 (HDAC1), 
HDAC2, heterochromatin protein 1 (HP1) and the histone methyltransferase Suv39h1 
(Dick, 2007; Frolov and Dyson, 2004; Lai et al., 2001; Nielsen et al., 2001; Vandel et al., 
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2001; Chen and Wang, 2000; Dahiya et al., 2000; Magnaghi-Jaulin et al., 1998). 
The E2F transcription factor family is classically divided into activator E2Fs 
(E2F1, E2F2 and E2F3a) and repressor E2Fs (E2F3b, E2F4, E2F5, E2F6a, E2F6b, 
E2F7a, E2F7b and E2F8). pRB interacts with E2F1-4 (Moberg et al., 1996), whereas 
p130 and p107 interact with E2F4 and E2F5. E2F6-8 function independently of the pocket 
proteins (DeGregori and Johnson, 2006; Dimova and Dyson, 2005; Frolov and Dyson, 
2004). Thus, whereas the transactivation function of activator E2Fs is simply inhibited 
by pRB binding, pocket protein-E2F-chromatin remodeling complexes can be formed 
by pRB-E2F3b, pRB-E2F4, p130/p107-E2F4 and p130/p107-E2F5. Of relevance, the 
division between activator and repressor E2Fs is far from absolute. The E2F3b, E2F4 and 
E2F5 ‘repressors’ contain a transcriptional activation domain, and both E2F3b and E2F4 
have been shown to function as transcriptional activators in vitro and in vivo (Chong et 
al., 2009a; Tsai et al., 2008; Kinross et al., 2006; Wu et al., 2001; Muller et al., 1997). 
Furthermore, E2F1-3a were recently shown to form pRB-E2F repressor complexes in 
differentiating cells (Sahin and Sladek, 2010; Chong et al., 2009b).
Loss of pocket proteins can intitiate tumorigenesis: in mice, Rb loss induces 
pituitary and thyroid tumors, and the tumor spectrum is extended by the additional loss 
of p130 or p107 (Dannenberg et al., 2004; Harrison et al., 1995; Maandag et al., 1994; 
Williams et al., 1994). However, it is unclear which of the E2F-regulating activities of 
pocket proteins is critical for tumor suppression. On the one hand, a view has emerged 
that mainly regulation of the ‘activator’, and not the ‘repressor’ E2Fs is involved in Rb-
mediated tumor suppression (Parisi et al., 2009; Lee et al., 2002; Yamasaki et al., 1998). 
On the other hand, pocket protein-chromatin remodeling complexes have been implicated 
in processes that are considered critical for tumor suppression, such as (irreversible) cell 
cycle arrest and senescence. The recruitment of p130 and E2F4 to silenced promoters in 
G0-arrested mouse fibroblasts (Rayman et al., 2002) and in G0-and G1-arrested human 
T98G cells (Takahashi et al., 2000) is suggestive for active repression. Furthermore, 
repression of E2F target genes involving pRB and LxCxE-containing proteins was 
detected under various growth inhibitory conditions, including serum starvation (Isaac 
et al., 2006; Morrison et al., 2002), RASV12-induced senescence (Narita et al., 2003) and 
cell cycle arrest induced by p16INK4A (Dahiya et al., 2001). Additionally, involvement 
of E2F-repressor complexes was demonstrated during contact inhibition and replicative 
or RASV12-induced senescence (Rowland et al., 2002; Zhang et al., 1999). pRB was 
also shown to be required for the establishment of irreversible cell cycle arrest during 
differentiation, via both silencing of cell cycle genes and the induction of differentiation 
specific genes. Interestingly, pRB-mediated silencing during differentiation is associated 
with the presence of repressive chromatin marks (Guo et al., 2009; Blais et al., 2007; 
Khidr and Chen, 2006; Thomas et al., 2001; Chen et al., 1996; Novitch et al., 1996; Gu 
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et al., 1993). Furthermore, a mutant form of human pRB that was deficient in binding 
LxCxE-containing proteins, was unable to establish irreversible cell cycle arrest during 
myogenic differentiation (Chen and Wang, 2000). Taken together, these studies indicate 
that the binding of pRB to LxCxE-containing proteins is involved in the establishment of 
cell cycle arrest under various conditions and is therefore predicted to function in tumor 
suppression. 
Although LxCxE-containing proteins, recruited by pRB, have been implicated 
in processes counteracting transformation, the requirement for these proteins to suppress 
tumorigenesis in vivo remains elusive. We aimed to dissect the involvement of pocket 
protein-chromatin remodeling complexes during tumor formation and therefore made use 
of a mutant form of pRB: pRBN750F. This mutant protein was able to inhibit E2F-induced 
transactivation, but was impaired in binding LxCxE-containing proteins (Chapter 4). 
Consequently, pRBN750F was unable to recruit chromatin remodelers to E2F regulated 
promoters via the LxCxE binding site. Surprisingly, we found that mice homozygously 
mutant for pRBN750F (RbN750F/N750F mice) were viable, had a normal lifespan and were not 
predisposed to tumor formation. Thus, the ablation of complexes consisting of pRB 
and LxCxE-containing proteins was not sufficient to drive tumorigenesis. Given the 
role of p130 in binding ‘repressor’ E2Fs and recruiting LxCxE-containing proteins, we 
combined the RbN750F mutation with loss of p130. We found that homozygous loss of 
p130 completely abolished live birth of RbN750F/N750F mice whereas RbN750F/N750Fp130+/- and 
RbN750F/wtp130-/- animals were viable. Surprisingly, these animals had a reduced lifespan but 
did not show increased tumor incidence. Thus, ablation of LxCxE-dependent interactions 
did not promote tumor formation, indicating that pRB’s tumor suppressor activity mainly 
operates via inhibition of activator E2Fs.
Results
p130 functionally compensates for loss of the pRB-LxCxE interaction
To investigate whether the pRB-LxCxE interaction is critical for pRB’s role in embryonic 
development, we have generated RbN750F/N750F mice. As described before (Vormer et al., 
Chapter 4), the pRBN750F protein was deficient in binding LxCxE-containing proteins, 
whereas inhibition of E2F-induced transcription remained intact. RbN750F/wt murine 
embryonic stem cells, previously generated by oligonucleotide-directed gene modification 
as described in Aarts et al. (2006), were used to generate RbN750F/wt mice. These animals 
were intercrossed and the resulting progeny was genotyped (Table 1). In contrast to full 
ablation of Rb, which was embryonic lethal (Clarke et al., 1992; Jacks et al., 1992; Lee 
et al., 1992), RbN750F/N750F animals were born according to mendelian ratio and survived 
into adulthood.
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Since the recruitment of chromatin-remodeling proteins may also be effectuated 
by other pocket proteins, we wondered whether the additional loss of p107 or p130 in 
RbN750F/N750F mice would cause embryonic or post natal death. RbN750F/wt mice were crossed 
with p130+/- or p107+/- animals and the resulting double heterozygotes were intercrossed. 
The F2 progeny was genotyped at postnatal day 21. RbN750F/N750Fp130-/- animals were 
completely absent in the F2 cohort of 226 animals, whereas 14 animals were expected 
(Table 2). In contrast, Rbwt/wtp130-/- animals were present at normal ratio, showing that 
loss of p130 did not negatively influence survival in an Rb wild-type background (12 
Rbwt/wtp130-/- animals were detected, whereas 14 were expected). RbN750F/N750Fp130+/- 
animals appeared to be underrepresented (13 observed; 28 expected) suggesting that two 
functional p130 alleles were required to fully compensate for the loss of the pRB-LxCxE 
interaction. However, the significance of this observation is doubtful as in this cross also 
RbN750F/N750Fp130+/+ mice were slightly underrepresented (8 observed; 14 expected). 
To determine whether the RbN750F/N750Fp130-/- genotype led to embryonic lethality, 
we crossed RbN750F/wtp130+/- females with RbN750F/wtp130-/- males and analyzed 43 embryos 
at E18.5. We found three RbN750F/N750Fp130-/- embryos, whereas five were expected. Two of 
the RbN750F/N750Fp130-/- embryos had an abnormal appearance compared to control embryos 
(one was small and one was pale). Within the group of control embryos, only 3 out of 40 
embryos had an abnormal appearance (one being small and two being small plus pale). 
Histologically, we did not detect abnormalities in the RbN750F/N750Fp130-/- embryos, except 
for degeneration of the myocardium in one of the three embryos. It has previously been 
Table 1: Genotypic analysis of life born animals derived from RbN750F/wt intercrosses. 64 F1 animals were 
analyzed at post natal day 21. Expected: number of animals expected based on mendelian inheritance. 
Observed: observed number of animals.
Table 2: Genotypic analysis of life born animals derived from RbN750F/wtp130+/- intercrosses. 226 F2 
animals were analyzed at post natal day 21. Expected: number of animals expected based on mendelian 
inheritance. Observed: observed number of animals.
Rb N750F/N750F N750F/wt wt/wt
Expected
Observed
14
0
total
226
226
p130 -/- +/-+/+ -/- +/-+/+ -/- +/-+/+
14
8
28
13
28
38
28
32
56
77
14
12
14
15
28
31
Rb N750F/N750F N750F/wt wt/wt
Expected
Observed
16
16
32
31
16
17
total
64
64
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shown that combined ablation of Rb and p130 in cardiac myocytes resulted in increased 
proliferation in the neonatal and adult myocardium, possibly contributing to the early 
death of these mice. Accordingly, pRB, p130 and E2F4 were suggested to repress the 
E2F-regulated Myc-promoter in cardiac myocytes in vitro (MacLellan et al., 2005). 
Our results indicate that RbN750F/N750Fp130-/- animals died at or shortly after E18.5. This 
suggests that pRB-E2F4/E2F3b and p130-E2F4/E2F5 chromatin remodeling complexes 
are required for late embryonic development or perinatal survival. 
Similarly, we investigated the combination of RbN750F and p107-null alleles 
by intercrossing RbN750F/wtp107+/- animals and genotyping the resulting F2 progeny at 
postnatal day 21 (Table 3). RbN750F/N750Fp107-/- animals were completely absent from 
this cohort of 130 animals, however also RbN750F/wtp107-/- and Rbwt/wtp107-/- animals were 
absent, whereas 16 and 8 were expected, respectively. Apparently, the FVB genetic 
background of mice was not compatible with p107 ablation and therefore the effects of 
the pRBN750F mutation in the absence of p107 could not be studied. However, similar to 
RbN750F/N750Fp130+/-, RbN750F/N750Fp107+/- animals were viable. 
 In conclusion, these analyses show that p130 is essential for the survival of 
RbN750F/N750F mice. In the absence of p130, loss of the pRB-LxCxE interaction causes 
pre- or perinatal death. RbN750F/N750Fp130+/- and RbN750F/wtp130-/- animals were viable and 
survived into adulthood.
 
Loss of the pRB-LxCxE interaction in combination with loss of p130 or p107 is not 
sufficient to drive tumorigenesis
RbN750F/N750F animals had a normal lifespan with a mean survival of approximately 75 
weeks, which was similar to that of RbN750F/wt and Rbwt/wt mice (Fig. 1). We did not detect 
any macroscopic or microscopic abnormalities in RbN750F/N750F mice (described below and 
data not shown). Seven sacrificed RbN750F/N750F and 19 sacrificed RbN750F/wt animals were 
microscopically analyzed for abnormalities in the lungs: lung adenomas had developed in 
29% of analyzed RbN750F/N750F and in 26% of analyzed RbN750F/wt mice. The frequency and 
latency of lung adenomas was similar as in Rbwt/wt mice indicating lung tumor development 
Table 3: Genotypic analysis of life born animals derived from RbN750F/wtp107+/- intercrosses. 130 F2 
animals were analyzed at post natal day 21. Expeted: number of animals expected based on mendelian 
inheritance. Observed: observed number of animals.
Rb N750F/N750F N750F/wt wt/wt
Expected
Observed
8
0
total
130
130
p107 -/- +/-+/+ -/- +/-+/+ -/- +/-+/+
8
11
16
13
16
0
16
28
32
56
8
0
8
7
16
15
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Figure 1: RbN750F/N750F mice have a normal life span. Animals of the indicated genotypes were followed 
during 111 weeks and sacrificed when ill. Shown is the percentage of surviving animals per time point.
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to be aging-related background pathology. We therefore conclude that ablation of the 
LxCxE-interacting domain in pRB did not cause tumor predisposition nor a decreased 
lifespan. 
The absence of tumor development in RbN750F/N750F mice sharply contrasts with the 
strong predisposition to pituitary and thyroid tumors in chimeric Rb-/- mice and Rb+/- mice 
(Harrison et al., 1995; Maandag et al., 1994; Williams et al., 1994). Our previous studies 
showed that the tumor spectrum induced by Rb loss, was broadened by the additional 
loss of p130 or p107, and included retinoblastoma, osteocarcoma, lymphosarcoma, 
pheochromocytoma and adenocarcinoma in the coecum (Dannenberg et al., 2004; 
Robanus-Maandag et al., 1998). We therefore wondered whether tumor development in 
RbN750F/N750F mice was suppressed by compensatory activities of p130 and p107. Several 
reports have shown that p130/p107 efficiently interacted with E2F4, bound chromatin 
remodeling proteins via their LxCxE binding sites (Nicolas et al., 2003; Ferreira et 
al., 1998), and were present at repressed, de-acetylated promoters in G0 (Balciunaite 
et al., 2005; Rayman et al., 2002; Takahashi et al., 2000). Since RbN750F/N750Fp130-/- and 
RbN750F/N750Fp107-/- animals were not viable, we analyzed the lifespan and tumor 
incidence in mice with three mutated alleles, i.e., RbN750F/N750Fp130+/-, RbN750F/wtp130-/- and 
RbN750F/N750Fp107+/-. Similar to previous observations in Rb+/-p107-/- chimeric mice, tumor 
development may ensue from loss of the remaining wild-type allele (Dannenberg et al., 
2004). Animals were followed during 70 weeks and sacrificed when ill. The survival of 
RbN750F/N750Fp130+/- and RbN750F/wtp130+/- animals (Fig. 2A) was approximately 80% at 50 
weeks of age, which was similar to that of RbN750F/N750Fp130+/+ mice (Fig. 1). After 70 weeks, 
the survival of RbN750F/N750Fp130+/- animals appeared lower: 40% of RbN750F/N750Fp130+/- 
animals was alive in contrast to 70% of RbN750F/wtp130+/- animals (Fig. 2A). Strikingly 
however, of the five sacrificed RbN750F/N750Fp130+/- animals, only one was diagnosed with 
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Figure 2: RbN750F/N750Fp130+/- mice (A), RbN750F/wtp130-/- mice (B) and RbN750F/N750Fp107+/- mice (C) have a 
decreased lifespan. Animals of the indicated genotypes were followed during 70 weeks and sacrificed 
when ill. Shown is the percentage of surviving animals per time point.
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a tumor: an alveolar-bronchiolar adenoma in an animal sacrificed at 61 weeks (Table 4). 
In comparison, two adenomas (one in the lung and one in the harderian gland) and one 
sarcomatoid neoplasia were detected in six sacrificed RbN750F/wtp130+/- animals (Table 4). 
In conclusion, although RbN750F/N750Fp130+/- mice showed a slightly reduced life span, we 
did not detect increased tumor formation in these animals before 70 weeks of age.
A severely reduced survival was seen in the cohort of RbN750F/wtp130-/- animals 
(Fig. 2B). Fifty percent of these animals had died by 32 weeks of age, and only 13.5% 
of the cohort was alive after 60 weeks. This was in sharp contrast to RbN750F/wtp130+/- 
and Rbwt/wtp130-/- animals, of which approximately 75% was still alive at 60 weeks. 
RbN750F/wtp130-/- animals generally appeared unhealthy (most were skinny and had an 
irregular structure of the coat) and rapidly became very ill requiring them to be sacrificed. 
Of the cohort of 37 animals, 24 were sacrificed due to ill appearance and 8 animals had 
suddenly died before 60 weeks of age. In none of these animals we could detect overt 
macroscopical defects upon autopsy. Only limited microscopic analysis was possible for 
the animals that had suddenly died: we did not find indications for tumor formation or any 
other abnormalities in these animals. Tissues of the sacrificed 24 animals were elaborately 
analyzed at the microscopic level: pituitary (n=10), thyroid (n=16), brain (n=24), eyes 
(n=23), digestive system (stomach, intestines, liver, pancreas; n=22), testes (n=7), ovary 
(n=15), heart (n=15), lungs (n=22), adrenals (n=16), spleen (n=22), thymus (n=19), and 
bone marrow (sternum, hind leg, head; n=16). Except for some abnormalities in the 
spleen (see below) and some rare cases of tumor formation, all these tissues appeared 
generally normal. Remarkably, only 3 of these animals were diagnosed with tumor(s): 
1 alveolar-bronchiolar adenoma, 2 adenomas in the pituitary gland and 1 lymphoma. 
All tumors were detected in animals older than 50 weeks (Table 4). For comparison, 
previous studies demonstrated that Rb+/- animals had to be sacrificed between 32 and 36 
weeks of age due to pituitary tumors (Maandag et al., 1994; Williams et al., 1994), and 
in Rb+/-p130-/- chimeric mice, 5 out of 15 animals developed a tumor (Dannenberg et al., 
2004). Taken together, we conclude that RbN750F/wtp130-/- animals were not predisposed to 
tumorigenesis. 
We also analyzed the survival of RbN750F/N750Fp107+/- animals (Fig. 2C). 
Forty percent of these animals were still alive at 70 weeks of age, which was lower 
than in the cohorts of RbN750F/wtp107+/- and RbN750F/N750Fp107+/+ animals, of which 
70% and 60% survived till week 70, respectively (Figs. 1 and 2C). Tumors were 
detected in 2 of the 18 sacrificed RbN750F/N750Fp107+/- animals, at an age of 51 
and 58 weeks, however, tumors were also detected in 2 RbN750F/wtp107+/- animals 
that were sacrificed at 58 and 70 weeks of age (Table 4). Therefore, also RbN750F/
N750Fp107+/- animals were not predisposed to tumorigenesis before 70 weeks of age. 
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Table 4: Overview of tumors and pre-neoplastic lesions detected in mice of various genotypes, which 
were sacrificed when ill. Shown are mice sacrificed before or at 70 weeks of age.
*1: 5 animals out of this cohort (n=10) were sacrificed before 70 weeks of age, 1 additional animal was 
found dead
*2: 6 animals out of this cohort (n=22) were sacrificed before 70 weeks of age
*3: 24 animals out of this cohort (n=37) were sacrificed before 70 weeks of age, 8 additional animals were 
found dead
*4: 6 animals out of this cohort (n=11) were sacrificed at or before 70 weeks of age
*5:18 animals out of this cohort (n=31) were sacrificed at or before 70 weeks of age, 2 additional animals 
were found dead
*6: 2 animals out of this cohort (n=14) were sacrificed at or before 70 weeks of age, 1 additional animal 
was found dead
Genotype: RbN750F/N750Fp130+/- *1
alveolar/bronchiolar adenoma 1 61
Tumor type/pre-neoplastic lesion Number of cases detected Age at sacrice (weeks)
Tumor type/pre-neoplastic lesion Number of cases detected Age at sacrice (weeks)
Tumor type/pre-neoplastic lesion Number of cases detected Age at sacrice (weeks)
Tumor type/pre-neoplastic lesion Number of cases detected Age at sacrice (weeks)
Tumor type/pre-neoplastic lesion Number of cases detected Age at sacrice (weeks)
Genotype: RbN750F/wtp130+/- *2
alveolar/bronchiolar adenoma
nodular hyperplasia in adrenal-cortex
sarcomatoid neoplasia
papillary adenoma harderian glands
1
1
1
1
33
61
61
64
Genotype: RbN750F/wtp130-/- *3
alveolar/bronchiolar adenoma
lymphoma
adenoma pars distalis pituitary
1
1
2
51
55
51 and 59
Genotype: Rbwt/wtp130-/- *4
adenomatous hyperplasia in 
   pars distalis pituitary
2 66 and 70
Genotype: RbN750F/N750Fp107+/- *5
Tumor type/pre-neoplastic lesion Number of cases detected Age at sacrice (weeks)
Genotype: RbN750F/wtp107+/- *6
alveolar/bronchiolar adenocarcinoma
adenomatous hyperplasia in 
   mucosa epithelia ileum
adenoma in mucosa ileum
1
1
1
51
51
58
papillary adenoma in lung
adenomatous hyperplasia in      
   alveolar/bronchiolar epithelium
sarcomatoid neoplasia
1
1
1
58
58
70
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 In conclusion, we have found that RbN750F/N750Fp130+/-, RbN750F/wtp130-/- and 
RbN750F/N750Fp107+/- animals were not predisposed to tumorigenesis, although these 
genotypes did affect survival. 
Possible causes of increased mortality in RbN750F/wtp130-/- animals
In an attempt to explain the strongly reduced lifespan of RbN750F/wtp130-/- animals we 
looked for defects in the hematopoietic compartment. Defective hematopoiesis was 
suggested by the reduced number of hematopoietic cells in the red pulp of the spleen 
(referred to as ‘reduced cellularity’) in 24% of sacrificed RbN750F/wtp130-/- animals (n=21; 
included are the animals described above that were analyzed for the spleen, minus the 
animal that was diagnosed with lymphoma). Reduced cellularity was not detected in 
spleens of sacrificed RbN750F/wtp130+/- and Rbwt/wtp130-/- animals (both n=6). Increased 
break down of red blood cells (hemosiderosis) in the spleen was detected in 38% of 
RbN750F/wtp130-/- mice, but also in RbN750F/wtp130+/- and Rbwt/wtp130-/- mice (30 and 50%, 
respectively). Although the pocket proteins have been reported to function in controlling 
proliferation and mobilization of hematopoietic stem cells in the bone marrow (Viatour 
et al., 2008; Walkley et al., 2007), we were unable to link the defects in the spleen to 
defects in the bone marrow. First, we microscopically analyzed bone marrow in hind 
leg, head and/or sternum. Table 5 summarizes this analysis, which was performed on 
8 ill RbN750F/wtp130-/- animals with abnormalities in the spleen (reduced cellularity and/
or hemosiderosis), and on 5 ill RbN750F/wtp130-/- animals, in which no abnormalities in the 
spleen were detected. Reduced cellularity in the red pulp of the spleen was in 3 out of 
5 cases accompanied with hemosiderosis but 3 cases of hemosiderosis were seen with 
normal cellularity, indicating that these two abnormalities were unrelated. Furthermore, 
reduced cellularity in the red pulp of the spleen was accompanied by reduced cellularity 
in the white pulp in 2 out of 5 cases and by increased apoptosis in the white pulp in 2 of 5 
cases (Table 5). Additionally, in two out of five cases, hematopoietic defects in the spleen 
coincided with reduced hematopoiesis in the bone marrow (animals 1 and 2 in Table 5, 
both animals displayed reduced cellularity in both red and white pulp). In conclusion, 
reduced cellularity in the spleen could not be explained by increased breakdown of red 
blood cells in the red pulp or increased apoptosis in the white pulp. Furthermore, defective 
production of hematopoietic cells in the bone marrow could not account for the observed 
reduced cellularity in the red pulp of the spleen. Strikingly though, reduced cellularity in 
the bone marrow was observed in the 2 animals that displayed reduced cellularity in both 
the red and the white pulp of the spleen. 
Finally, we determined red and white blood cell counts in 5 ill RbN750F/wtp130-/- 
animals (Table 6). Compared to the reported minimum values in healthy mice (Carpenter, 
2005; Quesenberry and Carpenter, 2003), red blood cell count was low in 2 of the 5 
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Table 5: Microscopic analysis of spleen and bone marrow in ill RbN750F/wtp130-/- animals (n=13).
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animals (mouse 3 and 7), whereas white blood cell count was low in 3 of the 5 mice 
(mouse 2, 3 and 7). Thus, reduced cellularity in the spleen did not correlated with reduced 
red blood cell count (compare Tables 5 and 6) and therefore the cause and significance of 
this observation remain elusive. 
To investigate the hematopoietic system in more detail, FACS analysis was 
performed for spleen, bone marrow, peripheral blood and thymus in four RbN750F/wt
p130-/- animals, of which two where severely ill, and in two healthy RbN750F/wtp130+/- and 
two healthy Rbwt/wtp130-/- animals (Table S1 and data not shown). Consistent with the lack 
of abnormalities in the microscopic analysis (Table 5), we detected normal percentages 
of the following populations in the bone marrow of RbN750F/wtp130-/- animals: LSK, LT-
HSC, ST-HSC, myeloid progenitors, lymphoid progenitors, erythroid progenitors, 
monocytes and granulocytes (data not shown). Two of the four RbN750F/wtp130-/- animals 
had a decreased population of cells with intermediate levels of staining for CD19 and 
B220, which possibly reflects a defective pre-B cell population (mouse a and c in Table 
S1; 0.75 and 1.7% respectively, versus on average 6.6% in RbN750F/wtp130+/- and Rbwt/wt
p130-/- control animals). However, mature B cells, characterized by high levels of CD19 
and B220, where only mildly reduced (1.7 and 2.1%, versus on average 3.3% in control 
animals, see Table S1 for the percentages in the individual animals). Additionally, the 
percentage of B and T cells in spleen, peripheral blood and thymus were normal (data 
not shown), arguing against a B cell defect in RbN750F/wtp130-/- mice. In conclusion, both 
the microscopic and the FACS analyses argue against a major bone marrow defect in 
RbN750F/wtp130-/- animals. Microscopic analysis did show defects in the spleen, which may 
have contributed to the early death of RbN750F/wtp130-/- animals. However, as only 24% of 
RbN750F/wtp130-/- animals displayed these defects, it is likely that other defects, which were 
not detected in our study, had contributed to the reduced life span of these mice. 
Table 6: Red and white blood cell count in ill RbN750F/wtp130-/- animals. Animal numbering corresponds 
to that in Table 5. Depicted is the red or white blood cell count in the peripheral blood divided by the 
minimum reported value in healthy mice.
Animal WBC count in peripheral blood/ 
minimum value in healthy mice
RBC count in peripheral blood/ 
minimum value in healthy mice
2
3
1 1,17 1,25
0,45
0,25
1,54
0,60
7 0,150,51
13 1,901,34
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Discussion
LxCxE-containing proteins are good candidates to execute pRB’s tumor suppressor role. 
The recruitment of LxCxE-containing proteins by chromatin-bound pocket protein-E2F 
complexes has been associated with silencing of E2F target genes, and importantly, 
repression of E2F target genes involving pRB and LxCxE-containing proteins was 
detected under various growth inhibitory conditions, such as serum starvation (Isaac et 
al., 2006; Morrison et al., 2002), RASV12-induced senescence (Narita et al., 2003) and cell 
cycle arrest induced by p16INK4A (Dahiya et al., 2001). Additionally, pRB is required for 
the establishment of irreversible cell cycle arrest during differentiation (Guo et al., 2009; 
Blais et al., 2007; Novitch et al., 1996), which possibly involves silencing of cell cycle 
genes by LxCxE-containing proteins. For example, pRB-mediated silencing of cell cycle 
genes during muscle differentiation correlated with the presence of repressive chromatin 
marks (Blais et al., 2007) and additionally, the Suv39H1 methylase, which binds to the 
pocket proteins at the LxCxE-binding site, has been implicated in establishing terminal 
silencing of cell cycle genes during muscle differentiation (Ait-Si-Ali et al., 2004). 
 We aimed to determine whether the capacity of pRB to recruit LxCxE-
containing proteins is critical for mouse development and survival and for suppression of 
tumorigenesis. Therefore, we generated RbN750F/N750F mice, which expressed the pRBN750F 
protein from the endogenous locus. The pRBN750F protein retained the ability to inhibit 
E2F-induced transactivation, but was impaired in binding LxCxE-containing proteins. 
pRBN750F was impaired in repressing transcription in various reporter assays and was 
unable to bind the LxCxE-containing protein SV40 large T antigen (Chapter 4). Because 
of the compensatory role of p130 and p107, which could bind chromatin remodeling 
proteins via their LxCxE binding sites (Nicolas et al., 2003; Ferreira et al., 1998) and were 
detected at repressed, de-acetylated promoters in G0 (Balciunaite et al., 2005; Rayman et 
al., 2002; Takahashi et al., 2000), we combined the RbN750F mutation with loss of either 
p130 or p107.
Embryonic development
In sharp contrast to the embryonic lethal phenotype of Rb-/- mice (Clarke et al., 1992; 
Jacks et al., 1992; Lee et al., 1992), RbN750F/N750F mice were born alive and had a normal 
lifespan (Table 1 and Fig. 1). Strikingly though, RbN750F/N750Fp130-/- animals could not be 
recovered at postnatal day 21 (Table 2), and we have strong indications that these animals 
had died during late embryonic development (post E18.5). Unfortunately, the effect of 
p107 ablation on survival of RbN750F/N750F mice could not be assessed as p107 deficiency 
alone already caused perinatal death in FVB mice (Table 3). Our results imply that 
recruitment of chromatin remodeling complexes is essential for completion of embryonic 
development and that this can be achieved by either pRB-E2F4/E2F3b or p130-E2F4/
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E2F5 complexes. The importance of LxCxE-mediated interactions during development is 
consistent with previous studies on p130-/-p107-/- and E2F4-/-E2F5-/- mice, which could not 
be recovered as life newborns (Gaubatz et al., 2000; Cobrinik et al., 1996). Thus, partial 
ablation of pocket protein-E2F-chromatin remodeling complexes is not compatible with 
postnatal survival.
Tumorigenesis
RbN750F/N750F mice had a normal lifespan and where not tumor prone (Fig. 1). Since 
Rb+/- mice and chimeric Rb-/- mice were strongly predisposed to pituitary and thyroid 
tumors (Harrison et al., 1995; Maandag et al., 1994; Williams et al., 1994), this 
implies that, in a p130/p107-proficient background, regulation of E2F transactivation 
activity by pRB is sufficient for pRB’s tumor suppressive activity. To our surprise, also 
RbN750F/N750Fp130+/-, RbN750F/wtp130-/- and RbN750F/N750Fp107+/- mice did not show increased 
tumor susceptibility, although these animals, in particular RbN750F/wtp130-/- mice, did show 
a reduced lifespan (Fig. 2). Our previous studies demonstrated that Rb+/-p107-/- chimeric 
mice developed a wide spectrum of tumors. Importantly, the wild-type Rb allele was lost 
in 100% of the detected pituitary tumors and in 70% of the other tumors (osteosarcomas, 
lymphosarcomas, adenocarcinomas in the coecum, and others). Also Rb+/-p130-/- chimeric 
mice developed tumors, although with lower incidence (5 tumors were detected in 15 
chimeras (Dannenberg et al., 2004)). The absence of tumor susceptibility in RbN750F/N750F
p130+/-, RbN750F/wtp130-/- and RbN750F/N750Fp107+/- mice implies that RbN750F/N750Fp130-/- and 
RbN750F/N750Fp107-/- cells, which are expected to frequently arise by spontaneous loss of 
heterozygosity, do not readily undergo oncogenic transformation. Our results therefore 
argue against a major role for LxCxE-containing proteins in tumor suppression and rather 
suggest that inhibiting the transactivation function of E2Fs is the main mechanism of 
tumor suppression by pRB. This finding is surprising in view of the importance of LxCxE-
containing proteins in transcriptional regulation and cell cycle arrest. Moreover, the 
human mutant protein pRBR611W causes retinoblastoma with reduced penetrance, although 
it is impaired in binding E2Fs (Sellers et al., 1998; Otterson et al., 1997). It has therefore 
been suggested that, next to E2Fs, other pRB interactors are involved in pRB-mediated 
tumor suppression. LxCxE-containing proteins were considered good candidates, but this 
is now questioned by our observations. 
There are several explanations for the absence of tumor predisposition in mice 
with an ablated pRB-LxCxE interaction. First, chromatin remodelers that interact with 
pRB independent of the LxCxE-binding site might contribute to pRB-mediated silencing. 
Via its LxCxE binding site, pRB interacts with chromatin remodelers, such as Suv39h1, 
HP1 and HDAC1 and -2, which are co-operatively involved in silencing. For example, 
Suv39h1, which enhances pRB-mediated repression (Nielsen et al., 2001) and creates a 
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binding site for HP1 (Lachner et al., 2001), can only methylate H3K9 when this residue 
is not acetylated (Rea et al., 2000), suggesting a cooperation between pRB, Suv39h1, 
HDACs and HP1 in silencing. Indeed, Suv39h1 was shown to interact with HDAC1, 2 
and 3 and Suv39h1-mediated repression required HDAC activity (Vaute et al., 2002). 
Moreover, both pRB, Suv39h1 and HP1 bound to a methylated H3K9 peptide (Nielsen et 
al., 2001). However, also LxCxE-independent interactions between pRB and chromatin 
remodelers have been described, such as the interaction between pRB and Suv4-20h1 and 
Suv4-20h2 (Isaac et al., 2006). It is therefore possible that silencing can also be achieved 
by chromatin remodelers that interact with pRB outside the LxCxE-binding domain.
Second, we haven’t studied the effect of complete ablation of the pocket protein-
LxCxE interaction, so possibly, the remaining pocket protein forms sufficient LxCxE 
dependent interactions to inhibit tumor formation. Embryonic lethality of RbN750F/N750F
p130-/- and RbN750F/N750Fp107-/- mice complicated our analysis but it may be possible to 
analyze tumor predisposition in chimeras generated with RbN750F/N750Fp130-/-p107-/- ES cells. 
 Third, one can envision that, although we did not detect tumor predisposition 
in this study, loss of the pRB-LxCxE interaction may stimulate tumor formation under 
specific conditions. Interestingly, we have found that RbN750F/N750Fp130-/- MEFs were 
impaired in arresting the cell cycle upon γ-irradiation or expression of oncogenic RASV12 
(Chapter 4). This demonstrates that G1 arrest after DNA damage involves the interaction 
between pRB and LxCxE-containing proteins, suggesting that mice deficient for the 
pRB-LxCxE interaction might be susceptible to tumor formation upon DNA damage. 
In conclusion, we have shown that ablating the interaction between pocket 
proteins and LxCxE-containing proteins was not sufficient to initiate tumorigenesis. This 
may be explained by a compensatory role of a remaining pocket protein or non-LxCxE-
containing chromatin remodelers that still interact with mutant pRB. Nonetheless, as the 
pRB-LxCxE interaction was involved in establishing cell cycle arrest in MEFs in response 
to expression of oncogenic RAS or ionizing radiation (Chapter 4), it is of interest to assess 
the susceptibility of RbN750F/N750F mice to radiation- or carcinogen-induced tumorigenesis.
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Materials and Methods
Mice
RbN750F/wt mice were previously generated by injecting an RbN750F/wt embryonic stem cell clone into 
B6 blastocysts. The RbN750F/wt embryonic stem cell clone was generated by oligonucleotide-directed 
modification of the endogenous Rb gene in 129OLA embryonic stem cells (Aarts et al., 2006). The 
resulting RbN750F/wt chimeras were backcrossed to FVB. Intercrossing the resulting RbN750F/wt mice 
generated both RbN750F/N750F and RbN750F/wt mice, which were used to study tumor predisposition. 
RbN750F/wt mice were also crossed with previously generated p130wt/- FVB mice (Dannenberg et al., 
2000), generating RbN750F/wtp130wt/- mice. Intercrossing these animals generated RbN750F/N750Fp130wt/-, 
RbN750F/wtp130-/- and RbN750F/wtp130wt/- mice, which were used to study tumor predisposition. Additionally, 
RbN750F/wt mice were crossed with p107wt/- FVB mice, which were previously generated by injecting 
p107-/- ES cells (Robanus-Maandag et al., 1998) into B6 blastocysts and subsequent backcrossing 
of the resulting chimeras with FVB mice. RbN750F/wtp107wt/- mice were intercrossed, generating 
RbN750F/N750Fp107wt/- mice RbN750F/wtp107wt/- mice, which were used to study tumor predisposition. Mice 
were inspected twice a week and sacrificed when ill.
Cellular preparations and FACS analysis
All cellular preparations were performed at 4°C, except where indicated. Splenocytes: spleens were 
chopped with scissors and digested for 20 min at room temperature in a mixture of 6 mL RPMI-
2% containing 7 mg Collagenase (121 U/mg - Type III, Worthington Biochemicals) with a further 
addition of 1 mL of DNase (1mg/mL) (Roche). Pipetting the tissue through a wide bore pipette 
tip repetitively during digestion facilitated dispersion to single cell suspension. EDTA (600 mL of 
0.1 M solution) was then added and mixed by pipetting for a further 5 min to ensure separation 
of dendritic cells and T cells. Undigested fragments were removed by using a 70 µM filter. Bone 
marrow: bone marrow was extracted from the tibia and femur with RMPI-2% using a 3 mL syringe 
and 21-gauge needle. This single cell suspension was then centrifuged and the pellet was resuspended 
in a small volume (0.5-2 mL) RCRB for 1 minute to lyse erythrocytes. Subsequently, cells were 
diluted up to 10 mL in RPMI-2% and washed 2-3 times. Pellets were resuspended in RPMI-2% and 
passed through a sieve to remove bone fragments and dead cell clumps. Blood leukocytes: blood 
was collected by lumbar puncture into heparinized syringes using a 25-gauge needle and collected 
directly into 1mL of RCRB, mixed and kept on ice. Cells were centrifuged, washed in medium and 
resuspended in FACS buffer. Thymus: thymus cells were isolated by mashing through a 70 µM filter. 
Staining: cells were stained in the antibody cocktails for 15-20 min on ice at a concentration of 1 x 
106 per 10 µL in FACS buffer containing 2mM EDTA and 2% BSA in PBS. Cells were subsequently 
washed in 10 volumes of FACS buffer and subsequently suspended in FACS buffer plus propidium 
iodide. FACS analysis was performed using a Cyan flow cytometer (Dako). Stains used to identify 
the different cell populations were as follows: LSK: c-kit high/sca1 high; LT-HSC: pre-gate: c-kit 
high/sca1 high gate: CD150-slam high/CD48 low; ST-HSC: pre-gate: c-kit high/sca1 high gate: 
CD150-slam low/CD48 high; myeloid progenitors: pre-gate (1): lin negative/c-kit positive; pre-gate 
(2): TER119 negative; gate: FC receptor high/IL7 receptor low; lymphoid progenitors: pre-gate (1): 
lin negative/c-kit positive; pre-gate (2): TER119 negative; gate: FC receptor low/IL7 receptor high; 
erythroid progenitors: pre-gate: lin negative/c-kit positive; gate: TER119 high; monocytes: Ly6Chi 
^high/Gr1^int; granulacytes: Ly6Chi^intermediate/Gr1^hi; B-cells: CD19 high/CD3 low and CD19 
high/B220 high; T-cells: CD19 low/CD3 high and B220 low/CD3 high.
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Determination of red and white blood cell count in peripheral blood
Blood was collected into heparinized tubes and diluted 2x in PBS. Red- and white blood cell counts 
were determined using a Coulter-counter.
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Supplemental Table
Table S1: FACS analysis of bone marrow of mice with the indicated genotypes shows that 2 out of 4 
RbN750F/wtp130-/- mice display a decreased amount of cells with an intermediate level of staining for CD19 
and B220 (possibly reflecting a pre-B cell population).
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Tumorigenesis is a gradual process, which includes multiple alterations in both tumor 
suppressor- and oncogenic pathways. The retinoblastoma pathway comprises a major 
tumor suppressor pathway and is often found deregulated in both human and mouse cancer 
(Hanahan and Weinberg, 2000; Sherr, 1996). Ablation of the retinoblastoma proteins 
pRB, p107 and p130, also known as ‘pocket proteins’, bypassed cell cycle arrest that 
is normally induced by several growth inhibitory signals in vitro, but was not sufficient 
to establish full transformation. We focused on the identification of genetic events, 
cooperating with loss of pocket proteins in transformation. Additionally, we analyzed the 
role of the interaction between pRB and proteins containing and LxCxE motif during cell 
cycle arrest and tumorigenesis.
Tumor suppression mechanisms in mouse embryonic fibroblasts (MEFs) 
The family of pocket proteins plays a key role in cell cycle regulation by inhibiting 
E2F transcription factors during G1 (Frolov and Dyson, 2004). Consistently, ablation of 
pocket proteins in MEFs abrogated G1 arrest in response to various inhibitory signals, 
including the expression of constitutively active (ca) RAS, RASV12. However, our 
previous experiments demonstrated that pocket protein-ablation was not sufficient for 
RASV12-induced transformation and required additional events (Dannenberg et al., 2004; 
Dannenberg et al., 2000; Peeper et al., 2001). The first part of this thesis is focused on 
the identification of genetic events that in collaboration with loss of pocket proteins and 
expression of RASV12 promote transformation of MEFs.
Requirements for RASV12-induced transformation
In a genetic screen we found that RASV12-induced transformation of pocket protein-
deficient MEFs could be accomplished by expression of TBX2. Importantly, transformation 
was only achieved upon concomitant ablation of pocket proteins, expression of RASV12 
and over-expression of TBX2. Thus, expression of RASV12 and TBX2 in the presence of 
pocket proteins was not sufficient for transformation. In line with the down-modulating 
role of TBX2 on the p53 pathway, we subsequently found that down-regulation of p53 
or p21CIP by RNA interference was sufficient to promote anchorage-independent growth 
of RASV12/pocket protein-deficient MEFs (Vormer et al., 2008; Chapter 2). Our results 
demonstrate that MEFs were protected from transformation by the synergistic activities 
of the pocket protein- and the p53 pathways. This could be explained by their synergistic 
role in regulating the activity of cyclin-dependent kinases (cdks). Loss of pocket proteins 
induced both G1- and G2-associated cdk activities, which was dramatically counteracted by 
loss of anchorage. Dependent on the level of pocket proteins present, this resulted in cell 
cycle arrest in G1 and G2 phase. Loss of pocket proteins plus down-regulation of p21CIP1 
caused an additive rise in cdk activity, which was sufficient to overcome the suppression 
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of cdk activities by loss of anchorage, and could therefore induce transformation. 
 In Chapter 3, we describe a second genetic screen aimed to identify inducers of 
anchorage-independent growth of RASV12/pocket protein-deficient MEFs. In this screen, 
we identified Mapkapk3 as a suppressor of anchorage-independent growth of RASV12/
pocket protein-deficient MEFs. Interestingly, Mapkapk3 was transcriptionally induced 
upon loss of anchorage, which could be counteracted by expression of TBX2. These 
results suggest that part of the transforming activity of TBX2 was mediated by down-
regulation of Mapkapk3. Mapkapk3 has been linked to the induction of p19ARF and 
p16INK4A via release of BMI1 from the chromatin (Voncken et al., 2005), again pointing 
to the necessity of down-regulating both the pocket protein and the p19ARF/p53 pathway 
during transformation. 
In conclusion, the results described in Chapters 2 and 3 point to the compensatory 
role of the pocket protein- and the p53 pathways during tumor suppression. Others have 
repeatedly claimed that down-regulation of either the pocket protein- or the p53/p21CIP1 
pathway was sufficient for RASV12-induced transformation of MEFs (Rangarajan et al., 
2004; Sage et al., 2000). Our results, however, clearly demonstrate that ablation of both 
pathways is required to bypass cell cycle arrest under growth-inhibiting conditions. Both 
pathways regulate cdk activity and various combinations of disturbances to different 
degrees can add up to a situation enabling tumorigenesis.
 In line with the results described above, the results described in Chapter 4 
further demonstrate that transformation of MEFs requires a very specific combination of 
events. Specifically, we found that MEFs, expressing a mutant form of pRB and deficient 
for p130 (RbN750F/N750Fp130-/- MEFs), bypassed RASV12-induced senescence, but could not 
grow anchorage independently upon expression of RASV12 and TBX2. This is in contrast 
to Rb-/-p130-/- MEFs, which bypassed RASV12-induced senescence and were able to grow 
anchorage independently upon expression of RASV12 and TBX2. Thus, pocket protein-
ablation to a level sufficient to bypass RASV12-induced senescence, was not sufficient 
to support RASV12/TBX2-induced transformation. These results underline the stringent 
requirements for transformation. At the molecular level, this can possibly be explained 
by control of the E2F-target gene Cyclin E, which is known to involve the activity of 
chromatin remodeling proteins (Morrison et al., 2002; Dahiya et al., 2001; Nielsen et 
al., 2001). RbN750F/N750Fp130-/- MEFs were impaired in the formation of pRB-chromatin 
remodeling complexes, whereas still able to inhibit E2F-mediated transactivation (see 
below). As a result, these MEFs expressed increased levels of Cyclin E compared to 
wild-type or p130-/- MEFs, but decreased levels compared to Rb-/-p130-/- MEFs (Chapter 
4). Possibly, the Cyclin E level in RbN750F/N750Fp130-/- MEFs was sufficiently high to 
bypass RASV12-induced senescence, but insufficient to support TBX2/RASV12-induced 
transformation. 
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Senescence and DNA damage signaling pathways
Similar to expression of TBX2, we found that downregulation of Mapkapk3 or of p38 
MAPK promoted anchorage-independent growth in RASV12/Rb-/-p107-/-  MEFs (Chapter 
3). Previous studies have designated p38 as a mediator of RASV12-induced senescence, 
since chemical inhibition of p38 bypassed senescence that was induced by either RASV12, 
caMEK1 or caMKK3/6 (both upstream inducers of p38) (Wang et al., 2002; Han and 
Sun, 2007). This raises the possibility that despite bypass of RASV12-induced senescence 
under adherent conditions, pocket protein-deficient MEFs are still sensitive to some of 
the inhibitory effects of RASV12, which becomes apparent upon removal of anchorage. 
Loss of anchorage might induce p38/Mapkapk3, which needs to be inhibited in order to 
stimulate anchorage-independent growth of pocket protein-deficient cells. 
As observed for loss of anchorage, the removal of growth factors induced G2 
arrest in Rb-/-p107-/-p130-/- (TKO) and TKO MEFs expressing Bcl2 (TKO-Bcl2 MEFs) 
(Foijer et al., 2005). Strikingly, growth factor deprivation in TKO-Bcl2 MEFs induced 
DNA double stranded breaks and Rad51/γH2AX foci. Moreover, inhibition of the DNA 
damage response accelerated cell cycle re-entry of mitogen re-stimulated TKO-Bcl2 
MEFs (van Harn, Foijer and te Riele, in preparation). In line with this, Cremona and 
Lloyd (2009) suggested recently that culturing without anchorage could induce DNA 
damage. Specifically, large T-expressing rat Schwann cells were impaired in cell cycle 
progression upon removal of anchorage, which was linked to the formation of giant 
nuclei and an increase in the percentage of cells containing more than 42 chromosomes. 
In contrast, we were unable to detect DNA damage in arrested, anchorage deprived, 
RASV12/TKO MEFs (see below), although we did observe an increase in the percentage 
of cells with an 8N DNA content, which is indicative of endoreduplication. Several 
explanations can be envisaged. During a normal cell cycle, entry into M phase is induced 
by high CDK1 activity, whereas exit from M is driven by APC/C-induced proteolysis 
of Cyclin B1, resulting in down-regulation of CDK1 activity. Additionally, APC/C 
induces the proteolysis of Geminin, a protein that inhibits the assembly of pre-replication 
complexes. A combination of low CDK activity and proteolysis of Geminin during late 
M/early G1 enables the assembly of pre-replication complexes at replication origins 
(Porter, 2008). Anchorage-deprived RASV12/TKO MEFs have low CDK1 activity due to 
high levels of p21CIP1 and p27KIP1. This prevents entry into M phase, but possibly renders 
them more sensitive to the premature assembly of pre-replication complexes. The latter 
may be achieved by aberrant down-regulation of Geminin or over-expression of factors 
promoting the assembly of pre-replication complexes, which would result in entry into 
a next G1 phase without progression through M and cytokinesis. Alternatively, a subset 
of the anchorage-deprived cells may slip through G2 and enter M phase in the absence of 
anchorage, but then encounter problems with cytokinesis. Both mechanisms would lead 
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to replication of a 4N genome causing the appearance of cells with an 8N DNA content 
in the absence of anchorage.
As mentioned above, we could not detect DNA damage in anchorage-deprived, 
RASV12/TKO MEFs. Specifically, RASV12/TKO MEFs were cultured without anchorage 
for 4 days and analyzed for the presence of γH2AX/Rad51 double foci after 2 and 4 hours 
of re-attachment. In striking contrast to the situation upon growth factor withdrawal, we 
only observed background levels of γH2AX/Rad51 double foci in re-attached RASV12/
TKO MEFs (Vormer and van Harn, unpublished results). It remains possible that a high 
level of DNA damage prevented re-attachment, and thus prevented the detection of DNA 
damage in our set-up. Therefore, further study is required to determine whether loss of 
anchorage can promote the acquisition of DNA damage. Our preliminary results indicate 
that, if present, the magnitude of DNA damage is much lower in anchorage-deprived cells 
compared to growth factor-deprived cells. We speculate that growth factor deprivation in 
TKO MEFs interferes with DNA replication, which is likely to contribute to tumorigenesis 
via the promotion of genomic instability. In contrast, anchorage deprivation does not 
interfere with DNA replication and hence under these circumstances, G2 arrest may act as 
a bona fide tumor suppressor mechanism.
Involvement of pocket protein-chromatin remodeling complexes in tumor suppression?
In the second part of this thesis, we aimed to determine the role of pocket protein-bound, 
LxCxE-containing proteins in tumor suppression. 
During G1, pocket proteins inhibit the activity of E2F transcription factors via 
binding and masking E2F’s transactivation domain and via binding proteins containing an 
LxCxE- motif. Since many LxCxE-containing proteins function in chromatin remodeling 
and transcriptional repression, the formation of such complexes is thought to actively 
repress E2F target genes via the promotion of a chromatin structure that is unfavorable 
for transcription (Dick, 2007). Importantly, many studies have pointed to the involvement 
of pocket protein-chromatin remodeling complexes in (irreversible) cell cycle arrest and 
senescence (Narita et al., 2003; Morrison et al., 2002; Rayman et al., 2002; Dahiya et al., 
2001; Chen and Wang, 2000).
To study the involvement of pocket protein-bound, LxCxE-containing proteins, 
we generated mice and MEFs expressing a mutant form of pRB (pRBN750F). The 
pRBN750F protein was unable to bind LxCxE-containing proteins, whereas inhibition 
of E2F-mediated transactivation remained intact (Chapters 4 and 5). Previous studies 
have suggested that mainly deregulation of ‘activator’ E2Fs contributed to the tumor 
susceptibility of Rb+/- mice (Lee et al., 2002; Yamasaki et al., 1998). However, the 
classical division between ‘activator’ and ‘repressor’ E2Fs seems incorrect, and a view 
is now emerging that individual E2Fs can perform both functions (Chong et al., 2009a; 
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Chong et al., 2009b; Kinross et al., 2006). The benefit of the current approach is that 
we studied exclusively the involvement of pocket protein-bound, LxCxE-containing 
proteins. Therefore, the interpretation of our data is independent of which E2F family 
member, ‘activator ‘or ‘repressor’, was bound by pRB.
 
In Chapter 4, we demonstrate that the pRB-LxCxE interaction was not required 
for cell cycle arrest in response to growth factor deprivation or contact inhibition. 
However, the pRB-LxCxE interaction was critical for cell cycle arrest in response to 
γ-irradiation or expression of RASV12, indicating that LxCxE-mediated repression of E2F 
target genes was involved during these types of cell cycle arrest. Strikingly, experiments 
by Avni and co-workers (2003) demonstrated that γ-irradiation caused recruitment of 
pRB to origins of replication. Together, this raises the possibility that upon DNA damage, 
pRB might directly inhibit DNA replication via the recruitment of an LxCxE-containing 
protein. It remains the subject of further study to determine which LxCxE-containing 
protein(s) is involved in cell cycle arrest under these conditions.
 Although we found that ablation of the pRB-LxCxE interaction did alleviate 
RASV12-induced senescence, it did not promote in vitro transformation induced by RASV12 
and TBX2. Consistently, we found that RbN750F/N750F mice had a normal lifespan and were 
not predisposed to tumorigenesis. Even upon concomitant inactivation of p130 or p107, 
we could not detect tumor susceptibility. I.e., RbN750F/N750Fp130+/-, RbN750F/wtp130-/- and 
RbN750F/N750Fp107+/- mice were not tumor prone, although they had a (slightly) reduced 
lifespan (Chapter 5). To exclude that the absence of tumor predisposition was caused 
by the recruitment of LxCxE-containing proteins via the remaining pocket protein, it 
will be helpful to study tumor predisposition in chimeric RbN750F/N750Fp130-/-p107-/- mice. 
Nevertheless, the sharp contrast between strong tumor predisposition in Rb+/- mice and 
Rb-/- chimeras (Maandag et al., 1994; Williams et al., 1994) and the complete absence 
of tumor predisposition in RbN750F/N750F mice, suggests that inhibition of E2F-mediated 
transactivation is the main tumor suppressor mechanism of pRB. Since we did observe 
an involvement of the pRB-LxCxE interaction during cell cycle arrest upon γ-irradiation 
or expression of RASV12, it remains possible that mice with an ablated pRB-LxCxE 
interaction display increased tumor susceptibility in response to for example irradiation 
or upon chemical activation of RAS signaling.
 Lastly, we note that our experiments using pRBN750F focused exclusively on 
the involvement of pRB-bound, LxCxE-containing proteins. As described in Chapter 
5, pRB-mediated repression probably involves many different chromatin remodeling 
proteins, and moreover, complex formation between these remodelers and the pocket 
proteins has not been completely elucidated. Thus, ablation of the interaction between 
pRB and LxCxE-containing proteins might not be sufficient to completely block pRB-
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mediated recruitment of chromatin remodeling complexes. Therefore, our study can not 
exclude that pocket protein-chromatin remodeling complexes could still contribute to 
tumor suppression. Importantly, our study does exclude a main involvement of the pRB-
LxCxE interaction in tumor suppression in vivo.
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English summary
Cancer is the result of a multistep process involving the gradual change of a normal 
cell into a cancerous cell. This process is called oncogenic transformation and requires 
the perturbation of essential cellular processes such as cell cycle regulation and 
apoptosis. Oncogenic transformation can be accomplished by multiple alterations in 
oncogenic and tumor suppressor pathways. The retinoblastoma pathway comprises a 
major tumor suppressor pathway that is found deregulated in the majority of human and 
mouse cancers. However, perturbation of this pathway is not sufficient for oncogenic 
transformation. This thesis describes the identification of genetic events that together with 
loss of the retinoblastoma suppressor pathway are required for oncogenic transformation. 
Furthermore, the involvement of the different activities of the retinoblastoma protein in 
tumor suppression has been studied. 
 pRB belongs to the retinoblastoma protein family, also called pocket protein 
family, which also includes p130 and p107. These proteins inhibit the progression 
from G1 into S phase and as such play an essential role during cell cycle regulation. 
In response to growth inhibitory signals, pocket proteins are stabilized in their active, 
hypophosphorylated form, and subsequently induce an arrest in G1 phase. Consistently, 
loss of pocket proteins was found to induce uncontrolled proliferation in vitro and to 
bypass G1 arrest in response to various growth-inhibitory signals.
The expression of constitutively active RAS (RASV12) is an oncogenic signal that, 
strikingly, induces a pocket protein-dependent G1 arrest in Mouse Embryonic Fibroblasts 
(MEFs). We have previously found that bypass of RASV12-induced cell cycle arrest by 
loss of pocket proteins was not sufficient to support RASV12-induced transformation. To 
gain insights into the mechanisms of oncogenic transformation, Chapters 2 and 3 of this 
thesis are focused on the identification of genetic events that in collaboration with loss of 
pocket proteins support RASV12-induced transformation. 
In Chapter 2, we performed a gain-of-function screen to identify genetic events 
that enabled RASV12/pocket protein-deficient MEFs to grow anchorage independently, 
a hallmark of transformation. We found that expression of TBX2 in RASV12/pocket 
protein-deficient MEFs induced anchorage-independent growth in vitro and enabled 
tumor formation upon injection of cells into nude mice. Our experiments show that the 
combined actions of pocket protein-loss, TBX2 expression and RASV12 expression were 
required to induce oncogenic transformation in MEFs.  
TBX2 is a transcriptional regulator that inhibits the p19ARF/p53/p21CIP1 pathway. 
Consistently, we found that downregulating the p53 pathway by RNA interference 
supported anchorage-independent growth of RASV12/pocket protein-deficient MEFs. 
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Our results demonstrate that the pocket protein and p53 pathways were co-operatively 
involved in counteracting anchorage-independent growth in MEFs. This can be explained 
by the role of these pathways in the inhibition of cyclin-dependent kinases (cdks). In 
the absence of anchorage, G1- and G2-associated cdks were dramatically downregulated. 
Dependent on the level of pocket proteins present, this resulted in an arrest in G1 or G2 
phase. Although loss of pocket proteins induced both G1- and G2-associated cdk activities 
and resulted in a (partial) override of the G1 arrest, it was not sufficient to counteract the 
major reduction in cdk activities in response to loss of anchorage. Downregulating the 
p53 pathway in pocket protein-deficient MEFs caused an additive rise in cdk activities 
that was sufficient to support anchorage-independent proliferation, and thus oncogenic 
transformation. Since transformation of human fibroblasts also requires ablation of 
both the pocket protein and p53 pathways, our results demonstrate that in this aspect, 
transformation of MEFs is not fundamentally different from transformation of human 
fibroblasts, as was previously claimed by others.  
By performing an insertional mutagenesis screen, we found in Chapter 3 that, 
similar to overexpression of TBX2, downregulation of the p38/Mapkapk3 pathway 
supported RASV12-induced transformation of pocket protein-deficient MEFs. Strikingly, 
we found that loss of anchorage induced Mapkapk3 in RASV12/pocket protein-deficient 
MEFs and could be reverted by expression of TBX2. Experiments by others have linked 
activation of Mapkapk3 to the release of BMI1 from the chromatin and the subsequent 
induction of p19ARF. Together, this implies that the oncogenic effect of TBX2 might be 
partly explained by downregulation of Mapkapk3 resulting in downregulation of the 
p19ARF/p53 pathway.
 Our results provide a rationale for the frequent loss of pRB in tumors. The second 
part of this thesis is focused on identifying which of the different activities of pRB are 
required for tumor suppression. 
pRB interacts with many cellular proteins, including the family of E2F 
transcription factors, which promote S phase entry and subsequent cell cycle progression. 
Binding of pRB to E2F blocks E2F’s transactivation domain and inhibits transcription 
of E2F target genes, thereby inhibiting S phase entry. In addition to binding E2F, pRB 
can simultaneously bind to proteins containing an LxCxE motif (x encoding any amino 
acid). Since many LxCxE-proteins function in chromatin remodeling and transcriptional 
repression, the pRB-mediated recruitment of such complexes to E2F target sites favors a 
chromatin state incompatible with transcription.
We wondered whether the recruitment of chromatin remodeling proteins by pRB 
is essential for pRB’s tumor suppressor role. To this aim, we made use of a mutant form 
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of pRB, pRBN750F. This mutant protein was impaired in binding proteins containing an 
LxCxE motif, but was still able to inhibit E2F-mediated transactivation. 
First, we analyzed whether ablation of the pRB-LxCxE interaction affected 
the induction of cell cycle arrest in response to growth inhibitory signals, an essential 
component of pRB’s tumor suppressor function. In Chapter 4, we describe that 
RbN750F/N750F MEFs were impaired in arresting in G1 in response to γ-irradiation. 
Additionally RbN750F/N750Fp130-/- MEFs were impaired in arresting in response to RASV12. 
This is in contrast to Rb+/+p130-/- MEFs, which entered RASV12-induced cell cycle arrest 
with similar kinetics as wild-type MEFs. These results demonstrate that the interaction 
between pRB and LxCxE-containing proteins is critical for the induction of cell cycle 
arrest in response to γ-irradiation or expression of RASV12.
Second, we studied whether ablation of the interaction between pRB and LxCxE-
containing proteins promoted oncogenic transformation in mice. Surprisingly, we found 
that RbN750F/N750F mice had a normal lifespan and were not prone to tumorigenesis (Chapter 
5). This is in sharp contrast to Rb+/- mice and Rb-/- chimeras, which were highly prone to 
the formation of tumors in the pituitary and thyroid gland. 
The pRB homologues p130 and p107 can also bind LxCxE-containing proteins 
and might therefore compensate for the ablated pRB-LxCxE interaction in RbN750F/N750F 
mice. Moreover, our previous studies showed that loss of p130 or p107 extended the 
tumor spectrum induced by loss of pRB only. We therefore wondered whether the ablation 
of p130 or p107 in RbN750F/N750F mice would cause increased tumor susceptibility. To this 
aim, we combined p130 or p107 ablation with RbN750F mutation in mice. Strikingly, the 
results showed that the RbN750F/N750Fp130-/- phenotype caused embryonic lethality around 
day 18.5. This suggests that the interaction between pocket proteins and LxCxE-proteins 
is required for embryonic development. 
To study whether RbN750F/N750F mice become prone to tumorigenesis upon 
ablation of p130 or p107, we analyzed mice with three mutated alleles: RbN750F/wtp130-/-, 
RbN750F/N750Fp130+/- and RbN750F/N750Fp107+/- mice. In these animals, RbN750F/N750Fp130-/- 
or RbN750F/N750Fp107-/- cells are expected to arise frequently due to spontaneous loss of 
heterozygosity. Mice with three mutated alleles displayed a reduced survival, which was 
most prominent in RbN750F/wtp130-/- animals. Upon detailed macroscopic and microscopic 
analysis, we were however unable to detect increased tumor formation in these animals. 
In conclusion, the second part of this thesis shows that the interaction between 
pRB and LxCxE-containing proteins was critical for the induction of cell cycle arrest in 
response to γ-irradiation or expression of RASV12. This suggested that the pRB-LxCxE 
interaction contributes to the tumor suppressor function of pRB. However, ablation of 
the pRB-LxCxE interaction did not promote spontaneous tumorigenesis in mice. These 
results suggest that under the tested conditions, inhibition of the transactivation function 
English summary
144
of E2Fs was the dominant mechanism of tumor suppression by pRB. It remains the 
subject of further study to determine whether ablation of the pocket protein-LxCxE 
interaction causes increased tumor susceptibility in response to oncogenic stimuli, such 
as γ-irradiation or expression of RASV12.
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De retinoblastoom eiwitten in tumor suppressie:  
interacterende eiwitten en samenwerkende signaleringsroutes
In een gezond lichaam is er sprake van gereguleerde celdeling. Celdeling is nodig om 
weefsels te vernieuwen of te herstellen wanneer er een beschadiging is opgetreden. Een 
cel ontvangt continu signalen die celdeling stimuleren en tegelijkertijd signalen die 
celdeling remmen. Of en hoe snel een cel deelt wordt bepaald door het totaal van deze 
signalen en door de reactie van de cel op deze signalen. Bij kanker is de natuurlijke 
regulatie van celdeling volledig verstoord. Cellen delen ongecontroleerd en reageren niet 
meer op signalen die normaal gesproken de celdeling remmen en het evenwicht bewaren. 
De celdeling wordt gecontroleerd door twee soorten genen: oncogenen die de 
celdeling stimuleren en tumorsuppressorgenen die de celdeling remmen. Een gen is 
een stukje van het genetisch materiaal van de cel, het DNA, dat codeert voor een eiwit. 
Wanneer er een verandering in een gen optreedt, kan dit er toe leiden dat er een eiwit in 
de cel gevormd wordt dat niet meer normaal functioneert. Om de celdeling volledig te 
verstoren zijn er meerdere veranderingen nodig in oncogenen en tumorsuppressorgenen. 
Dit resulteert erin dat er meerdere eiwitten in de cel aanwezig zijn die niet meer 
functioneren zoals ze dat in de gezonde situatie deden, waardoor de celdeling niet meer 
goed gecontroleerd wordt.
Een belangrijke groep van tumorsuppressorgenen die een essentiële rol spelen 
tijdens het reguleren van celdeling zijn de retinoblastoom genen. Deze coderen voor 
de retinoblastoom eiwitten, pRB, p130 en p107, die ook wel de ‘pocket eiwitten’ 
worden genoemd. Wanneer een cel delingsremmende signalen ontvangt, worden de 
retinoblastoom eiwitten geactiveerd en wordt de celdeling geremd. In bijna alle vormen 
van kanker functioneren de retinoblastoom eiwitten niet meer goed, wat er aan bijdraagt 
dat cellen ongecontroleerd delen.
Om het ontstaan van kanker te bestuderen worden zowel muizen als cellen uit 
muizen gebruikt. In het eerste deel van dit proefschrift zijn cellen uit muizen embryo’s, 
embryonale fibroblast cellen, gebruikt waarin de retinoblastoom eiwitten (gedeeltelijk) zijn 
uitgeschakeld. Wanneer deze cellen in kweek worden gebracht, delen ze ongecontroleerd 
als gevolg van de afwezigheid van de retinoblastoom eiwitten. Ook wanneer in deze 
cellen een grote hoeveelheid RAS eiwit wordt gebracht, blijven de cellen delen. Dit laatste 
is opvallend, aangezien cellen mèt retinoblastoom eiwitten stoppen met delen wanneer 
er veel RAS aanwezig is. RAS is een oncogen, een gen dat het ontstaan van kanker 
bevordert. Door te stoppen met delen beschermt de cel zich tegen de kankerbevorderende 
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eigenschappen van RAS. Als de retinoblastoom eiwitten echter zijn uitgeschakeld, kan 
de cel in een reactie op RAS niet meer stoppen met delen. Hieruit concluderen we dat de 
retinoblastoom eiwitten betrokken zijn bij de bescherming tegen het kankerbevorderende 
eiwit RAS. 
Echter, cellen zónder retinoblastoom eiwitten gedragen zich nog niet als 
kankercellen. Dit blijkt wanneer je de cellen kweekt onder een conditie waarbij ze 
niet kunnen hechten aan een ondergrond. Net als normale cellen stoppen in dit geval 
de cellen zonder retinoblastoom eiwitten met delen. De cellen reageren dus nog steeds 
normaal op het weghalen van hechting, een groeiremmend signaal. Kankercellen kunnen 
onder deze condities daarentegen wèl delen. Hoewel dus ten gevolge van het verlies van 
retinoblastoom eiwitten bepaalde beschermingsmechanismen tegen kanker niet meer 
goed werken, is voor de volledige ontwikkeling tot kankercellen méér nodig. In hoofdstuk 
2 en 3 van dit proefschrift worden genetische veranderingen beschreven die samen met 
het verlies van de retinoblastoom genen ervoor zorgen dat cellen zonder hechting kunnen 
delen en dus een stap verder zijn in de ontwikkeling tot kankercellen.
In hoofdstuk 2 laten we zien dat overexpressie (= de aanwezigheid van een grote 
hoeveelheid) van TBX2 één van deze genetische veranderingen is die ervoor zorgt dat 
cellen zonder retinoblastoom eiwitten kunnen delen in de afwezigheid van een ondergrond 
om aan te hechten. Cellen zonder pRB en p130 (Rb-/-p130-/- fibroblasten), cellen 
zonder pRB en p107 (Rb-/-p107-/- fibroblasten) en cellen zonder pRB en p130 en p107 
(Rb-/-p130-/-p107-/- fibroblasten) kunnen delen in de afwezigheid van hechting wanneer 
zowel TBX2 als RAS tot overexpressie worden gebracht. Wanneer deze cellen met TBX2 
en RAS in muizen worden geïnjecteerd, vormen ze bovendien tumoren. 
TBX2 is een oncogen dat een effect heeft op een grote hoeveelheid andere genen. 
Zo zorgt TBX2 er onder andere voor dat de activiteit van de groeiremmende eiwitroute 
p19ARF/p53/p21CIP1 wordt geremd. In hoofdstuk 2 hebben we getest of het remmen van 
deze route leidt tot hechtingsonafhankelijke groei van cellen zonder retinoblastoom 
eiwitten. Dit blijkt het geval: het remmen van òfwel p19ARF òfwel p53 òfwel p21CIP1 in 
deze cellen zorgt ervoor dat ze kunnen delen in de afwezigheid van hechting. Het feit dat 
het remmen van deze route leidt tot hechtingsonafhankelijke groei kan verklaard worden 
door het effect van deze route op de zogenoemde cycline-afhankelijke-kinases. Deze 
kinases vormen een groep eiwitten die de celdeling juist stimuleren. Door het remmen van 
de p19ARF/p53/p21CIP1 route valt de remming van deze route op de cycline-afhankelijke-
kinases weg en zijn de kinases vrij om de celdeling te stimuleren. 
Samenvattend kan geconcludeerd worden dat cellen zonder retinoblastoom 
eiwitten niet delen in de afwezigheid van een ondergrond om aan te hechten. Het tot 
overexpressie brengen van TBX2 òf het remmen van de p19ARF/p53/p21CIP1 route leidt 
tot het stimuleren van de cycline-afhankelijke-kinases. Dit zorgt ervoor dat de celdeling 
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geïnduceerd wordt en dat de cellen nu wel kunnen delen in de afwezigheid van hechting. 
Dit wijst erop dat de cellen een stap verder zijn in de ontwikkeling naar kankercellen 
en dat deregulatie van de TBX2/p19ARF/p53/p21CIP1 route in combinatie met verlies van 
de retinoblastoom eiwitten belangrijk is voor het ontstaan van kankercellen. Dit wordt 
bevestigd door het feit dat Rb-/-p130-/- cellen die TBX2 en RAS tot overexpressie brengen, 
tumoren vormen wanneer ze in muizen geïnjecteerd worden.
In hoofdstuk 3 beschrijven we een andere genetische verandering die er toe 
leidt dat cellen zonder retinoblastoom eiwitten kunnen delen in de afwezigheid van 
een ondergrond om aan te hechten. We hebben gevonden dat remming van de p38/
Mapkapk3 signaleringsroute cellen zonder retinoblastoom eiwitten stimuleert tot 
hechtingsonafhankelijke groei. Opvallend genoeg vinden we in hoofdstuk 3 dat TBX2 
een effect heeft op Mapkapk3: in aanwezigheid van TBX2 wordt Mapkapk3 onderdrukt 
(Mapkapk3 wordt ‘uitgezet’). Recente experimenten door anderen laten zien dat 
Mapkapk3 bovendien een effect heeft op p19ARF, een onderdeel van de p19ARF/p53/p21CIP1 
route. Dus wellicht draagt het effect van TBX2 op Mapkapk3 en vervolgens op de p19ARF/
p53/p21CIP1 route bij aan het feit dat TBX2 hechtingsonafhankelijke groei, en dus kanker, 
stimuleert.
Het verlies van de retinoblastoom eiwitten, pRB, p130 en p107, draagt bij aan het ontstaan 
van kanker. Het tweede deel van dit proefschrift is gericht op de vraag welke van de 
specifieke functies van het pRB eiwit nodig is voor het onderdrukken van kanker. Dit 
eiwit kan met zeer veel verschillende eiwitten een interactie aangaan, o.a. met de E2F 
transcriptiefactoren, maar ook met eiwitten met een zogenoemd LxCxE motief die een 
belangrijke rol spelen bij de structuur van het chromatine (=  het complex van DNA en 
eiwitten). Het effect en de significantie van vele van deze interacties is echter tot nog 
toe onduidelijk. Een complex bestaande uit pRB, een LxCxE-eiwit en een E2F eiwit, 
kan binden aan het DNA. Het LxCxE-eiwit zorgt vervolgens voor een meer ‘gesloten’ 
secundaire structuur van het DNA. Dit heeft tot gevolg dat een gen, dat ligt op de plek 
waarop het complex gebonden is, minder efficiënt kan worden afgelezen voor de vorming 
van een eiwit. Met andere woorden, de pRB-LxCxE interactie zorgt voor langdurige 
remming van de eiwitproductie van bepaalde genen. 
Hoofdstuk 4 beschrijft het effect van het verbreken van de interactie tussen pRB 
en eiwitten met een LxCxE motief op de capaciteit van pRB om de celdeling te remmen. 
Hiertoe hebben we gebruik gemaakt van een veranderde vorm van pRB, namelijk 
pRBN750F. In tegenstelling tot het onveranderde pRB eiwit (wild-type pRB), kan pRBN750F 
geen interactie aangaan met eiwitten die het LxCxE motief bevatten. Daarentegen is de 
interactie van pRBN750F met de E2F eiwitten intact gebleven.
 Uit de experimenten is gebleken dat in tegenstelling tot cellen met wild-type 
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pRB, cellen met pRBN750F niet goed kunnen stoppen met delen wanneer ze behandeld 
worden met γ-straling. Verder is gebleken dat cellen met pRBN750F waarin bovendien p130 
is uitgeschakeld, niet goed kunnen stoppen met delen wanneer er een grote hoeveelheid 
RAS in de cel wordt gebracht. Zoals hierboven beschreven wordt het stoppen met delen 
in reactie op RAS gezien als een beschermingsmechanisme tegen de kankerbevorderende 
eigenschappen van RAS. Samengevat laat hoofdstuk 4 zien dat het verbreken van de 
interactie tussen pRB en eiwitten met een LxCxE motief leidt tot een verminderde 
bescherming tegen signalen die kanker kunnen stimuleren, zoals γ-straling en het RAS 
oncogen.
In hoofdstuk 5 analyseren we het effect van het verbreken van de pRB-LxCxE 
interactie op de vorming van kanker in muizen. Hiertoe hebben we muizen gemaakt 
die alleen het mutante pRBN750F eiwit kunnen maken. Verassend genoeg hebben deze 
RbN750F/N750F muizen een normale levensduur en vinden we geen verhoogde ontwikkeling 
van kanker in deze muizen. Aangezien de familieleden van pRB (p130 en p107) zouden 
kunnen compenseren voor de afwezigheid van de pRB-LxCxE interactie, hebben we in 
de muizen met het pRBN750F eiwit ook p130 of p107 (gedeeltelijk) uitgeschakeld. Deze 
dieren hebben wel een verkorte levensduur, maar ook hier vinden we geen aanwijzingen 
voor een verhoogde ontwikkeling van kanker. Uit het tweede deel van dit proefschrift 
kunnen we concluderen dat het verbreken van de interactie tussen pRB en LxCxE-eiwitten 
bepaalde beschermingsmechanismen tegen kanker uitschakelt. Desalniettemin hebben 
we geen aanwijzingen gevonden voor een verhoogde spontane kankerontwikkeling in 
muizen met een verbroken pRB-LxCxE interactie. Echter, het is zeer goed mogelijk dat 
onder specifieke omstandigheden, bijvoorbeeld in combinatie met andere genetische 
veranderingen of na bestraling, muizen met een verbroken pRB-LxCxE interactie wel 
gevoeliger zijn voor kanker. 
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Nou, daar is ie dan, mijn proefschrift!
Tijdens de lange weg hiernaartoe hebben mensen me regelmatig gevraagd waarom ik 
toch altijd tot ’s avonds laat en in het weekend op het NKI zat en of ik daar niet helemaal 
gek van werd. Tegen de tijd dat ik avonden en weekenden aan het lay-outen was, heb ik 
deze vraag trouwens niet meer gekregen, dus ik vrees dat mijn omgeving het opgegeven 
heeft…. Toch ging ik zelden met tegenzin naar het NKI. Dat kwam voor een groot deel 
omdat het altijd (ja zelfs in het weekend!) zo gezellig en inspirerend was! Daarom wil ik 
hier al mijn collega’s bedanken voor de collegialiteit en voor alle leuke momenten!
Maar allereerst bedank ik natuurlijk jou, Hein, voor het gestelde vertrouwen in 
mij. Ik vond het altijd knap hoe je via het stellen van vragen, het gedachteproces een 
andere kant op probeerde te krijgen om tot nieuwe inzichten te komen. Ongelofelijk hoe 
je met zoveel verschillende onderwerpen in de groep, altijd weer een interessante vraag 
weet te stellen of inzicht weet te brengen! Ook je filosofische kijk op de dingen was vaak 
verrassend, en je rust om een hele middag alle discussiepunten van een project door te 
nemen vond ik altijd erg positief.
 Dan mijn drie (!) paranimfen Elske, Tanja en Angela, wat leuk dat jullie naast 
me willen staan! Elske, vanaf het eerste college in Wageningen hebben we onze studie- 
en promotietijd samen gedeeld, en ik ga ervan uit dat we in de toekomst nog veel meer 
dingen te delen hebben! Of we elkaar nu veel of weinig zien, het gevoel is altijd hetzelfde, 
wat toont hoe goed we elkaar kennen en hoezeer we onszelf zijn als we elkaar spreken. 
Bedankt voor je vriendschap en ik hoop dan ook echt dat je er 26 november bij kunt zijn! 
Angela, ik ben blij dat ook jij mijn paranimf wilt zijn, en ik zal het erg leuk vinden als je 
op die dag naast me staat! Fijn dat we de promotieperikelen hebben kunnen delen, en dat 
we ook altijd over andere zaken kunnen bijkletsen. 
Tanja, jouw komst naar het NKI heeft er voor gezorgd dat ik het onderzoek weer 
een stuk leuker ging vinden! Nadat Floris naar Boston was gegaan, vond ik het erg saai 
om als enige in de groep aan pRB te werken en jouw komst heeft me zeker opgevrolijkt. 
Helaas heb ik jou daarna als enige pRB-er achtergelaten…. Ik vond het erg leuk om 
samen over resultaten en papers te discussiëren en daarnaast hebben we ook heel wat 
andere dingen besproken. En geloof me, ik heb jouw humoristische directheid altijd erg 
handig en grappig gevonden! In bepaalde situaties (bv als mensen me vragen of ik op de 
fiets ben, of als ik uit moet leggen dat ik om 8 uur ’s ochtends de celkweek schoonmaken 
toch echt een slecht idee vind) denk ik met een glimlach aan jouw commentaar dat hier 
ongetwijfeld op gevolgd zou hebben! Bedankt voor de leuke tijd!
Marieke, we hebben inderdaad heel wat afgekletst in de celkweek! We hebben 
lang samen op het NKI gezeten en hebben wel het een en ander aan ups en downs gedeeld. 
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Jammer dat ik je via de Thai weer hielp herinneren aan waar je allergisch voor bent… 
En trouwens, ik snap nog steeds niet hoe jij op een feestje later wegging dan ik, en de 
volgende ochtend alweer fris en fruitig proeven aan het doen was! 
Eva, ik vind het een eer dat ik maar liefst twee keer een chocoladetaart op mijn 
bureau vond! Het gebaar maakte uiteraard mijn dag goed, en dan waren ze natuurlijk ook 
nog eens héééél erg lekker. Als ik een recept zie, denk ik nog regelmatig, ‘tja het lijkt me 
erg veel gedoe, maar Eva zou er vast niet voor terug schrikken!’ Dank voor je gezelligheid 
en luisterend oor, en ik wens je natuurlijk veel succes bij het afronden van je proefschrift.
Sietske, ook wij hebben heel wat besproken in de kweek en ook het doen van 
honderden staart-PCRs schept een band! Je betrokkenheid, zowel werkgerelateerd als 
prive, heb ik altijd erg gewaardeerd. Succes met het schrijven van je proefschrift!
Rob, jij als AMC-er die naar het NKI ging, en ik als NKI-er die naar het AMC 
ging, konden heel goed samen ervaringen uitwisselen! Ook was je een goede adviseur 
bij problemen op het lab, en jouw suggestie om survival curves in sigmaplot te maken, 
maakte mijn leven een stuk aangenamer!
Camiel, we zaten zowel op de kamer als op het lab naast elkaar, en ik vind het 
leuk dat we jouw screens en mijn cellen hebben kunnen combineren! Als ik Fokke en 
Sukke voorbij zie komen, hoor ik in gedachten jouw gegrinnik naast me!
Anja, wat een heftige jaren zijn het geweest! We hebben heel wat gedeeld, 
zowel op het werk als privé. Bedankt voor alle organisatorische zaken op het lab, het 
muizenwerk, je bereidheid om bij te springen als het nodig was, en voor het geven van 
peptalks wanneer ik het niet meer zag zitten. Ik vrees dat ik het vaker zeg, maar het wordt 
tijd dat we weer eens wat gezelligs gaan doen!
Elly, jouw humoristische verhalen zorgden altijd voor een vrolijke noot! Bedankt 
voor het zorgen voor de muizen, het organiseren van alle kruisingen, en voor je coulance 
wanneer die muizen van mij toch nog niet weg mochten (want wie weet zouden we ze 
later eventueel misschien toch nog nodig kunnen hebben!). Tja, wat er nou mis was met 
die mottige kwakkel muizen, weten we helaas nog steeds niet! 
Marleen en Sandra, wie had nu gedacht dat jullie pRB proefjes voor me zouden 
gaan doen? Jullie volgens mij niet, maar jullie waren wel de redder in de nood! Wel 
jammer Marleen, dat je, zoals je zelf ooit zei, jouw geluk niet op het project hebt kunnen 
overbrengen! Ik hoop dat ik je niet al te erg geïrriteerd heb met het laten rondslingeren 
van troep, de vele lades met spullen die toch echt niet weggegooid mochten worden en 
waar ik tegelijkertijd geen tijd voor had om uit te zoeken, en het te laat schoonmaken van 
de stoof… Bedankt allebei voor jullie betrokkenheid en natuurlijk voor alle gezelligheid!
Floris, jouw eeuwige enthousiasme voor de wetenschap heb ik altijd erg 
motiverend gevonden. Vooral toen je weg was realiseerde ik me hoe saai het was om jouw 
visie te moeten missen op een arrest van de cellen of op een dubbele band op een blot 
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(weet je nog, die RAS blot die ik helemaal in het begin gedaan heb?) waar we volgens 
jou toch echt wel een Nature paper van zouden kunnen brouwen! Helaas dus…. Ook als 
ik je iets over de mail stuurde had je altijd enthousiast en opbeurend commentaar, dank 
hiervoor.
Jacob, I started my time at NKI under your supervision, and I couldn’t have 
wished for a better supervisor! I learned a lot from you on how to set up experiments and 
of course about pRB. Your enthusiastic comments on results or papers in the field were 
always motivating. I wish you good luck in personal life and of course in science.
Marije, we zijn samen aan het project begonnen maar hebben het helaas niet 
samen afgemaakt. Leuk dat je weer in de wetenschap werkt en het zou leuk zijn als we 
samen met Camiel nog wat van het Mapkap verhaal kunnen maken!
Jan-Hermen, jouw proefschrift heeft heel vaak binnen handbereik op mijn bureau 
gelegen! Ik ben blij dat je weer terug was op het NKI toen ik met de Rb750 mutant bezig 
was, en ik je kon lastigvallen met vragen over hoe je die TKO proeven destijds nu precies 
gedaan had. Leuk dat je in de commissie zit!
Mijn studenten, Judith en David, wil ik bedanken voor het analyseren van een 
hele berg soft agar kolonies, niet het meest dankbare werk… 
En dan zijn er natuurlijk nog de Wolthuisjes; Rob, Wouter, Linda, Erik, Bas en 
Janneke, die voor een hoop levendigheid zorgden op het lab en die altijd klaar stonden om 
advies te geven over blots en IPs, of om de geheimen van Mitose nog eens te benadrukken! 
Ook de groepen van Jos Jonkers, Piet Borst en in de H8-tijd René Medema, zorgden altijd 
voor de nodige gezelligheid en interactie. En niet te vergeten de groep van Daniel Peeper, 
waar ik helemaal in het begin van Theo het shuttelen leerde, en wat later mijn eerste stop 
werd op een ‘shop-ronde’ wanneer ik op zoek was naar antilichamen of constructen. 
Tom en Linda, bedankt voor de organisatorische zaken, het was altijd gezellig 
om even langs te lopen! Frank en Anita wil ik bedanken voor al het FACS advies, Lauran 
en Lenny voor de hulp bij het fotograferen van celkweek-platen, en Minze en Erwin 
voor het opslaan en organiseren van alle cellen. Wat ben ik blij dat ik dat niet hoefde 
te doen! Ji-Ying en Martin, bedankt voor de pathologische analyse. Ji-Ying, thanks for 
looking through an enormous amount of slides and for your enthusiastic involvement in 
the project. En natuurlijk alle medewerkers van het muizenhuis voor het verzorgen en 
controleren van de muizen!
Also, I would like to thank my new colleagues at the AMC for listening 
to my stories and complains about lay-outing, thesis printing and planning a date 
for the defence. After a period of ´solitary confinement’ to write my thesis, I was 
very relieved to be able to share scientific and non-scientific things with you! 
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Harriet en Victor, bedankt voor de dansinspiratie en het voorkomen van tunnelvisie! 
 Stefanie, bedankt voor het jarenlange aanhoren van mijn verhalen, waarvan ik 
vrees dat ze met de jaren steeds langer en klaaglijker werden… En natuurlijk voor alle 
gezelligheid en voor het feit dat je me voorzien hebt van een groot aantal maaltijden, 
waarbij je nooit boos werd dat ik weer eens (veel te) laat was omdat die proef toch weer 
wat langer duurde dan ik had gedacht….
Suzanne, bedankt voor de mooie cover die je voor me gemaakt hebt! Ik vond 
het leuk om mijn onderzoek aan je uit te leggen en om samen te brainstormen over een 
manier om dit symbolisch weer te geven. 
Frizo, mijn lieve broer, wat fijn dat je altijd zo met me meeleeft. Je weet altijd 
verstandige adviezen te geven waar ik van opknap en je laat me ook vaak dingen inzien 
die ik zelf niet zag. Veel geluk met Vanessa en Femka Amelie, en ik kom jullie zeker 
stalken in Australië! Jammer van de afstand, maar ik denk wel dat we ons daardoor beter 
realiseren hoe goed onze band is!
Lieve pap en mam! Wat had ik zonder jullie moeten beginnen? Tijdens het 
schrijven van dit dankwoord realiseer ik me dat hoe meer mensen voor me betekenen, 
hoe moeilijker het is om iets pakkends te schrijven, want waar zal ik eens beginnen? Bij 
het aanhoren van mijn verhalen, het meedenken over problemen, het personal-assistent-
aspect, de gezelligheid? Jullie hebben me altijd gesteund en gezelligheid gebracht. Dank 
voor al jullie liefde en steun door de jaren!
Tinke


